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ABSTRACT 
Curcuminoids are plant phenolic compounds with great anti-cancer potential. This thesis 
addresses the construction of an artificial biosynthetic pathway for curcuminoids 
production in Escherichia coli. This production was triggered by chemical or thermal 
induction to be used in industrial applications or bacterial therapies, respectively.  
To produce curcuminoids, including curcumin, from tyrosine, caffeic acid was produced 
as an intermediate in the pathway. The caffeic acid pathway design included tyrosine 
ammonia lyase (TAL) from Rhodotorula glutinis to convert tyrosine to p-coumaric acid 
and 4-coumarate 3-hydroxylase (C3H) from Saccharothrix espanaensis or cytochrome 
P450 CYP199A2 from Rhodopseudomonas palustris to convert p-coumaric acid to 
caffeic acid. TAL was able to efficiently convert tyrosine to p-coumaric acid and 
CYP199A2 exhibited higher catalytic activity towards p-coumaric acid than C3H. This is 
the first study that shows caffeic acid production using CYP199A2 and tyrosine as the 
initial precursor; 280 mg/L of caffeic acid was produced.  
After validating the first steps of the pathway, curcuminoids production was studied. The 
best results were obtained with Arabidopsis thaliana 4-coumaroyl-CoA ligase (4CL1) and 
Curcuma longa diketide-CoA synthase (DCS) and curcumin synthase (CURS1), yielding 
70 mg/L of curcumin from ferulic acid. To produce curcumin through the caffeic acid 
pathway, caffeoyl-CoA O-methyltransferase from Medicago sativa was used to convert 
caffeoyl-CoA to feruloyl-CoA. Using caffeic acid, p-coumaric acid or tyrosine as a 
substrate, 3.90 mg/L, 0.26 mg/L and 0.20 mg/L of curcumin were produced, respectively. 
Finally, caffeic acid and curcumin production was induced by heat using the dnaK heat 
shock promoter. Caffeic acid was successfully produced from tyrosine using TAL, C3H 
or CYP199A2 and the highest production was 14.41 mg/L. Regarding curcumin, 0.37 
mg/L was produced from ferulic acid using 4CL1, DCS and CURS1.  
This is the first report on the in vivo use of DCS and CURS1 to produce curcuminoids. It 
was also demonstrated that curcumin can be produced from tyrosine using a pathway 
through the caffeic acid production. This alternative pathway represents a significant 
improvement in the heterologous production of curcuminoids using E. coli. In addition, 
caffeic acid and curcumin production in E. coli can be triggered by heat, thus suggesting 
its potential for the development of new bacterial therapies. 
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SUMÁRIO 
Os curcuminóides são compostos fenólicos de plantas com grande potencial anti-
cancerígeno. Esta tese aborda a construção de uma via biossintética para a produção 
artificial de curcuminóides em Escherichia coli. Esta produção foi induzida por via 
química ou térmica para ser usada em aplicações industriais ou em terapias bacterianas. 
Para produzir os curcuminóides, incluindo a curcumina, a partir da tirosina, o ácido 
cafeico foi produzido como intermediário na via. A via do ácido cafeico incluiu a tirosina 
amónia liase (TAL) da Rhodotorula glutinis para converter a tirosina em ácido p-
cumárico e o 4-cumarato 3-hidroxilase (C3H) da Saccharothrix espanaensis ou o 
citocromo P450 CYP199A2 da Rhodopseudomonas palustris para converter o ácido p-
cumárico em cafeico. TAL foi capaz de converter de forma eficiente a tirosina em ácido 
p-cumárico e CYP199A2 exibiu uma maior actividade catalítica em relação ao ácido p-
cumárico do que C3H. Este é o primeiro estudo que mostra a produção de ácido cafeico 
utilizando CYP199A2 e a tirosina como precursor; tendo sido produzidos 280 mg/L. 
Depois de validar os primeiros passos da via, os curcuminóides foram produzidos. Os 
melhores resultados foram obtidos com a 4-cumaroil-CoA ligase (4CL1) da Arabidopsis 
thaliana e com a dicetídeo-CoA sintase (DCS) e curcumina sintase 1 (CURS1) da 
Curcuma longa e 70 mg/L de curcumina foram produzidos a partir do ácido ferúlico. Para 
produzir curcumina pela via do ácido cafeico, a cafeoil-CoA O-metiltransferase da 
Medicago sativa foi utilizada para converter o cafeoil-CoA em feruloil-CoA. Utilizando o 
ácido cafeico, o ácido p-cumárico e a tirosina como substrato, 3.90 mg/L, 0.26 mg/L e 
0.20 mg/L de curcumina foram produzidos, respectivamente. 
Finalmente, a produção de ácido cafeico e de curcumina foi induzida por calor utilizando 
o promotor de choque térmico dnaK. O ácido cafeico foi produzido com sucesso usando 
TAL, C3H ou CYP199A2 e a sua maior produção foi de 14,41 mg/L. Em relação à 
curcumina, foram produzidos 0,37 mg/L usando 4CL1, DCS e CURS1. 
Este é o primeiro estudo sobre a utilização in vivo de DCS e CURS1 para produzir 
curcuminóides. A curcumina foi também produzida pela primeira vez a partir da tirosina 
usando a via de produção de ácido cafeico. A produção de ácido cafeico e de curcumina 
pode também ser despoletada por calor, sugerindo assim o seu potencial para o 
desenvolvimento de novas terapias bacterianas. 
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CHAPTER 1 
General Introduction 
 
 
Curcuminoids are phenolic compounds extracted from turmeric known for their 
therapeutic properties, including anticancer. This thesis addresses the construction of an 
artificial biosynthetic pathway for the production of curcuminoids in E. coli. This 
production can be triggered by chemical or thermal induction and can be used for 
industrial applications, although the focus of this study is its potential future use as a 
therapeutic approach. Conceptually, curcuminoids can be used in bacterial therapies 
triggered by ultrasound or laser therapies that increase cellular temperature. Since the 
curcuminoids have a poor bioavailability, this in situ production would be advantageous 
for the use of these compounds in treatments. 
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1.1 Context and Motivation 
Cancer is the leading cause of mortality worldwide. According to recent studies, it is 
predicted that the diagnosis of new cancer cases will increase from 14 million to 22-25 
million and cancer deaths from 8.2 million in 2012 to 13 million in 2032 (Bender, 2014; 
Bray et al., 2012; Stewart and Wild, 2014). Breast cancer is the most common cancer 
diagnosis in women and the second leading cause of cancer death, preceded only by lung 
cancer (Siegel et al., 2014). Despite all the scientific advances that humankind has seen 
over the last centuries, there are still no clear and defined solutions to diagnose and treat 
cancer. In this sense, the search for innovative and efficient solutions continues to drive 
research and investment in this field, whether searching for new biomarkers, drugs or 
treatments (Duarte et al., 2014; Francisco et al., 2013; Gudiña et al., 2013; Rodrigues et 
al., 2009; Rodrigues et al., 2007). Ultrasound and laser therapy are two of the techniques 
often used to treat breast solid tumors. However, these techniques are not always 
successful, as sometimes they just heat the tumor without destroying it. If these 
treatments could be linked with the expression/release of a therapeutic agent, the 
combination could be more effective. Some efforts have been made in this direction, 
although to date the results have not been very encouraging; potential reasons include the 
lack of precise control over administration of the drug. Therefore, the purpose of this 
thesis was to overcome this barrier using synthetic biology strategies to engineer a model 
bacterium to trigger the release of a therapeutic agent concurrent with temperature 
increase, as a consequence of laser therapy and/or ultrasound treatment. 
The concept behind this thesis is that the therapeutic agent can be synthesized and 
released when exposed to heat by making use of the existing heat shock response (HSR) 
machinery from Escherichia coli. By cloning the genes of interest under the control of E. 
coli heat shock promoters that are temperature sensitive, gene expression is triggered in 
situ. Curcuminoids, due to their recognized therapeutic properties, were chosen to 
demonstrate the proof-of-concept that the production of a therapeutic agent in E. coli can 
be triggered by temperature increase. In the future, this strategy can allow bacterial 
therapies to be used in combination with ultrasound and laser therapies. Curcuminoids are 
phenolic compounds produced from the rhizome of Curcuma longa that are known for 
their anticancer, antioxidant, anti-inflammatory and antimicrobial properties (Prasad et 
al., 2014). Most studies were carried out with curcumin, which is the major curcuminoid 
4 | Chapter 1 
(Aoki et al., 2007; Dhillon et al., 2008; Liu and Chen, 2013; Yallapu et al., 2013). 
Although curcumin has attractive properties, it is well known that it has poor 
bioavailability. Cellular uptake is slow, and it is quickly metabolized into poorly active 
metabolites, requiring repetitive oral doses to achieve sufficient concentration inside the 
cells for therapeutic activity (Anand et al., 2007; Ireson et al., 2001; Lin et al., 2001; Pan 
et al., 1999). Hence, the possibility of synthesizing curcumin and other curcuminoids in 
situ in a controlled way, as proposed in this thesis, would provide a powerful alternative 
to the oral administration of those compounds.  
The model bacterium chosen was E. coli since it has several advantages over other 
possible hosts such as its low cost, simplicity, fast cultivation, extensive genetic 
knowledge and large number of compatible molecular biology tools available (cloning 
vectors and mutant host strains commercially available). In addition, E. coli presents a 
heat shock response above 42 ºC which is supposedly similar to the temperature reached 
by the normal cells surrounding the tumor tissue after it is subjected to an ultrasound or 
laser treatment. Also, curcuminoids production by this bacterium has been studied before 
(Katsuyama et al., 2010a; Katsuyama et al., 2009a; Katsuyama et al., 2009b; Katsuyama 
et al., 2007c; Katsuyama et al., 2008), and these data provided a starting point for the 
development of the pathway and its further optimization. Although curcumin and other 
curcuminoids have been synthesized in vitro and in vivo, curcumin (the most studied 
curcuminoid for therapeutic purposes) has only been produced from the precursor ferulic 
acid (in vivo) or feruloyl-CoA (in vitro), starter substrates that are not naturally produced 
by E. coli. Natural precursors would be essential to achieve the final goal of using 
therapeutic bacteria in the treatment of breast or other cancer. In this thesis, a biosynthetic 
pathway is proposed that allows the use of tyrosine, an amino acid produced 
endogenously by E. coli, to produce the three major curcuminoids from C. longa, 
bisdemethoxycurcumin, demethoxycurcumin and the most important of them, curcumin. 
Unlike the other pathways described before, this pathway synthesizes caffeic acid as an 
intermediate that after two enzymatic steps is converted to feruloyl-CoA, the substrate 
needed to produce curcumin. Caffeic acid production itself can be advantageous since this 
compound has also been reported to have anticancer properties (Prasad et al., 2011). 
Curcumin is produced from tyrosine after seven enzymatic steps performed by five or six 
enzymes. Although endogenous tyrosine produced by E. coli may not be sufficient for  
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curcuminoids production, there is always the possibility of increasing it (Juminaga et al., 
2012).  
 
1.2 Research Aims 
The overall purpose of this thesis was to achieve the proof-of-concept that by using 
synthetic biology strategies a model bacterium can be engineered to trigger the release of 
a therapeutic agent concurrent with temperature increase. The goal was to engineer the 
existing HSR machinery from E. coli to trigger the synthesis and release of curcuminoids 
in situ according to the specific aims as follows: 
1. Design, construction and optimization of the several enzymatic steps involved in 
the biosynthesis of curcuminoids in E. coli using different genetic engineering 
strategies.  
2. Assessment of the most expressed heat shock genes in E. coli at different 
temperature exposures. Selection and validation of the strongest heat shock promoters 
in E. coli by RT-qPCR and through the construction of a stress probe using an 
adequate reporter gene.  
3. Validation of the intermediate metabolites and curcuminoids production by E. coli 
using heat shock induction. 
 
1.3 Outline of the Thesis  
This thesis was structured in eight chapters that cover the research aims stated above: 
- The context and motivation of this thesis and the research aims are presented in 
the current chapter (Chapter 1). The structure of the thesis is also outlined. 
- Chapter 2 concerns the literature review that starts with a general overview of 
curcuminoids therapeutic properties and natural production. Heterologous production of 
curcuminoids and pathway optimization were subsequently reviewed and discussed 
thoroughly. 
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The different sections of Experimental Results are presented from Chapter 3 to 
Chapter 6. In each chapter a brief introduction, materials and methods, results, 
discussion and conclusions is given. 
- In Chapter 3 the results concerning caffeic acid production in E. coli are 
reported. Caffeic acid was produced from tyrosine or p-coumaric acid and several 
combinations of plasmids and genes were tested. Caffeic acid production was studied and 
optimized since its biosynthetic pathway can be included in the first steps of 
curcuminoids biosynthetic pathway. 
- Curcuminoids production in E. coli from different precursors is described in 
Chapter 4. Different enzymes for each enzymatic step were studied and different plasmid 
combinations were used. First, curcuminoids production was studied using 
hydroxycinnamic acids (caffeic acid, p-coumaric acid and ferulic acid) as substrates. The 
titers of the three different curcuminoids produced (bisdemethoxycurcumin, 
demethoxycurcumin and curcumin) were determined by HPLC. Curcuminoids production 
from tyrosine through a six step enzymatic biosynthetic pathway is also described. In 
addition to shake flask production, bioreactor production of curcumin is also reported. 
- In Chapter 5 the HSR of E. coli was studied. The strongest heat shock 
promoters were identified using microarray experiments. After an extensive discussion of 
different promoters’ strength, three heat shock promoters were selected and validated by 
RT-qPCR. The construction and characterization of stress probes using green fluorescent 
protein is also described. The evaluation and optimization of the ribosome binding site 
strength of these probes using computational tools are also shown. 
- One of the strongest promoters identified in the previous chapter was used in 
Chapter 6 to demonstrate that E. coli heat shock promoters can be used in synthetic 
biology approaches to reprogram organisms and trigger the expression of novel 
biosynthetic pathways. The heat shock promoter described before was used to induce 
caffeic acid or curcumin expression in E. coli by heat. Different plasmids, gene 
combinations and ribosome binding sites were tested to optimize production. In this 
chapter the possible use of temperature increase to trigger in situ bacterial therapies is 
also discussed.  
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- Chapter 7 contains the concluding remarks and perspectives for further research 
in this topic. 
- Finally, Chapter 8 gathers all the key references used in this work. 
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CHAPTER 2 
Literature Review 
 
Curcuminoids, components of the rhizome of turmeric, show several beneficial biological 
activities including anticarcinogenic, antioxidant, anti-inflammatory and antitumor 
activities. Despite their uncountless pharmaceutical important properties, the low natural 
abundance of curcuminoids represents a major drawback for their use as therapeutic 
agents. Therefore, they represent attractive targets for heterologous production and 
metabolic engineering. The understanding of curcuminoids biosynthesis in turmeric made 
remarkable advances in the last decade and as a result, several efforts to produce them in 
heterologous organisms have been reported. The artificial biosynthetic pathway (e.g. in 
Escherichia coli) can start with the supplementation of the amino acids tyrosine or 
phenylalanine or with carboxylic acids and lead to the production of several natural 
curcuminoids. Unnatural carboxylic acids can also be supplemented as precursors and 
lead to the production of unnatural compounds with possible novel therapeutic properties. 
In this chapter, the natural conversion of curcuminoids in turmeric and its production by 
E. coli using an artificial biosynthetic pathway was reviewed. In addition, the potential of 
other enzymes to increase curcuminoids yield and activity – either discovered recently, or 
already used in other similar biosynthetic pathways, like flavonoids and stilbenoids – is 
explored. 
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2.1 Introduction 
Curcuminoids are polyphenolic compounds, more specifically diarylheptanoids (C6-C7-
C6), isolated from the rhizome of turmeric (Curcuma longa Linn.) that gives it its yellow 
colour (Jayaprakasha et al., 2005). These compounds have been used in traditional 
medicine and as food additives, especially as a curry spice, preservative, coloring (E100) 
and flavoring agent in Asian countries such as China and India (Sharma et al., 2005; 
Tayyem et al., 2006). The rhizome of turmeric contains a mixture of curcuminoids 
wherein curcumin, also known as diferuloyl-methane, is the main active chemical 
constituent (Srinivasan, 1953). Other curcuminoids present in such mixtures include 
demethoxycurcumin and bisdemethoxycurcumin. Curcuminoids are abundantly present in 
C. longa but also occur in other Curcuma species. However, since different Curcuma 
species are difficult to distinguish due to their similar morphologies and their different 
names given in Latin and by Japanese, Chinese and Indian cultures, pharmacological 
studies are very scarce (Tohda et al., 2006). Nevertheless, curcumin, and in some cases 
bisdemethoxycurcumin and demethoxycurcumin, have also been isolated from Curcuma 
mangga (Abas et al., 2005; Malek et al., 2011), Curcuma xanthorrhiza (Ruslay et al., 
2007; Uehara et al., 1987), Curcuma zedoaria (Lobo et al., 2009; Syu et al., 1998), 
Curcuma phaeocaulis (Tohda et al., 2006), Curcuma aromatica (Tohda et al., 2006) and 
other species like Etlingera elatior (Mohamad et al., 2005). Other type of complex 
curcuminoids, cassumunin and cassumunarin, were isolated from Zingiber cassumunar 
(Masuda and Jitoe, 1994; Masuda et al., 1995). Curcuminoids, depending on the cultivar, 
constitute 2-4% of dry weight of the rhizome (Bagchi, 2012; Ravindran et al., 2007; 
Tayyem et al., 2006). The commercial grade curcumin is isolated from the powdered dry 
rhizome of C. longa and consists of a mixture of curcumin (~77%), demethoxycurcumin 
(~18%) and bisdemethoxycurcumin (~5%) (Aggarwal et al., 2003; Goel et al., 2008). 
Generally, the term curcumin is used to represent all the three curcuminoids found in the 
turmeric extract.  
 
2.1.1 Curcuminoids “Biological” Relevance 
Curcumin was discovered and isolated almost two centuries ago by Vogel and Pelletier 
(1815); however, its biological properties were not identified until the middle of the 20
th
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century when Schraufstätter and Bernt (1949) reported its antibacterial activity. Since 
then, the biosynthesis and properties of curcumin and other curcuminoids have attracted 
much interest from the scientific community. Besides antibacterial potential (Kim et al., 
2003; Negi et al., 1999; Reddy et al., 2005), these compounds present several properties 
that are beneficial to human health (Table 2.1). Therapeutic properties of curcuminoids 
have been reviewed in several papers (Aggarwal et al., 2003; Aggarwal and Sung, 2009; 
Bisht et al., 2010; Goel et al., 2008; Liu and Chen, 2013; Prasad et al., 2014; Sharma et 
al., 2005; Shimatsu et al., 2012; Strimpakos and Sharma, 2008).   
Even though curcumin, demethoxycurcumin and bisdemethoxycurcumin have been 
extensively studied, it has not been completely elucidated if the three analogues exhibit 
equal therapeutic activity. Also, although curcumin was found to be most potent/active in 
some systems (Ahsan et al., 1999), in other cases it was concluded that the activity of the 
three analogues is very similar (Sreejayan and Rao, 1997), while in other systems 
bisdemethoxycurcumin was found to exhibit the highest cytotoxic activity (Anto et al., 
2002; Ruby et al., 1995; Syu et al., 1998; Thapliyal and Maru, 2001). Furthermore, the 
mixture of all three curcuminoids has been suggested to have a more effective 
bioprotectant activity than any one alone due to synergistic effects (Majeed et al., 2002).  
 
 
Table 2.1. Some of the therapeutic applications of curcumin/curcuminoids. 
Biological 
activities 
Therapeutic effects References 
Anticancer 
- suppress cancer cells proliferation – inhibit nuclear 
transcription factor кB (NF-кB) and consequently 
downregulate NF-кB-regulated gene products such as 
cyclooxygenase-2 (COX-2) protein and other proteins that 
are associated with carcinogenesis, tumor initiation, 
promotion and metastasis in a wide variety of cancers 
- induce apoptosis (programmed cell death type I) - by 
activation of caspase-8, BH3 interacting-domain death 
agonist cleavage, cytochrome c release and down-regulation 
of Bcl-2 expression 
- induce autophagy (programmed cell death type II) - 
regulated by simultaneous inhibition of the 
Akt/mTOR/p70S6K pathway and stimulation of the ERK1/2 
pathway 
(Anto et al., 2002; 
Anuchapreeda et al., 2008; 
Aoki et al., 2007; Bharti et 
al., 2003; Dhillon et al., 
2008; Kuttan et al., 1985; 
Ruby et al., 1995; Singh and 
Aggarwal, 1995; Skommer 
et al., 2006; Yallapu et al., 
2013; Yallapu et al., 2010) 
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Table 2.1. Some of the therapeutic applications of curcumin/curcuminoids (continuation). 
Biological 
activities 
Therapeutic effects References 
Cholesterol-
lowering 
- decrease low-density lipoprotein cholesterol, total 
cholesterol and triglycerides and raise high-density 
lipoprotein or good cholesterol 
- up-regulate cholesterol 7a-hydroxylase (CYP7A1), a rate 
limiting enzyme in the biosynthesis of bile acid from 
cholesterol in liver that is involved in the decrease of 
cholesterol. This induction of CYP7A1 increases the 
conversion of cholesterol into bile acids and its excretion 
(Kim and Kim, 2010; Rao 
et al., 1970) 
Anti-diabetic 
- suppress the expression of hepatic gluconeogenesis genes 
(phosphoenol pyruvate carboxy kinase – PEPCK - and 
glucose6-phosphatase - G6Pase) similarly to insulin 
- activates adenosine monophosphate kinase (AMPK) and 
downregulates acetyl-CoA carboxylase (ACC), also 
implicated in glucose transport and shown to suppress the key 
gluconeogenic genes PEPCK and G6Pase 
(Arun and Nalini, 2002; 
Kim et al., 2009; Kumar et 
al., 2010; Peeyush et al., 
2009) 
Anti-
inflammatory 
- inhibit NF-кB,  COX-2, 5-lipoxygenase (5-LOX), inducible 
nitric oxide synthase (iNOS) and other molecules that 
mediate inflammatory effect 
(Huang et al., 1991; 
Menon and Sudheer, 2007; 
Motterlini et al., 2000; 
Mukhopadhyay et al., 
1982; Sandur et al., 2007; 
Singh and Aggarwal, 
1995; Srimal and Dhawan, 
1973) 
Anti-oxidant 
- protect biomembranes against lipid peroxidative damage by 
scavenging the reactive free radicals involved in the 
peroxidation 
(Ahsan et al., 1999; 
Motterlini et al., 2000; 
Ruby et al., 1995; Sandur 
et al., 2007; Sharma, 1976; 
Toda et al., 1985) 
Anti- 
Alzheimer’s 
- reduce amyloid plaques and accumulated β-amyloid 
aggregates 
- suppress pro-oxidant, pro-inflammatory, and c-Jun N-
terminal kinase (JNK) mediated toxic amyloid aggregate 
effects 
(Garcia‐Alloza et al., 
2007; Lim et al., 2001; 
Ringman et al., 2005; Ryu 
et al., 2006) 
Anti-HIV 
- inhibit human immunodeficiency virus (HIV) replication 
- inhibit HIV-1 and HIV-2 proteases 
(Gandapu et al., 2011; 
Jordan and Drew, 1996; 
Sui et al., 1993) 
Wound 
healing 
- protect tissue from oxidative damage due to their 
antioxidant properties 
- increase the formation of granulation tissue and the 
biosynthesis of extracellular matrix proteins, especially lower 
in diabetic wounds 
(Gopinath et al., 2004; 
Sidhu et al., 1999) 
Anti-
Parkinson 
- reduce the aggregation of α-synuclein 
-protect dopaminergic neurons from apoptosis by inhibition 
of JNK 
(Pan et al., 2012; Pandey 
et al., 2008) 
 
14 | Chapter 2 
 
2.1.2 Curcuminoids Bioavailability 
Nowadays, curcumin is considered a safe, novel and promising drug for the prevention 
and treatment of cancer, chronic inflammation and other diseases (Hsu and Cheng, 2007; 
Li et al., 2011). Several clinical trials have been conducted to confirm its effectiveness 
(Cheng et al., 2001; Dhillon et al., 2008; Hsu and Cheng, 2007; Sharma et al., 2004; 
Vareed et al., 2008) and have revealed that curcumin is safe for humans at a high oral 
dosage of 10-12 g per day (Hsu and Cheng, 2007; Vareed et al., 2008). 
In August 2009, Sabinsa Corporation received a “generally regarded as safe” (GRAS) 
status for the branded ingredient Curcumin C3 Complex® (Majeed et al., 2002) after a 
review of safety and toxicology data by Soni & Associates, Inc. In February 2013, due to 
curcumin’s health benefits and the results obtained in clinical trials, the US Food and 
Drug Administration issued a “no objection letter” to Sabinsa for the self-affirmed GRAS 
status of its Curcumin C3 Complex® for use in food and beverages (Thomas et al., 2013). 
Although the therapeutic applications of curcuminoids appear very promising, to date 
clinical trials are still preliminary and the true value of curcumin as a therapeutic agent for 
human diseases remains elusive (Hsu and Cheng, 2007). It is imperative that well-
designed clinical trials, with improved curcuminoids formulations or novel routes of 
administration (Hsu and Cheng, 2007), are conducted in the near future. Animal studies 
and phase I and II clinical trials conducted so far showed that curcumin, and other 
curcuminoids, exhibit a poor bioavailability which is the main reason why it has not yet 
been approved as a therapeutic agent (Anand et al., 2007). Curcuminoids poor 
bioavailability appears to be due to their poor absorption, distribution, rapid metabolism 
and rapid systemic elimination (excretion) (Anand et al., 2007). These compounds are 
insoluble and unstable in water and, in general, after administration, their presence in 
serum is very low or undetectable (Anand et al., 2007). Several approaches have been 
evaluated to improve the bioavailability of curcumin and the other curcuminoids. The use 
of adjuvants that can block metabolism of the curcuminoids is one of the most studied 
ways to improve their bioavailability (Cruz–Correa et al., 2006). For example, the co-
administration of piperine proved to highly increase curcumin serum concentration, 
absorption and bioavailability in rats and humans (Anand et al., 2007; Shoba et al., 1998). 
Other promising approaches to improve curcumin bioavailability include the use of 
liposomes (Kunwar et al., 2006; Li et al., 2007; Li et al., 2005), micelles (Letchford et al., 
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2008; Ma et al., 2007; Suresh and Srinivasan, 2007), nanoparticles (Anand et al., 2010; 
Basniwal et al., 2011; Bisht et al., 2007; Kim et al., 2011a; Mulik et al., 2010; Shaikh et 
al., 2009; Shimatsu et al., 2012; Tiyaboonchai et al., 2007), phospholipid complexes (Liu 
et al., 2006; Maiti et al., 2007) and curcuminoid derivatives and structural analogues 
(Mosley et al., 2007; Ohori et al., 2006; Ryu et al., 2006).  
An efficient application of curcumin requires specific lesion-oriented delivery methods to 
guarantee the needed concentrations in tissues. Non-invasive and invasive drug delivery 
methods can be used (Helson, 2013). Non-invasive methods are usually painless, and 
easy to use, and the most common routes of administration include peroral, topical and 
transmucosal (nasal, vaginal, rectal, urethral) routes (i.e. oral lozenges, vaginal 
suppository tablets and pomades). Invasive methods penetrate the cutaneous barrier to 
reach either the circulatory system or the diseased tissue, and include for example 
intravenous, intramuscular and subcutaneous methods.  
To solve the curcuminoids bioavailability problem, new methods for its production 
process and delivery at the intended body site need to be developed. According to Hsu 
and Cheng (2007) it is very likely that, to obtain active curcumin concentrations in 
tissues, it is necessary to apply the drugs locally or topically using a targeted drug 
delivery system. Controlled in situ drug delivery and production, using combinatorial 
biosynthesis and a host microorganism, is a very promising approach. In this chapter the 
production of curcuminoids in C. longa and by Escherichia coli using an artificial 
biosynthetic pathway is reviewed. New approaches using metabolic engineering and 
synthetic biology tools to increase the curcuminoids yield and activity are also suggested.  
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2.2 Curcuminoids Production in Curcuma longa 
Curcuminoids are produced by type III polyketide synthases (PKSs) in plants and consist 
of two phenylpropanoid units chemically derived from the amino acid phenylalanine and 
connected by a central carbon unit derived from malonyl-CoA (Katsuyama et al., 2009a). 
Until the work by Ramirez-Ahumada et al. (2006), very little was known about 
curcuminoids biosynthesis in turmeric. The authors identified the enzymes in the 
curcuminoids biosynthetic pathway and confirmed the involvement of the 
phenylpropanoid pathway in the production of these compounds in plants. The first 
enzyme identified was phenylalanine ammonia lyase (PAL) that is involved in amino acid 
metabolism, but also in the biosynthesis of plant natural products, as the branch point 
between primary and secondary metabolism (Dixon and Paiva, 1995). Other enzymes 
identified include p-coumaroyl shikimate transferase (CST), p-coumaroyl quinate 
transferase (CQT), caffeic acid O-methyltransferase (COMT) and caffeoyl-CoA O-
methyltransferase (CCoAOMT). The results of PKS in in vitro assays showed detectable 
curcuminoids synthase activity in the extracts from turmeric. However, the authors were 
not able to characterize the enzyme(s) responsible for this reaction (Ramirez-Ahumada et 
al., 2006). Furthermore, Katsuyama et al. (2009a) proposed a pathway for curcuminoids 
biosynthesis in the herb C. longa, which included two type III PKS (Figure 2.1). One of 
the PKS, named diketide-CoA synthase (DCS), catalyzes the formation of 
feruloyldiketide-CoA from feruloyl-CoA and malonyl-CoA. The other PKS, named 
curcumin synthase 1 (CURS1), catalyzes two reactions. First it catalyzes the hydrolysis of 
feruloyldiketide-CoA in a β-keto acid. Second, using the β-keto acid and other molecule 
of feruloyl-CoA, it catalyzes the formation of curcumin. β-keto acid is not detected in 
vitro because it is not released from the enzyme (Katsuyama et al., 2007c; Katsuyama et 
al., 2011). Both DCS and CURS1 accept p-coumaroyl-CoA, but at low efficiency, and are 
capable of synthesizing bisdemethoxycurcumin. The asymmetric curcuminoid 
demethoxycurcumin can also be produced from p-coumaroyldiketide-CoA and feruloyl-
CoA, or feruloyldiketide-CoA and p-coumaroyl-CoA. DCS and CURS1 share 62% amino 
acid sequence identity and a conserved Cys-His-Asn catalytic triad (Katsuyama et al., 
2009a). 
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Figure 2.1. Curcuminoid biosynthetic pathway in Curcuma longa. Cinnamic acid is synthesized from 
phenylalanine by phenylalanine ammonia lyase (PAL) and converted to p-coumaric acid by cinnamate-4-
hydroxylase (C4H). Then, 4-coumarate-CoA ligase (4CL) converts p-coumaric acid to p-coumaroyl-CoA 
and p-coumaroyl shikimate transferase (CST), p-coumaroyl 5-O-shikimate 3’-hydroxylase (CS3’H) and 
caffeoyl-CoA O-methyltransferase (CCoAOMT) converts it to feruloyl-CoA. p-Coumaroyl-CoA and 
feruloyl-CoA are then converted by diketide-CoA synthase (DCS) to diketide-CoAs by condensation with 
malonyl-CoA. In the end, curcumin synthases (CURSs) catalyze the formation of curcuminoids by 
condensing the diketide-CoAs with p-coumaroyl-CoA and feruloyl-CoA. Depending on the combination, 
different curcuminoids are produced, namely bisdemethoxycurcumin, demethoxycurcumin and curcumin. 
The route indicated by dashed arrows corresponds to a less central phenylpropanoid pathway and may not 
occur in vivo in C. longa.   
 
 
The same authors identified and characterized two other type III PKS from turmeric, 
named CURS2 and CURS3 (Katsuyama et al., 2009b). In vitro analysis revealed that 
CURS2 preferred feruloyl-CoA as substrate, while CURS3 used both feruloyl-CoA and 
p-coumaroyl-CoA (Table 2.2). CURS2 and CURS3 share 81% identity, and CURS2 and 
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CURS3 share 78% and 81% identity with CURS1 and 62% and 66% with DCS, 
respectively. The existence of these three curcumin synthases with distinctive substrate 
specificities might explain the distribution of the three curcuminoids (curcumin, 
demethoxycurcumin and bisdemethoxycurcumin) in C. longa. Before it was known that 
C. longa had different CURSs with different specificities, and that they could utilize both 
CoA esters of p-coumaric acid and ferulic acid, Ramirez-Ahumada et al. (2006) proposed 
that bisdemethoxycurcumin (synthesized only from p-coumaroyl-CoA) would be 
transformed in demethoxycurcumin, and then in curcumin by hydroxylation followed by 
O-methylation. This hypothesis was never confirmed and was almost discarded after the 
finding of curcumin synthase, which was able to use feruloyl-CoA to produce curcumin. 
 
Table 2.2. Kinetic parameters of DCS, CURS1, CURS2 and CURS3 from Curcuma longa.  
EC-
number 
Enzyme name 
GenBank 
Accession 
no. 
Substrate 
KM 
(μM) 
kcat  
(s
-1
) 
kcat/KM 
(s
-1
M
-1
) 
References 
2.3.1.218 
Diketide-
CoA 
synthase 
DCS AB495006 
Feruloyl-CoA 
Malonyl-CoA 
- 
8.4 
0.020 
0.011 
- 
1329 
(Katsuyama 
et al., 
2009a)
a
 
2.3.1.217/ 
2.3.1.219 
Curcumin 
synthase/ 
Demethoxy 
curcumin 
synthase 
CURS1 AB495007 
Feruloyl-CoA 
p-Coumaroyl-CoA 
18 
189 
0.018 
0.014 
1001 
75 
(Katsuyama 
et al., 2009a) 
CURS2 AB506762 
Feruloyl-CoA 
p-Coumaroyl-CoA 
4.3 
89 
0.007 
0.016 
1622 
176 
(Katsuyama 
et al., 2009b) 
CURS3 AB506763 
Feruloyl-CoA 
p-Coumaroyl-CoA 
2.2 
3.4 
0.003 
0.006 
2017 
1742 
(Katsuyama 
et al., 2009b) 
a Kinetic properties of DCS for feruloyl-CoA were calculated according to its allosteric properties (sigmoidal curve). The S50, kcat, and 
Hill slope values were 46 μM, 0.02 s-1 and 1.8. 
 
 
 
 
In addition to the well-known curcuminoids, other diarylheptanoids can also be found in 
turmeric. The biosynthetic pathway of these diarylheptanoids has not yet been elucidated 
and several routes have been hypothesized. Xie et al. (2009), after using metabolic 
profiling analysis, proposed that the biosynthetic pathway of other diarylheptanoids 
belongs to a different metabolite module (Figure 2.2) and that they are not intermediates 
in curcuminoids biosynthesis that belong to another biosynthetic module (Figure 2.1). 
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Figure 2.2. Biosynthetic production pathway of some diarylheptanoids in Curcuma longa. CST: p-
coumaroyl shikimate transferase; CS3’H: p-coumaroyl 5-O-shikimate 3’-hydroxylase; CCoAOMT: 
caffeoyl-CoA O-methyltransferase. 
 
According to Xie et al. (2009), caffeoyl-CoA in combination with p-coumaroyl-CoA or 
feruloyl-CoA is used to produce 3’-hydroxy-bisdemethoxycurcumin and 3’-hydroxy-
demethoxycurcumin, respectively. The polyketide synthases responsible for these 
reactions have different specificities than the ones from the other module (Figure 2.1) 
that cannot use caffeoyl-CoA as a substrate, and that produce the major curcuminoids. 
Furthermore, Xie et al. (2009) reported that some PKS, instead of using caffeoyl-CoA, 
use 5-hydroxy-feruloyl-CoA or feruloyl-CoA and p-coumaroyl-CoA to produce 5’-
hydroxy-curcumin and 5’-hydroxy-demethoxycurcumin, respectively.  
Dihydrocurcuminoids, that are dihydro derivatives of curcuminoids (Resmi and Soniya, 
2012), have also been identified in the plant C. longa, for example 
dihydrodemethoxycurcumin, dihydrobisdemethoxycurcumin and dihydrocurcumin. Kita 
et al. (2009) considered two hypotheses for the production of these dihydrocurcuminoids. 
In one hypothesis, an enzyme accepts one dihydrophenylpropanoid and one 
phenylpropanoid instead of the two phenylpropanoids used in the production of the major 
curcuminoids. The other hypothesis considers the reduction of a double bond of the major 
curcuminoids by a reductase.  
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2.3 Heterologous Production of Curcuminoids 
Curcuminoids, as many plant secondary metabolites, accumulate at low quantities over 
very long growth periods in plants and are difficult and expensive to isolate and hard to 
synthesize chemically. These reasons, in combination with the wide benefits of 
curcuminoids and their application potential, have led to an increased interest in the last 
ten years, and attempts to implement the heterologous biosynthesis of curcuminoids have 
been reported (Katsuyama et al., 2008). One of the approaches to produce curcuminoids 
is the combinatorial biosynthesis that consists of combining enzyme-encoding genes from 
different species and designing a new set of gene clusters to produce bioactive 
compounds in a heterologous host (Horinouchi, 2008; Horinouchi, 2009). Heterologous 
production of curcuminoids in microorganisms is highly advantageous since they can 
grow on inexpensive substrates and, compared to plants, they are easier to manipulate and 
have very rapid production cycles (Lussier et al., 2012) allowing curcuminoids to be 
produced faster and maybe in higher amounts. Large-scale microbial fermentation and 
downstream purification can also be more easily attained since microorganisms usually 
do not have competing pathways to transgenic metabolism (Chemler and Koffas, 2008). 
Heterologous production in plants has the advantage of requiring the introduction of only 
one or two genes since the other genes from the phenylpropanoid pathway are already 
present in the plant kingdom (Jeandet et al., 2012). Also, the engineering of plants can 
lead to an increase in antioxidants activities and in disease resistance in the transgenic 
plants, and extend the post-harvest shelf life of some fruits, such as in the cases where 
resveratrol is engineered in plants (Halls and Yu, 2008; Jeandet et al., 2012). However, 
introducing genetically modified crops has a high cost and there is public resistance to the 
acceptance of these food products. Genetically modified regulations for microorganisms 
are simpler than for crops (Halls and Yu, 2008). Thus, taking into consideration all the 
pros and cons, the commercial application of curcuminoids heterologous production by 
microorganisms is more attractive.  
Although DCS and CURS are the enzymes responsible for the last steps of the 
curcuminoids pathway in C. longa, these enzymes were only discovered in 2009 
(Katsuyama et al., 2009a). At that time, Katsuyama et al. (2008) had already implemented 
in E. coli an artificial biosynthetic pathway to produce curcuminoids. The authors 
identified a type III PKS from rice, Oryza sativa. This enzyme was named curcuminoids 
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synthase (CUS; GenBank accession number AK109558) and was the first identified type 
III PKS capable of catalyzing the “one-pot” synthesis of bisdemethoxycurcumin from two 
molecules of p-coumaroyl-CoA (starter substrates) and one molecule of malonyl-CoA 
(extender substrate). CUS itself catalyzes all the steps catalyzed by DCS and CURS in C. 
longa, disobeying the traditional model of head-to-tail polyketide assembly by only 
catalyzing condensation reactions without a cyclization (Miyazono et al., 2011). Morita et 
al. (2010) proposed that CUS has a unique downward expanding active-site architecture 
that allows accommodation of two p-coumaroyl molecules (p-coumaroyl-CoA and p-
coumaroyl β-keto acid) and one malonyl-CoA molecule, and a putative nucleophilic 
water molecule that forms hydrogen bond networks at the active-site center. These unique 
structural features are the basis for the “one-pot” synthesis of bisdemethoxycurcumin. 
Thus, the use of CUS in the artificial biosynthetic production of curcuminoids is simpler 
than the DCS/CURS system. The Cys-His-Asn catalytic triad is conserved in CUS 
(Miyazono et al., 2011; Morita et al., 2010), and the enzyme shares 51% amino acid 
identity with DCS and 45% identity with CURS1. Although CUS also accepts cinnamoyl-
CoA and feruloyl-CoA as a substrate to produce dicinnamoylmethane and curcumin, it 
prefers p-coumaroyl-CoA. To date, curcuminoids have not been reported in O. sativa and 
CUS activity in vivo remains to be identified. Hypothetically, the rice CUS may produce 
curcuminoids, albeit in undetectable amounts (Katsuyama et al., 2007c). In addition to 
curcuminoids synthesis, CUS also proved to be able to produce gingerol derivatives 
(Katsuyama et al., 2007c; Katsuyama et al., 2010b). 
The artificial curcuminoids biosynthetic pathway in E. coli, designed by Katsuyama et al. 
(2008), is the first study demonstrating the production of curcuminoids in a heterologous 
organism. This pathway (Figure 2.3) starts with the reaction of phenylalanine ammonia 
lyase (PAL) from the yeast Rhodotorula rubra that converts phenylalanine to cinnamic 
acid. This enzyme was previously shown to have tyrosine ammonia lyase (TAL) activity 
(Hwang et al., 2003; Miyahisa et al., 2005). Using this enzymatic feature, tyrosine can be 
used as a precursor and further converted to p-coumaric acid. The carboxylic acids are 
converted to CoA esters by 4-coumarate-CoA ligase (4CL) from Lithospermum 
erythrorhizon (Le4CL1) and then to curcuminoids by CUS from O. sativa. Acetyl-CoA 
carboxylase (ACC) from Corynebacterium glutamicum was also overexpressed to 
increase the intracellular pool of malonyl-CoA in E. coli. The enzymes and 
microorganisms in this pathway were chosen after the successful production of flavonoid 
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and stilbene compounds whose pathway included some of the same enzymes (Katsuyama 
et al., 2007a; Katsuyama et al., 2007b). The recombinant E. coli was cultivated in M9 
medium with the supplementation of tyrosine or/and phenylalanine (3 mM), the 
precursors of the phenylpropanoid pathway. Bisdemethoxycurcumin, 
dicinnamoylmethane and cinnamoyl-p-coumaroylmethane were produced. In another 
experiment, phenylpropanoid acids (p-coumaric acid, cinnamic acid and ferulic acid, 1 
mM) were directly supplied to test a system with only 4CL, CUS and ACC genes. The 
goal was to increase the CoA esters concentration in the cell by removing the PAL step 
where the amino acids are converted to carboxylic acids. E. coli produced 91±23 mg/L of 
bisdemethoxycurcumin, 84±15 mg/L of dicinnamoylmethane and 113±22 mg/L of 
curcumin. Furthermore, rice bran pitch was used for curcumin production. Rice bran pitch 
is an industrial waste obtained from rice bran in the production of rice oil (Kikuzaki et al., 
2002). It is known that rice bran pitch is rich in ferulic acid. Starting with 11±1.4 mg of 
ferulic acid extracted from 500 mg of rice bran pitch, the engineered E. coli strain by 
Katsuyama et al. (2008), harboring 4CL, CUS and ACC genes, produced 57±21 mg/L of 
curcumin.  
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Figure 2.3. Biosynthesis of curcuminoids by recombinant Escherichia coli, using tyrosine and/or 
phenylalanine as starter substrates that are converted to carboxylic acids by PAL (phenylalanine ammonia 
lyase). The carboxylic acids, which can also be added directly to the medium, are converted into the 
corresponding CoA esters by 4CL (4-coumarate-CoA ligase) (A) followed by several reactions catalyzed by 
curcuminoids synthase (CUS) (B). Malonyl-CoA is overproduced by ACC (acetyl-CoA carboxylase). 
Adapted from Katsuyama et al. (2008) and Katsuyama et al. (2007c). 
 
Using the same pathway (4CL, CUS and ACC), the authors produced 15 asymmetric 
curcuminoids (9 of these compounds are not found in nature) by adding two different 
unnatural carboxylic acids simultaneously (analogs of p-coumaric acid) (Katsuyama et 
al., 2010a). This precursor–directed biosynthesis system is possible due to the unusually 
broad, promiscuous substrate specificities of the enzymes involved in the pathway that 
allows production of unnatural novel polyketides. This way of producing unnatural 
curcuminoids may provide novel drug candidates. 
(A) 
(B) 
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Curcuminoids production in E. coli was also used to develop a reporter assay for the 
screening of PAL enzyme efficiency (Wang et al., 2013). PALs were co-expressed with 
4CL1 from A. thaliana (At4CL1) and CUS from O. sativa in E. coli. The yellow color of 
the product allowed the development of a microplate-based assay to measure 
dicinnamoylmethane. Using this system the authors screened three PALs (PAL1, PAL3 
and PAL4) from Trifolium pratense. PAL1 showed the best results by producing 0.36 g/L 
of dicinnamoylmethane. This combination of enzymes allowed around 3.4 times more 
dicinnamoylmethane from phenylalanine than that obtained by Katsuyama et al. (2008) 
using PAL from R. rubra and 4CL from L. erythrorhizon. Furthermore, the ACC enzyme 
was not used which means that, at least in this case, the naturally present malonyl-CoA 
was enough for a successful production. In addition, by feeding 2-fluoro-L-phenylalanine, 
Wang and colleagues produced three curcuminoids: dicinnamoylmethane, 6,6’-difluoro-
dicinnamoylmethane, and 6-fluoro-dicinnamoylmethane, a new unnatural compound 
(Wang et al., 2013).  
 
2.4 Optimization of the Curcuminoids Heterologous Pathway and 
Alternative Hosts  
The success of a biosynthetic pathway depends significantly on the use of appropriate 
synthetic enzymes. Curcuminoids production can be improved by exploring alternative 
enzymes from other microorganisms compatible with the heterologous host that allow 
higher curcuminoids yield, or more specific enzymes that allow production of the desired 
curcuminoid with fewer undesired byproducts.  
Heterologous synthesis of curcuminoids has only been accomplished so far in E. coli. 
Saccharomyces cerevisiae, which is also easy to grow and manipulate and is well 
characterized, has only been used to produce other polyketides like resveratrol, 
naringenin, pinocembrim, among others (Becker et al., 2003; Beekwilder et al., 2006; 
Jiang et al., 2005; Katsuyama et al., 2010b; Koopman et al., 2012; Leonard et al., 2005; 
Shin et al., 2012; Trantas et al., 2009; Wang et al., 2011b; Yan et al., 2005; Zhang et al., 
2006). However, as a eukaryote, it presents some unique advantages over E. coli for the 
design and construction of a biosynthetic pathway for the production of curcuminoids. 
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First of all, it has a food-grade status (GRAS organism) which allows its use in human 
nutrition and pharmaceuticals. Furthermore, unlike E. coli, S. cerevisiae harbors a post-
translational machinery, with intracellular compartments similar to plant cells (Jiang et 
al., 2005). Also, membrane proteins such as cytochrome P450 (C4H) would be more 
adequately expressed in a eukaryotic organism. These questions have been properly 
addressed and reviewed recently (Sahdev et al., 2008), and emerging strategies have been 
employed to overcome the problems when expressing eukaryotic proteins in a bacterial 
host. Nevertheless, in some cases the use of a eukaryotic organism like S. cerevisiae 
would be simpler. 
 
2.4.1 Tyrosine/Phenylalanine Overproducing Strains 
E. coli and S. cerevisiae lack the CoA-ester starter substrates needed for curcuminoid 
production, and the naturally produced amino acids (phenylalanine and tyrosine) that are 
converted to the phenylpropanoic acids are not produced in sufficient amounts, which 
represents a limiting step (Jiang et al., 2005; Kang et al., 2012; Lin and Yan, 2012). 
Although the amino acids and phenylpropanoic acids can be supplemented to the culture 
medium, the development of strains capable of converting glucose or other simple carbon 
sources to curcuminoids represents an important strategy for the engineering process. 
This approach eliminates the need to add expensive precursors to the medium thus 
decreasing the production cost. Large scale production would be more suitable too. This 
medium simplification would also be very advantageous in cases where curcuminoids are 
to be used as drugs that need to be produced and delivered in situ.  
The aromatic amino acid biosynthesis in E. coli is a very complex, highly regulated 
branched pathway (Figure 2.4). This pathway is regulated at both the transcriptional and 
allosteric level. One of the most regulated steps of the pathway is the one catalyzed by 3-
deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase (Sprenger, 2007). The 
three isoenzymes of this DAHP synthase (aroH, aroF and aroG) are feedback-inhibited 
by the end products. Another regulatory point is present at the chorismate branch point 
with the enzymes chorismate mutase and prephenate dehydratase (pheA and tyrA). These 
bifunctional enzymes are feedback-regulated by their end products, phenylalanine and 
tyrosine. In addition to the allosteric inhibition, it is necessary to take into account the 
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transcriptional control mediated by the protein TyrR (tyrosine repressor). In case of 
amino acid overproduction, TyrR can repress aroF, aroG, tyrA and tyrB (Pittard et al., 
2005). As a result, the elimination of TyrR-mediated control was shown to be an 
important target for the successful overexpression of amino acids (Bongaerts et al., 2001). 
Also, the sequence of the repressed genes was modified so that their products were no 
longer sensitive to feedback inhibition. The overexpression of feedback inhibition-
resistant derivatives of aroG (aroG
fbr
) and tyrA (tyrA
fbr
) genes proved to help in amino 
acids overexpression (Berry, 1996; Draths et al., 1992; Juminaga et al., 2012; Lütke-
Eversloh and Stephanopoulos, 2005; Lütke-Eversloh and Stephanopoulos, 2007). 
 
 
Figure 2.4. Biosynthesis of aromatic amino acids in Escherichia coli. Dashed lines show the regulation 
points.  
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Engineering the central carbon metabolism to increase the availability of the two main 
precursors, phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P), has been 
another approach to overexpress these amino acids. Several strategies have been tested, 
for example the overexpression of ppsA (PEP synthase) and tktA (transkelotase) (Draths 
et al., 1992; Juminaga et al., 2012; Lütke-Eversloh and Stephanopoulos, 2007).  
Some studies related to phenylpropanoic acids (Huang et al., 2013; Kang et al., 2012; Lin 
and Yan, 2012; Santos et al., 2011; Zhang and Stephanopoulos, 2013) and flavonoids 
production (Kim et al., 2013) have used tyrosine or phenylalanine overproducing strains, 
and all obtained better results with these strains than with the wild-type. All of them used 
similar approaches, in which they overexpressed aroG
fbr 
and tyrA
fbr
, and in some cases 
ppsA and tktA, and deleted tyrR (ΔtyrR). To direct the pathway to tyrosine production 
they also deleted the pheA gene (ΔpheA). Huang et al. (2013) engineered a well-
developed phenylalanine overproducer strain to obtain a tyrosine overproducing strain. 
The phenylalanine overproducing strain E. coli ATCC31884 overexpresses aroG
fbr
, 
aroF
fbr
 and pheA
fbr 
and suppresses tyrR. This strain was transformed into a tyrosine 
overproducing strain by disruption of pheA
fbr
 and tyrA loci and insertion of tyrA
fbr
. 
Also in S. cerevisiae, aromatic amino acid biosynthesis is subject to strong feedback 
inhibition by tyrosine and phenylalanine. To overcome this problem, Koopman et al. 
(2012) introduced a tyrosine feedback inhibition-resistant derivative of aro4 (aro4
fbr
) in 
combination with the deletion of aro3, the other allele of DAHP synthase. The authors 
also eliminated the competing activity of phenylpyruvate decarboxylase (that yields 
phenyl acetaldehyde instead of phenylalanine) by deleting aro10, pdc5 and pdc6 genes 
that encode it. This engineered S. cerevisiae allowed significantly higher production of 
naringenin than the wild-type strain. 
 
2.4.2 From Tyrosine/Phenylalanine to p-Coumaric Acid - Caffeic Acid – Ferulic 
Acid and their Corresponding CoA Esters 
In the last years, several studies have used the enzymes involved in the phenylpropanoid 
pathway to produce compounds other than curcuminoids, like phenylpropanoic acids (p-
coumaric acid, caffeic acid and ferulic acid) (Berner et al., 2006; Choi et al., 2011; Furuya 
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et al., 2012; Huang et al., 2013; Kang et al., 2012; Lin and Yan, 2012; Vannelli et al., 
2007b; Zhang and Stephanopoulos, 2013), stilbenoids (Choi et al., 2011; Watts et al., 
2006) and flavonoids (Choi et al., 2011; Hwang et al., 2003; Leonard et al., 2006a; 
Leonard et al., 2006b; Miyahisa et al., 2006; Miyahisa et al., 2005; Santos et al., 2011; 
Watts et al., 2004). In the design and construction of those pathways some enzymes from 
other organisms were used that could also be considered for the optimization of the 
heterologous production of curcuminoids.  
The caffeic acid biosynthetic pathway, due to its valuable pharmacological properties, 
among them antioxidant (Mori and Iwahashi, 2009), anti-inflammatory (Chao et al., 
2009) and anticancer (Prasad et al., 2011), has been intensively studied in the last decade. 
Berner et al. (2006) studied the caffeic acid biosynthetic pathway in the Actinomycete 
Saccharothrix espanaensis and heterologously expressed it in Streptomyces fradiae XKS, 
a PKS-defective mutant strain that is considered to be a very convenient host for 
expression experiments (Mulert et al., 2004). Streptomyces, applied in the production of a 
wide range of secondary metabolites including polyketides, can be another candidate for 
the heterologous production of plant-specific polyketides (Park et al., 2009). Berner et al. 
(2006) concluded that tyrosine (and not phenylalanine) is converted to p-coumaric acid by 
sam8, encoding TAL (SeTAL). This is not in accordance with the general 
phenylpropanoid pathway in plants, but it allows a simpler pathway that can be integrated 
in the heterologous production of curcuminoids by E. coli. Other authors also reported 
their findings on other bacterial TALs. Rhodobacter capsulatus TAL (RcTAL) and 
Rhodobacter sphaeroides TAL (RsTAL) catalytic efficiencies showed a clear preference 
of these enzymes for tyrosine instead of phenylalanine (Table 2.3). These TAL enzymes 
that allow p-coumaric acid to be produced without requiring the C4H step, where this 
enzyme converts cinnamic acid to p-coumaric acid, are highly advantageous since one 
can avoid the use of the C4H enzyme that is not successfully expressed in prokaryotic 
organisms, thus creating a blockage in the biosynthetic pathways (Watts et al., 2004). 
C4H is a membrane-bound cytochrome P450-dependent hydroxylase and its expression in 
bacteria is very challenging due to protein instability and insolubility, as well as the lack 
of cytochrome P450-reductase activity that is necessary for P450 function (redox 
partners) (Horinouchi, 2008; Hotze et al., 1995). After producing p-coumaric acid, caffeic 
acid is directly converted by sam5, encoding a 4-coumarate 3-hydroxylase (C3H). C3H 
can also convert p-coumaroyl-CoA to caffeoyl-CoA (Kneusel et al., 1989). Moreover, 
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Berner et al. (2006) identified sam7, encoding a caffeoyl-CoA ligase (4CL) that catalyzes 
the ligation of caffeic acid to CoA leading to caffeoyl-CoA. This route, producing caffeic 
acid and then caffeoyl-CoA, can be very useful to ultimately produce curcumin since 
caffeoyl-CoA can be converted to feruloyl-CoA by CCoAOMT (Figure 2.1) and 
curcumin is produced from two molecules of feruloyl-CoA and one of malonyl-CoA.  
Table 2.3. Kinetic parameters of PALs/TALs from different organisms towards phenylalanine (Phe) and 
tyrosine (Tyr). 
 
 a kcat and kcat/KM were not determined. However, the enzyme showed Vmax of 0.169 μmol min
-1 mg-1 for Phe and 0.033 μmol min-1 mg-1 
for Tyr. 
b Kinetic properties at pH 8.5. At pH 9.5 the RgTAL enzyme showed kcat,  KM and kcat/KM values of 1.5 s
-1, 126 μM and 1.2 x 104 s-1 M-1 
for Phe and 0.93 s-1, 68 μM and 1.4 x 104 s-1 M-1 for Tyr. 
 
The pathway described by Berner et al. (2006) was afterwards reconstituted in E. coli by 
Choi et al. (2011) and Kang et al. (2012) to produce phenylpropanoic acids such as p-
coumaric acid, caffeic acid and ferulic acid. In their pathways, the authors used SeTAL 
and sam5 (C3H) from S. espanaensis and COMT from Arabidopsis thaliana. Although 
Choi et al. (2011) reported positive results, ferulic acid production in the end was only 7.1 
mg/L. The pathway created by Kang et al. (2012) contained a codon-optimized tal gene 
that improved the productivity of p-coumaric acid and ferulic acid, but not caffeic acid. 
The authors also tested an overproducing tyrosine strain that produced 974 mg/L p-
coumaric acid, 150 mg/L caffeic acid and 196 mg/L ferulic acid in shake flasks after 36 h 
of cultivation. 
Lin and Yan (2012) and Huang et al. (2013) tested a different approach for caffeic acid 
production. Since one of the most challenging steps in the recreation of the plants 
phenylpropanoid pathway in E. coli is the one carried out by the cytochrome P450 
EC-
number 
Enzyme name Organism Substrate 
KM 
(μM) 
kcat 
(s
-1
) 
kcat/KM 
(s
-1
 M
-1
) 
References 
4.3.1.24 
Phenylalanine 
ammonia lyase 
PAL 
Rhodotorula 
rubra 
Phe 
Tyr 
446 
220 
- - 
(Vannelli et 
al., 2007b)
a
 
4.3.1.23 
Tyrosine 
ammonia lyase 
SeTAL 
Saccharothrix 
espanaensis 
Phe 
Tyr 
2860 
15.5 
0.0038 
0.015 
1.3 
968 
(Berner et 
al., 2006) 
Tyrosine 
ammonia lyase 
RsTAL 
Rhodobacter 
sphaeroides 
Phe 
Tyr 
560 
60 
0.01 
0.02 
18 
333 
(Xue et al., 
2007b) 
Tyrosine 
ammonia lyase 
RcTAL 
Rhodobacter 
capsulatus 
Phe 
Tyr 
560 
160 
0.04 
0.06 
57 
375 
(Xue et al., 
2007b) 
4.3.1.25 
Phenylalanine/ 
Tyrosine 
ammonia lyase 
RgTAL 
Rhodotorula 
glutinis 
Phe 
Tyr 
183 
615 
1.6 
0.53 
8.7 x 10
3
 
8.6 x 10
2
 
(Xue et al., 
2007a)
b
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dependent hydroxylases (Kim et al., 2011b), the search for alternative enzymes 
compatible with E. coli is crucial. With that in mind, Lin and Yan (2012) characterized an 
E. coli native hydroxylase complex – hydroxyphenylacetate 3-hydroxylase (4HPA3H) 
and concluded that this enzyme, besides converting tyrosine to L-dopa, was also able to 
efficiently convert p-coumaric acid to caffeic acid (Figure 2.5A). Furthermore, the 
authors found that RsTAL and RcTAL were able to accept tyrosine and L-dopa as 
substrates, with RcTAL being slightly more active towards both substrates. Hence, they 
were able to design an artificial dual and promiscuous pathway that used both p-coumaric 
acid and L-dopa as intermediates, resulting in the production of 50.2 mg/L caffeic acid in 
shake flasks after 48 h cultivation from simple carbon sources. This production was also 
obtained by alleviating feedback inhibition and redirecting carbon flux into tyrosine 
biosynthesis. Huang et al. (2013) explored the catalytic potential of 4HPA3H and were 
able to produce 3.82 g/L caffeic acid from 3.5 g/L p-coumaric acid in a wild-type E. coli 
strain. When using a tyrosine overproducing strain, 767 mg/L caffeic acid was produced 
in 72 h using shake flasks. In this work, the authors used Rhodotorula glutinis TAL 
(RgTAL), which was reported to be the most active TAL among all the identified ones 
(Gatenby et al., 2002; Lin et al., 2013; Santos et al., 2011; Vannelli et al., 2007a) (Table 
2.3). 
Zhang and Stephanopoulos (2013) also used RgTAL for caffeic acid biosynthesis, in an 
experiment using two parallel routes and a tyrosine overproducer strain (Figure 2.5B). 
The authors cloned 4CL from Petroselinum crispum (Pc4CL1) that converts p-coumaric 
acid to p-coumaroyl-CoA, and C3H from S. espanaensis that converts p-coumaroyl-CoA 
to caffeoyl-CoA or p-coumaric acid to caffeic acid. Caffeoyl-CoA is converted to caffeic 
acid by E. coli endogenous thioesterases (Beuerle and Pichersky, 2002). They obtained 
good results with TAL and C3H route – 106 mg/L caffeic acid in 2 L bioreactor. 
However, the introduction of the alternative biosynthesis route through p-coumaroyl-CoA 
and caffeoyl-CoA did not lead to increased caffeic acid production from glucose. On the 
contrary, it introduced an extra metabolic burden and led to a lower production. The 
problem could be due to inactive or low activity of E. coli endogenous thioesterases 
against caffeoyl-CoA. The authors suggested that low copies of TAL gene were sufficient 
to obtain high titer production, and that fine-tuning the C3H gene copy number should be 
pursued since the precursors were accumulating instead of being converted to caffeic 
acid.  
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Figure 2.5. Biosynthesis pathway of caffeic acid using the approaches described by Lin and Yan (2012) 
and Huang et al. (2013) (A) and Zhang and Stephanopoulos (2013) (B). TAL: Tyrosine ammonia lyase; 
C3H: 4-coumarate 3-hydroxylase; 4HPA3H: hydroxyphenylacetate 3-hydroxylase 4CL: 4-coumarate-CoA 
ligase.  
 
Furuya et al. (2012) found that Rhodopseudomonas palustris cytochrome P450 
CYP199A2 possesses hydroxylation activity towards p-coumaric acid - and cinnamic acid 
- and subjected it to site-directed mutagenesis to create mutants with novel and improved 
catalytic properties. E. coli co-expressed CYP199A2 with the redox partners’ 
putidaredoxin reductase (pdr) from Pseudomonas putida and palustrisredoxin (pux) from 
R. palustris. In this study, the authors constructed a CYP199A2 F185L mutant that 
showed 5.5 times higher hydroxylation activity toward p-coumaric acid (3.3 g/L) than the 
wild-type, reaching 2.8 g/L caffeic acid after 24 h in a glycerol medium. Furuya and Kino 
(2013) produced caffeic acid in E. coli from p-coumaric acid using 4HPA3H from 
Pseudomonas aeruginosa strain PAO1. In whole cells reaction, 10 mM of p-coumaric 
acid was converted to caffeic acid in 2 h. Since an initial p-coumaric acid concentration 
higher than 10-20 mM inhibited the reaction, during the 24 h fermentation, DMSO 
containing 20 mM p-coumaric acid was repeatedly added to the reaction mixture (2, 8 and 
14 h). The reaction with no energy source produced 4 times more caffeic acid than the 
one with glucose. However, the highest yield obtained (10.2 g/L) was in a glycerol 
(A) 
(B) 
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medium, thus showing once again that glycerol strongly enhanced the productivity. This 
is the highest production level attained so far. 
Santos et al. (2011) and Choi et al. (2011) optimized the heterologous pathway for the 
production of flavonoids and stilbenoids (naringenin and resveratrol) from glucose. 
Santos et al. (2011) used codon-optimized RgTAL, after discarding RsTAL. To convert p-
coumaric acid to p-coumaroyl-CoA, the authors compared P. crispus 4CL (Pc4CL1) and 
Streptomyces coelicolor 4CL2 (Sc4CL2) efficiencies and concluded that combining these 
enzymes with TAL enzyme completely abolished p-coumaric acid accumulation that was 
highly produced when TAL enzyme was expressed alone. Since codon-optimized 
Pc4CL1 performed slightly better than Sc4CL2, i.e. higher p-coumaric acid yield in 
combination with TAL, this enzyme was chosen to continue the optimization of the 
flavonoids production pathway. In the past, Sc4CL2 has proven to be more efficient when 
the conversion of cinnamic acid is also needed (Hwang et al., 2003; Miyahisa et al., 2006; 
Miyahisa et al., 2005), allowing the avoidance of the C4H step. This bacterial enzyme 
efficiently converts cinnamic acid (Table 2.4), which is usually a very poor substrate for 
plant 4CLs (Kaneko et al., 2003). Choi et al. (2011) used SeTAL and Sc4CL2 in the first 
part of the flavonoids and stilbenoids pathway and concluded that Sc4CL2 is specific for 
p-coumaric acid and that it could not use caffeic acid and ferulic acid as a substrate 
(Table 2.4). This conclusion is important since when using promiscuous enzymes in the 
curcuminoids pathway (Figure 2.3), the final product is a mixture of curcuminoids. This 
enzyme could help to direct the pathway to a specific curcuminoid if desired. Kim et al. 
(2013) produced flavonoids through comparison of three 4CL enzymes from three 
different organisms: P. crispum (Pc4CL2), O. sativa (Os4CL3) and S. coelicolor 
(Sc4CL2). The authors concluded that Os4CL3 was by far the one that allowed higher 
titers of flavonoids, followed by Pc4CL2. Furthermore, in their study the authors deleted 
the isocitrate dehydrogenase gene, icdA, to increase the amount of CoA in E. coli and, 
consequently, accelerated the production of p-coumaroyl-CoA. This deletion allowed for 
a higher yield of flavonoids.  
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Table 2.4. Kinetic parameters of 4-coumarate-CoA ligase (EC 6.2.1.12) from Petroselinum crispum, 
Arabidopsis thaliana, Oryza sativa and Streptomyces coelicolor A3(2). 
 
 
 
Organism Abbreviation Substrate 
KM 
(μM) 
Vmax 
(
a
) 
Vmax/KM 
(
a
) 
kcat 
(s
-1
) 
kcat/KM 
(s
-1
 M
-1
) 
References 
P.  
crispum 
Pc4CL1 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid 
2850 
14 
20 
33 
 
0.008 
0.020 
0.017 
0.018 
nmol s
-1
 
0.003 
1.429 
0.850 
0.545 
μL s-1 
- - 
(Knobloch 
and 
Hahlbrock, 
1977) 
A.  
thaliana 
 
At4CL1 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
6320 
38 
11 
199 
 
11.6 x 10
-4
 
11.3 x 10
-4
 
  3.1 x 10
-4
 
  6.0 x 10
-4
 
nmol s
-1
 mL
-1
 
0.184 
29.737 
28.182 
3.015 
μ s-1 
- - 
(Ehlting et 
al., 1999) 
 
At4CL2 
 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid 
6630 
252 
20 
n.c. 
 
0.6 x 10
-4
 
2.8 x 10
-4
 
2.1 x 10
-4
 
- 
nmol s
-1
 mL
-1
 
0.009 
1.111 
10.500 
- 
μ s-1 
- - 
At4CL3 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
2070 
23 
374 
166 
 
3.1 x 10
-4
 
1.9 x10
-4
 
2.5 x 10
-4
 
1.6 x 10
-4
 
nmol s
-1
 mL
-1
 
0.150 
8.261 
0.668 
0.964 
μ s-1 
- - 
At4CL4 
p-coumaric acid 
caffeic acid 
ferulic acid  
432 
186 
26 
 
129.6 
204.6 
171.6 
nmol s
-1
 
300 
1100 
6600 
μL s-1 
- - 
(Hamberger 
and 
Hahlbrock, 
2004) 
At4CL1 p-coumaric acid 66.7 - - 0.248 5365 
(Wang et 
al., 2011b) 
At4CL2 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
6642 
233 
22 
n.d 
 
203 
475 
236 
n.d. 
nmol s
-1
 mg
-1
 
31 
2039 
10727 
n.d. 
μL s-1 mg-1 
12.5 
29.5 
14.6 
n.d. 
 
1897 
126609 
663636 
n.d. 
 
(Schneider, 
2005; 
Schneider et 
al., 2003)  
 
At4CL2 
Mutant 
( M293P + 
K320L) 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
286 
22 
41 
30 
 
190 
321 
267 
247 
nmol s
-1
 mg
-1
 
664 
14591 
6512 
82333 
μL s-1 mg-1 
11.8 
20.0 
16.5 
15.3 
 
41259 
909091 
402439 
510000 
 
34 | Chapter 2 
 
Table 2.4. Kinetic parameters of 4-coumarate-CoA ligase (EC 6.2.1.12) from Petroselinum crispum, 
Arabidopsis thaliana, Oryza sativa and Streptomyces coelicolor A3(2) (continuation). 
 
a It was not possible to convert all the data to the same units for comparison purposes. The units are indicated for each case. 
(-) information was not available; n.d. not determined due to very low activity; n.c. no conversion, no enzymatic activity. 
 
Lin et al. (2013), aiming to produce coumarins using a biosynthetic pathway for the first 
time, used RgTAL since it possesses high activity towards tyrosine when compared with 
the RcTAL (Table 2.3) used in their previous work (Lin and Yan, 2012). They tested 
three different 4CLs (Pc4CL2, At4CL1 and At4CL2) (Table 2.5). When broad substrate 
specificity was needed, Pc4CL2 was used to synthesize the CoA esters of p-coumaric 
acid and ferulic acid since it was shown in the past that it can accept several 
phenylpropanoid acids as substrate (Leonard et al., 2006a; Lozoya et al., 1988). When 
higher catalytic efficiency towards p-coumaric acid was required, the enzyme At4CL1 
was used (Table 2.5). E. coli 4HPA3H was also used to hydroxylate p-coumaric acid to 
Organism Abbreviation Substrate 
KM 
(μM) 
Vmax 
(
a
) 
Vmax/KM 
(
a
) 
kcat 
(s
-1
) 
kcat/KM 
(s
-1
 M
-1
) 
References 
O. 
sativa 
Os4CL1 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
9.4 
11.9 
29.3 
8.3 
 
0.100 
0.130 
0.140 
0.110 
nmol s
-1
 mg
-1
 
10.638 
10.924 
4.778 
13.253 
μL s-1 mg-1 
0.006 
0.008 
0.009 
0.007 
 
663 
681 
296 
824 
 
(Gui et al., 
2011) 
Os4CL2 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
21.7 
16.8 
27.6 
2.2 
 
0.299 
0.629 
0.708 
0.613 
nmol s
-1
 mg
-1
 
13.779 
37.440 
25.652 
278.636 
μL s-1 mg-1 
0.019 
0.040 
0.045 
0.039 
 
867 
2351 
1612 
17295 
 
Os4CL3 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid  
28.2 
4.9 
10.9 
3.5 
 
3.010 
4.700 
4.210 
4.930 
nmol s
-1
 mg
-1
 
106.737 
959.184 
386.239 
1408.571 
μL s-1 mg-1 
0.182 
0.285 
0.255 
0.299 
 
6458 
58521 
23330 
84943 
 
Os4CL4 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid 
 
15.7 
3.9 
5.8 
4.6 
 
0.350 
0.770 
0.590 
0.520 
nmol s
-1
 mg
-1
 
22.293 
197.436 
101.724 
113.043 
μL s-1 mg-1 
0.021 
0.047 
0.036 
0.032 
 
1361 
12176 
6206 
6956 
 
Os4CL5 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid 
 
54.4 
10.3 
26.1 
6.9 
 
0.300 
0.830 
0.240 
0.590 
nmol s
-1
 mg
-1
 
5.515 
80.583 
9.195 
85.507 
μL s-1 mg-1 
0.017 
0.048 
0.014 
0.034 
 
312 
4660 
535 
4871 
 
S.  
coelicolor 
 A3(2) 
Sc4CL2 
cinnamic acid 
p-coumaric acid 
caffeic acid 
ferulic acid 
190 
131 
n.d. 
n.c. 
- - 
0.475 
0.202 
n.d. 
n.c. 
2499 
1545 
n.d. 
n.c. 
(Kaneko et 
al., 2003) 
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caffeic acid, as was shown in other studies (Huang et al., 2013; Lin and Yan, 2012) 
(Figure 2.5A). The 4-coumarate-CoA ligase used in this case was At4CL2 due to its 
higher affinity and catalytic activity towards caffeic acid as compared to Pc4CL2 and 
At4CL1. CCoAOMT1 from A. thaliana was used to convert caffeoyl-CoA to feruloyl-
CoA. Also with the goal of obtaining feruloyl-CoA, but from ferulic acid, Watts et al. 
(2006) used the recently reported 4-coumarate-CoA ligase At4CL4. This enzyme was 
shown to prefer ferulic acid as a substrate (Hamberger and Hahlbrock, 2004) (Table 2.4). 
However, the expected production of stilbene was not detectable by HPLC. This does not 
imply that At4CL4 was not working as the problem could be in the stilbene synthase step. 
Feruloyl-CoA conversion could be slow, causing an accumulation of feruloyl-CoA, which 
can be converted again to ferulic acid due to a balance between CoA ligase and 
endogenous E. coli thioesterases (Beuerle and Pichersky, 2002; Watts et al., 2006). Since 
the production of feruloyl-CoA would be highly advantageous in curcumin production, 
further characterization of At4CL4 should be considered. At4CL2 and its mutant (Table 
2.4) also seem to be very interesting options to be explored in the future.  
Table 2.5. Comparison of  kinetic parameters of 4-coumarate-CoA ligase (EC 6.2.1.12) from Petroselinum 
crispum and Arabidopsis thaliana from Lin et al. (2013) study. 
 
Organism Abbreviation Substrate 
KM 
(μM) 
Specific 
activity 
(nmol s
-1
 mg
-1
) 
Specific 
activity/KM 
(μL s-1 mg-1) 
P. 
crispum 
Pc4CL2 
p-coumaric acid 
caffeic acid 
ferulic acid 
11.8 
8.4 
11.2 
1.983 
1.533 
1.367 
168.051 
182.540 
122.054 
A. 
thaliana 
At4CL1 
p-coumaric acid 
caffeic acid 
ferulic acid 
28.7 
15.7 
40.8 
11.550 
5.267 
6.800 
403.439 
335.478 
166.667 
At4CL2 
p-coumaric acid 
caffeic acid 
ferulic acid 
45.1 
7.9 
n.d. 
10.433 
8.483 
- 
231.330 
1073.797 
- 
n.d. not determined due to very low activity 
 
Although S. cerevisiae has never been engineered to produce curcuminoids, it has been 
used to produce other polyketides, as was previously mentioned. Therefore, these already 
engineered and validated enzymatic steps may be used in the future for successful 
production of curcuminoids by the yeast. Furthermore, CUS has been already 
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successfully expressed in S. cerevisiae to produce gingerol derivatives (Katsuyama et al., 
2010b). 
Again, an attractive advantage of yeast compared to E. coli is its ability to functionally 
express plant cytochrome P450 monooxygenases. C4H from A. thaliana and Glycine max 
was successfully cloned and expressed in S. cerevisiae in several studies (Leonard et al., 
2005; Shin et al., 2012; Trantas et al., 2009; Yan et al., 2005). Although C4H was 
functionally expressed, its activity was still a rate limiting step. Since the endogenous 
CPR activity was not enough to support the C4H expression, CPR1 (NADPH-cytochrome 
P450 reductase) from S. cerevisiae or CPR from Populus hybrid (P. trichocarpa x P. 
deltoids) was overexpressed.    
Other enzymes from the phenylpropanoid pathway, like PAL from Rhodosporidium 
toruloides and Populus hybrid, RsTAL, RcTAL, RgTAL, 4CL2 from Nicotiana tabacum, 
4CL216 from Populus hybrid, 4CL from G. max, Le4CL1, At4CL1 and Pc4CL2 were 
also successfully expressed in yeast (Becker et al., 2003; Beekwilder et al., 2006; Jiang et 
al., 2005; Katsuyama et al., 2010b; Koopman et al., 2012; Leonard et al., 2005; Shin et 
al., 2012; Trantas et al., 2009; Vannelli et al., 2007a; Wang et al., 2011b; Yan et al., 2005; 
Zhang et al., 2006). The At4CL1 gene seems to be the best option to produce resveratrol 
in S. cerevisiae (Sydor et al., 2010) since its yield was more than 65 times higher than 
when using 4CL216 from Populus hybrid (Becker et al., 2003) and 4CL2 from Nicotiana 
tabacum (Beekwilder et al., 2006) in similar experiments using Vitis vinifera STS 
(stilbene synthase). Also, resveratrol yield in S. cerevisiae was 3.4 times higher than the 
maximum obtained with E. coli using At4CL1, but using Arachis hypogaea STS (Watts et 
al., 2006).  Shin et al. (2011) used At4CL1 and A. hypogaea STS in S. cerevisiae and 
obtained very low amounts of resveratrol compared to Sydor et al. (2010). This proves 
that the combination between 4CL and STS, as well as the host is very important to 
obtain excellent results and that the enzymes from some organisms work better together 
than others. Although flavonoids and stilbenoids production has been proven in some 
cases to be more efficient in bacteria (Beekwilder et al., 2006; Leonard et al., 2008; Yan 
et al., 2005), there are studies suggesting that S. cerevisiae is an adequate host for the 
expression of aromatic plant compounds (Sydor et al., 2010). 
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2.4.3 Type III Polyketide Synthases (PKSs) and the Biosynthesis of Curcuminoids 
In the last decade several advances have been made in curcuminoids biosynthesis as a 
result of the identification of DCS and multiple CURSs from C. longa, and CUS from O. 
sativa. However, DCS and CURSs enzymes have only been used to synthesize 
curcuminoids in vitro, never in vivo. CUS was chosen to produce curcuminoids in vivo 
(Katsuyama et al., 2010a; Katsuyama et al., 2008; Wang et al., 2013) since it was the first 
polyketide synthase involved in the curcuminoid biosynthesis to be reported. Also, CUS 
has the advantage of being able to produce curcuminoids directly from the CoA esters, 
unlike CURSs that need DCS to convert the CoA ester to the corresponding diketide-CoA 
ester. However, this advantage does not mean that an approach using DCS and CURS 
will not lead to higher yields, and this option should continue to be the object of further 
research. 
Due to the immense pharmaceutical value of curcuminoids, other genes encoding type III 
PKS curcumin/curcuminoid synthases are being sought. Brand et al. (2006) characterized 
a type III PKS from Wachendorfia thyrsiflora, WtPKS1 (GenBank accession number 
AY727928.1). The authors also characterized other PKS in W. thyrsiflora, WtPKS2 
(unpublished work, GenBank accession number AAW50922). W. thyrsiflora is known to 
synthesize phenylphenalenones which are thought to be synthesized from curcuminoids. 
Based on their high homology with C. longa DCS and CURS1 (WtPKS1 shares 63% 
identity to DCS and WtPKS2 shares 62% identity to CURS1) (Katsuyama et al., 2009a) it 
is assumed that WtPKS1 is a diketide synthase and WtPKS2 is a curcuminoid synthase 
and curcuminoids are synthesized by an enzyme system similar to the one of DCS and 
CURS1, not only in W. thyrsiflora but also in other plants. 
Also, with the goal of finding uncharacterized type III PKS in C. longa, Resmi and 
Soniya (2012) used RT-PCR genomic screening. This helped them to identify cDNAs 
that encode type III PKS proteins. One of the type III PKS, ClPKS10 (GenBank accession 
number JN017185) proved to possess all the possible requirements for catalyzing 
curcuminoid biosynthesis, namely it shares 93% identity with CURS1 and 81% identity 
with CURS2 and the putative active site environment - amino acids needed for p-
coumaroyl-CoA binding site and cyclization – showed the same characteristics found in 
the reported CURSs. However, ClPKS10 showed high expression level in leaf tissues, 
low in shoot and very low in rhizome and root. This is in contrast with the reported 
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curcuminoid expression pattern which can indicate the possible curcuminoid biosynthesis 
in aerial parts also. Dihydro derivatives of curcuminoids (dihydrocurcuminoids) also 
showed higher expression levels in leaves compared to rhizome (Kita et al., 2009). 
Ramirez-Ahumada et al. (2006) also concluded that the highest curcuminoid synthase 
activity from turmeric extracts was found in leaves followed by shoots and rhizome, 
which proves that curcuminoids and their analogs can be synthesized not only in the 
rhizomes but as well in the roots and the leaves. Future work to characterize ClPKS10, 
WtPKS1and WtPKS2 through in vitro and in vivo assays is required to confirm its 
curcuminoid synthase activity. 
 
2.4.4 Malonyl-CoA Availability 
Although it has been demonstrated that some curcuminoid synthases are able to catalyze 
two or more reactions from CoA esters and to efficiently produce curcuminoids 
heterologously, the presence of the precursor malonyl-CoA is still essential for these 
reactions to succeed. It is believed that flavonoids, stilbenoids and other polyketides 
biosynthetic production is controlled by the limited intracellular pool of malonyl-CoA 
(Leonard et al., 2007; Miyahisa et al., 2005; Xu et al., 2011). In flavonoid and stilbenoid 
pathways, three molecules of malonyl-CoA are needed to obtain the final product, 
whereas for curcuminoids production only one molecule is needed. Malonyl-CoA is 
naturally synthesized in microorganisms, but it is used for the production of fatty acids 
and phospholipids, leaving only a very limited amount available for the production of 
secondary metabolites (Takamura and Nomura, 1988). Therefore, it is essential to 
engineer the microbial host to achieve metabolic balance between the need for malonyl-
CoA for growth and secondary metabolite production (Xu et al., 2011). In the last decade 
several metabolic engineering approaches were developed to increase the intracellular 
pool of malonyl-CoA. One of them is the overexpression of acetyl-CoA carboxylase 
(ACC) that converts acetyl-CoA into malonyl-CoA (Katsuyama et al., 2008; Leonard et 
al., 2007; Malla et al., 2011; Miyahisa et al., 2005; Xu et al., 2013; Xu et al., 2012) 
(Figure 2.6).  Leonard et al. (2007) and Xu et al. (2013) overexpressed ACC encoded by 
accABCD from Photorhabdus luminescens and E. coli, respectively, and obtained an 
increase in the flavanone and fatty acid production. The ACC reaction is divided into two 
partial reactions (Figure 2.6). In the first reaction, biotin is attached to the biotin carboxyl 
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carrier protein (BCCP, encoded by accB) and is carboxylated via ATP consumption by 
the biotin carboxylase AccC. Then, the carboxyl group is transferred to acetyl-CoA by 
carboxyltransferase (AccAD). Since ACC requires biotinylation by the action of biotin 
ligase (BLP) to be completely functional, BLP (encoded by birA) overexpression was 
also studied using P. luminescens (Fowler et al., 2009; Leonard et al., 2007) and E. coli 
BLP (Leonard et al., 2007). Co-expression of ACC and BPL, both from P. luminescens, 
was found to be the best approach to improve the flavonoids yield (Leonard et al., 2007).  
 
 
Figure 2.6. Metabolic pathways connecting malonyl-CoA with the curcuminoids biosynthesis in 
Escherichia coli. 
 
The use of acetyl-CoA pathway to increase the supply of malonyl-CoA has also been 
explored (Leonard et al., 2007; Malla et al., 2011). When glucose is used as a carbon 
source, acetyl-CoA was converted to acetate under aerobic conditions, which is toxic for 
E. coli and inhibits its growth (Luli and Strohl, 1990). By over-expressing E. coli acetate 
assimilation pathways it is possible to increase the productivity of the desired compound 
and, at the same time, reduce acetate accumulation. The first pathway includes two 
enzymes, acetate kinase (ACK) and phosphotransacetylase (PTA) (El-Mansi and Holms, 
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1989), and the second pathway includes acetyl-CoA synthase (ACS). According to 
Leonard et al. (2007), ACS overexpression resulted in a more efficient acetate 
assimilation than the ACK-PTA overexpression. The better results obtained with ACS are 
likely due to the reversibility of the ACK-PTA pathway (Prüβ and Wolfe, 1994). ACS co-
expression with ACC increased flavonoids production up to 1221% (Leonard et al., 
2007). 
Another strategy to increase the malonyl-CoA supply is the overexpression of Rhizobium 
trifolii matB and matC genes encoding for malonate synthase and malonate carrier 
protein, respectively (Leonard et al., 2008; Santos et al., 2011; Wu et al., 2013). These 
enzymes allow the transport of supplemented malonate into the cell and its subsequent 
conversion to malonyl-CoA. Santos et al. (2011) obtained an increase of flavonoids 
synthesis up to 59% with this approach, while Leonard et al. (2008) obtained up to 250%.  
Other strategies include the deletion of the genes encoding succinate dehydrogenase 
(sdhA), acetaldehyde dehydrogenase (adhE), amino acid transporter (brnQ), citrate lyase 
(citE) (Fowler et al., 2009), fumarase (FUM, encoded by fumB and fumC), succinyl-CoA 
synthetase (SUCOAS, encoded by sucC and sucD) and overexpression of 
phosphoglycerate kinase (PGK), glyceraldehyde-3-phosphate dehydrogenase (GAPD) 
and pyruvate dehydrogenase (PDH, encoded by aceEF and lpdA) (Xu et al., 2011). 
Leonard et al. (2008) added the fatty acid inhibitor cerulenin to the fermentation to down-
regulate fatty acid biosynthesis (FAB) initiation. Cerulenin represses both fabB and fabF 
and led to an increase of flavonoids production by over 900%. Santos et al. (2011) also 
obtained a significant gain with cerulenin supplementation. However, the cost of 
cerulenin may be excessive if industrial scale fermentations are foreseen (Santos et al., 
2011). Therefore, a strategy that focuses on re-routing native metabolic flows and uses 
stoichiometric modeling (Fowler et al., 2009) to improve malonyl-CoA availability is 
more appropriate for increasing curcuminoids production.  
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2.4.5 Other Limitations 
Although several studies in the last years made significant progress in proving the 
practicality of curcuminoids production in E. coli, the established protocols still present 
some disadvantages that could be prohibitive during process scale-up. One of them is the 
dependence on precursor feeding, which may be solved by engineering strains capable of 
converting cheaper substrates as glucose. A second limitation is that fermentation often 
needs two separate cultivation steps to obtain high titers of curcuminoids. Usually strains 
are first grown in a rich medium like LB (Luria-Bertani) in order to produce large 
amounts of biomass and reach a suitable protein production level. Then, after reaching the 
exponential phase, the cells are harvested and transferred to minimal medium, like M9 
medium, where the substrates are added and the curcuminoids are produced. This strategy 
was pursued in curcuminoids production in vivo (Katsuyama et al., 2010a; Katsuyama et 
al., 2008; Wang et al., 2013) and also in other phenolic compounds (Choi et al., 2011; 
Fowler et al., 2009; Huang et al., 2013; Hwang et al., 2003; Kang et al., 2012; Kim et al., 
2013; Leonard et al., 2008; Malla et al., 2011; Miyahisa et al., 2005; Xu et al., 2011). The 
use of plasmids imposes a metabolic burden on the host strain that usually reduces the 
growth rate of the cell due to the expression of plasmid-born resistance and replication of 
the plasmids. Therefore, the two-step fermentation strategy is used to compensate the 
metabolic burden associated with protein overexpression and poor growth observed in 
minimal medium. Although this strategy is feasible at laboratory scale, the separation of 
biomass is much more difficult and expensive in large-scale fermentations (Santos et al., 
2011). Therefore, the development of vigorous strains that allow an efficient production 
in a single medium formulation is essential (Santos et al., 2011). The use of MOPS 
minimal medium (Neidhardt et al., 1974) has resulted in the successful production of 
flavonoids in a one-step fermentation (Santos et al., 2011; Wu et al., 2013) with no 
apparent growth deficiencies. Delaying the IPTG induction can also alleviate the 
metabolic burden. Induction should be performed at the exponential phase, since after that 
point, although bacteria are still growing, the production titers decrease (Santos et al., 
2011; Wu et al., 2013). During induction, temperature should be maintained or decreased 
to 26-30 ºC for optimal enzyme synthesis and substrate conversion. The compounds 
possibly used as substrates (caffeic acid, p-coumaric acid and ferulic acid) present some 
toxicity to the cells at high concentrations (Watts et al., 2006; Zhang and Stephanopoulos, 
2013) and cases where a lower concentration is added at the beginning of the experiment 
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and more is added after consumption is almost completed showed better results (Huang et 
al., 2013) and should be considered, as well as fed-batch fermentations. 
The success of the design and construction of heterologous pathways and their expression 
depends on many factors. These factors include cell growth characteristics, but also 
expression levels and biological activity of the proteins of interest. The host, the codon 
biases among different organisms and the strength of promoters linked to the potential 
toxicity of the protein to the host are topics that should always be considered in 
recombinant protein expression. A stable, robust and well characterized host cell capable 
of growing on minimal and inexpensive carbon sources is crucial for laboratory and 
large-scale production (Keasling, 2008). However, robust hosts are usually able to 
inactivate or rid themselves of the foreign DNA to minimize the metabolic burden. 
Several studies proved that genome reductions (removal of transposons, insertion 
sequence elements, cryptic phages, integrases, damaged genes and unknown function 
genes) improves metabolic efficiency and even electroporation efficiency and accurate 
propagation of foreign DNA that was unstable in other strains (Kolisnychenko et al., 
2002; Pósfai et al., 2006; Sharma et al., 2007a; Sharma et al., 2007b). These strains 
should be considered for curcuminoids production. The vector(s) used to carry the 
curcuminoids pathway should also be stable and consistent in copy number to ensure that 
all the cells in the culture have the plasmid and produce curcuminoids. Plasmids should 
also have copy numbers as low as possible to minimize burden on the host cell and the 
ability to carry large sequences of DNA. A better option is to integrate the genes of 
interest in the chromosome due to the increased stability. This insertion can dramatically 
impact the expression level of the heterologous genes; however, the promoter and 
ribosome binding strength can be adapted, as well as the stability of the mRNA and the 
resulting protein (Keasling, 2008; Keasling, 2012). When expressing multiple 
heterologous genes, several approaches can be used. For example, different inducible 
promoters can be used for each gene. This approach has the disadvantage of adding 
multiple inducers to the medium increasing the cost of production.  It is also possible to 
use the same inducible promoter for each gene but vary the promoter strength or to use 
non-native T7 RNA polymerase to control the expression (Katsuyama et al., 2008; Wang 
et al., 2013). Grouping multiple and related genes into operons is also a good approach 
for regulating several genes simultaneously using the same promoter (Furuya and Kino, 
2009; Juminaga et al., 2012).  
Literature Review | 43 
 
  Design and construction of a new biosynthetic pathway for the production of curcuminoids in E.coli 
Joana L. Rodrigues  Universidade do Minho, 2014 
The choice of the right promoter with the adequate strength is very important especially 
when the construction of the metabolic pathway involves the introduction of more than 
one heterologous gene, as is the case in curcuminoids production. Imbalances can lead to 
over- or underproduction of enzymes and accumulation of intermediate metabolites which 
may result in suboptimal titers. Codon bias is also a subject to take into consideration 
since rare codons in E. coli are often abundant in heterologous genes and expression of 
those genes can lead to translational errors, frameshifting events, stalling or premature 
translational termination, especially when transcripts containing rare codons accumulate 
in large quantities (McNulty et al., 2003). This codon bias can be solved using synthetic 
DNA with codon-optimization or by co-transformation of the host with a plasmid 
harboring rare tRNA thus increasing the copy number of the limiting tRNA (Leonard et 
al., 2006b). So far, in heterologous production of curcuminoids by E. coli using plant 
genes (Katsuyama et al., 2010a; Katsuyama et al., 2008; Wang et al., 2013), no 
approaches to solve codon bias were used, which proves that successful production can be 
achieved using plant cDNA. Since this is the simplest and least expensive approach, it is 
always worth testing it first. Flavonoids and stilbenes production was also achieved 
recently without codon-optimization (Hwang et al., 2003; Kim et al., 2013; Leonard et al., 
2006a; Miyahisa et al., 2005; Watts et al., 2006; Watts et al., 2004). In addition to Shine-
Dalgarno sequence importance in translation efficiency, the first codons downstream of 
the initiation codon also act as a translation enhancer and depending on this sequence, 
gene expression can vary considerably (Stenström and Isaksson, 2002; Stenström et al., 
2001; Valdivia and Isaksson, 2004). In summary, to achieve production-scalable titers, 
codon-optimization of recombinant plant proteins and improvement of catalytic activity, 
and also the identification of the best combination of plasmid copy number with the right 
promoters to achieve optimal expression levels instead of maximal need to be carefully 
studied. 
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2.5 Production of Curcuminoids in E. coli and the Development of New 
Bacterial Therapies 
Curcuminoids have been intensively studied as therapeutic agents, as mentioned before 
(section 2.1). It was found that, similarly to most of the other anticancer and antioxidant 
agents, their major drawbacks are their low aqueous solubility and low systemic 
bioavailability in vivo. These drawbacks limit the delivery of appropriate curcuminoids 
concentrations able to produce a therapeutic effect in certain tissues (Anand et al., 2007; 
Ireson et al., 2001; Lin et al., 2001; Lin et al., 2012; Pan et al., 1999). Thus, curcuminoids 
should ideally be supplied locally at the site of the disease to reach an effective 
concentration sufficient to kill tumor cells, having at the same time a beneficial 
antioxidant effect to nearby non-tumor cells (Lin et al., 2012). Taking these aspects into 
consideration, new methods for curcuminoids production process and delivery ought to be 
developed.  
 
2.5.1 Standard Cancer Treatments and their Limitations 
Every year millions of people are diagnosed with cancer. Standard treatments to destroy 
or weaken the tumor cells in different types of cancer commonly include surgery, 
chemotherapy and radiation. However, their success is limited and often these treatments 
cannot completely destroy all cancer cells, and also result in a considerable damage of the 
healthy tissue (Ruder et al., 2011). The lack of selective toxicity of anticancer drugs, as 
well as the incomplete drug targeting and penetration in the tumor are the main causes for 
such outcome (Minchinton and Tannock, 2006). Radiation therapy, which relies on the 
formation of oxygen radicals to damage DNA of cancer cells, is limited by the lack of 
oxygen in the poor vascularized tumor regions. These regions are also less sensitive to 
chemotherapy because drug delivery to these regions is suboptimal (Dang et al., 2001; 
Forbes, 2006).  
Besides the above mentioned standard treatments, laser therapy and ultrasound 
hyperthermia treatments have also been extensively used in cancer treatment, specifically 
in breast cancer (Al-Bataineh et al., 2012; Dowlatshahi and Alvarado, 2014). These 
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treatment techniques are less invasive and are localized, with the tumors being destroyed 
due to the direct heating of tumor cells that reach temperatures around 50-60 ºC (Lee et 
al., 2008; Yu et al., 2013). However, these treatments are often inefficient, just heating or 
fragmenting the tumors instead of completely destroying them.  
Since all cancer therapies have their drawbacks and limited efficacy, the development of 
new therapies is of utmost relevance to decrease cancer morbidity and mortality. 
 
2.5.2 Bacterial Therapies 
Synthetic biology can offer novel solutions for the development of therapeutic 
approaches, like bacterial therapies where bacteria are engineered to safely target and kill 
tumors. Indeed, bacterial therapies may be, in the future, the next generation of cancer 
therapeutics (Forbes, 2006; Forbes, 2010) since they possess unique features to overcome 
conventional therapy deficiencies. Bacteria can migrate to hypoxic, necrotic, apoptotic 
and/or quiescent regions of tumors that conventional cancer drugs cannot efficiently 
reach. Once they reach tumor regions they can invade cancer cells under specific in vivo 
conditions and, whenever inside, kill tumor cells. This represents a more effective way to 
kill all the cells in a tumor as bacteria compete for limited nutrients and can excrete drugs 
or cytotoxic agents in situ that target specific cancer-related pathways (Forbes, 2006; Lee, 
2012; Ruder et al., 2011). The appropriate concentration of the bioactive molecules, e.g. 
curcuminoids, could be optimized using an external stimulus, for example light or heat 
(Lee et al., 2008; Pitt et al., 2004). Bacterial therapy should be combined with other 
cancer therapies, which will have a synergistic effect to reduce the duration of cancer 
treatment, local recurrence, metastasis and cancer mortality (Forbes, 2006). 
Over the past years many anaerobic or facultative anaerobic bacteria, including 
Salmonella (Ganai et al., 2011), Escherichia (Jiang et al., 2010; Zhou et al., 2011), 
Clostridium (Dang et al., 2004; Dang et al., 2001; Roberts et al., 2014) and 
Bifidobacterium (Zhu et al., 2011) have been shown to selectively accumulate in tumors, 
reduce tumor growth and cause regression. Since many of these strains are intrinsically 
pathogenic, their toxicity has to be eliminated before their use in bacterial therapies can 
be considered. In the case of Clostridium and Salmonella, non-pathogenic strains or 
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strains with pathogenicity and immunogenicity related genes deleted have been used 
(Clairmont et al., 2000; Liu et al., 2002; Low et al., 1999; Zhang et al., 2014).  
The attenuated strain of Clostridium novyi (C. novyi-NT) has been proven to induce 
tumor localized response after intratumoral injection of C. novyi-NT spores in tumors of 
rats, dogs and one human patient (Roberts et al., 2014). Although this kind of treatment 
has proven to be very promising, it has a limitation that is also an advantage, namely 
obligate anaerobes like Clostridium germinate only in hypoxic regions of tumors and 
cannot target non-hypoxic tumor regions (Forbes, 2006). Therefore, these bacteria are 
non-toxic to healthy tissue. However, they leave viable tumor cells at the tumor periphery 
which allows these cells to continue to grow and repopulate the tumor, so permanent 
eradication is not always guaranteed (Forbes and Kasinskas, 2011). Facultative anaerobic 
bacteria like Salmonella typhimurium and E. coli have the advantage of being able to 
colonize both small metastatic lesions and large quiescent and apoptotic tumor regions 
(Kasinskas and Forbes, 2006; Thamm et al., 2005). Salmonella has been shown to 
selectively accumulate in tumors in amounts 1000 to 10000 fold higher than in any other 
healthy tissue in mice (Clairmont et al., 2000; Forbes et al., 2003; Ganai et al., 2009). 
Also, facultative anaerobes, unlike Clostridium, can be administered as active motile 
bacteria. These differences allow the tuning of the target mechanism of facultative 
anaerobes while the targeting mechanism of obligate anaerobes is fixed (Forbes, 2006; 
Toley and Forbes, 2012). Therefore, facultative and obligate anaerobic bacterial therapies 
might be combined since different bacteria will have different results in cancer treatment, 
depending on the location and tumor type. 
For bacterial treatments with E. coli, non-pathogenic strains have been used and invasin 
gene from Yersinia pseudotuberculosis and listeriolysin O gene from Listeria 
monocytogenes were expressed to enable them to be applied as gene delivery vectors 
(Anderson et al., 2006; Fajac et al., 2004; Grillot-Courvalin et al., 1998). The production 
of invasin enabled the bacteria to selectively invade the mammalian cells expressing β1-
integrins by phagocytosis. On the other hand, listeriolysin O expression triggers the 
breakdown of phagosome/lysosome membranes, thus releasing its content into the host 
cell cytoplasm (Critchley et al., 2004). This is also facilitated by the fact that the E. coli 
strain used is auxotrophic for diaminopimelic acid (DAP) due to the deletion of aspartate 
semi-aldehyde dehydrogenase, an enzyme necessary for DAP synthesis. DAP is usually 
present in the peptidoglycan layer of the gram-negative bacteria cell wall and its 
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deficiency impairs cell wall synthesis inducing lysis. The expression of invasin and 
listeriolysin O genes, as well as other genes of interest, can be under the control of 
promoters regulated by hypoxia, heat or other environmental condition (Anderson et al., 
2006; Arrach et al., 2008; Chang et al., 2011). This way, its expression will be 
preferentially induced in tumors and limited outside the tumor, reducing potential side 
effects to surrounding healthy tissues. All these successful modifications suggest that 
engineered E. coli can potentially be used as a delivery vector of therapeutic molecules 
(genes, proteins or pro-drugs). E. coli was also engineered to produce Staphylococcus 
aureus α-hemolysin (SAH) (Jean et al., 2014), a pore-forming protein/toxin that has been 
recently found to be naturally secreted in a fully functional form in E. coli and to 
aggressively kill mammalian cancer cells (Swofford et al., 2014). Microbial synthesized 
SAH was found to increase necrotic tissue and quickly reduce tumor volume (Jean et al., 
2014) by creating pores that disrupt and destroy cellular membranes, as well as induce 
cell swelling and lysis (Swofford et al., 2014). 
When applying bacterial therapy it is very important to choose the best expression 
inducer. For example, chemical inducers like arabinose are not the best choice due to its 
rapid clearance from the blood, poor tissue penetration and cellular consumption, 
resulting in insufficient amounts of drugs produced by the bacteria (Dai et al., 2013; 
Loessner et al., 2007; Seri et al., 1996). Also, bacteria and chemical inducers are cleared 
from the blood after 6 h of injection (Clairmont et al., 2000) and most bacteria are cleared 
from the spleen and liver (organs that accumulate more bacteria) after 48 h. Therefore, 
other induction methods should be considered. The use of heat shock to trigger the 
expression of the genes of interest can be a good option. Using this type of induction it is 
possible to induce the expression after bacteria have been cleared from normal organs and 
the drug is only expressed in the tumors (Jean et al., 2014). Also, the use of treatments 
that increase cellular temperature (ultrasounds or laser therapy) can be combined with 
these bacterial therapies leading to induced expression. The use of heat shock promoters 
has been evaluated for gene therapy, where human heat shock promoters have also been 
extensively studied (Huang and Liauh, 2012; Rohmer et al., 2008; Rome et al., 2005; 
Walther and Stein, 2009; Xu et al., 2004). Gene therapy needs a total space and temporal 
control of transgenic gene expression and by using the heat shock promoters there is no 
need to use invasive methods for control (Rome et al., 2005). 
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According to Forbes (2010), many key challenges remain before bacteria can be used 
routinely in treatments, including intrinsic bacterial toxicity, targeting efficiency, genetic 
instability and limited drug production. These challenges may be solved using synthetic 
biology techniques and in the future the engineered bacteria will be able to diagnose 
disease, and safely produce and deliver drugs by controlling their administration and 
production (Claesen and Fischbach, 2014).  
 
2.5.3 The Combination of Laser or Ultrasound with Bacterial Therapy in Curcumin 
Production and Administration 
Curcumin and ultrasound or laser therapies have been tested in the treatment of several 
types of cancer or in the eradication of antibiotic-resistant bacteria. Curcumin has shown 
promising results as an efficient enhancer of ultrasound treatment (Wang et al., 2014; 
Wang et al., 2011a). In vitro studies showed that cytotoxicity induced by ultrasound 
treatment alone and curcumin treatment alone in nasopharyngeal carcinoma cells was 
18% and 25%, respectively, and that the combined ultrasound and curcumin treatment 
significantly increased cytotoxicity to around 87% (Wang et al., 2011a).  
The development of a bacterial therapy combined with laser or ultrasound treatment that 
can be triggered in situ by heat, using bacterial heat shock promoters and producing 
curcumin or other curcuminoids might be very effective in the treatment of cancer. This 
type of induction directs drug production into tumors and prevents production in normal 
tissues. This way, the required dosage of curcumin, or other drug, is reduced and it will 
achieve a comparable therapeutic effect and at the same time the undesired side effects 
will be also reduced (Lee et al., 2008). 
 
2.6 Future Perspectives 
In the last decade, there have been remarkable advances in understanding the biosynthetic 
pathway of curcuminoids production in C. longa and its heterologous production in E. 
coli. However, continuous efforts towards exploiting new heterologous hosts and finding 
the most adequate synthetic enzymes and plasmids are needed. Several enzymes should 
Literature Review | 49 
 
  Design and construction of a new biosynthetic pathway for the production of curcuminoids in E.coli 
Joana L. Rodrigues  Universidade do Minho, 2014 
be studied to find the best candidates for each step of the curcuminoids production 
pathway to adequately transform the metabolic intermediates into the desired products. 
Intermediates accumulation should be avoided since it can be toxic to the heterologous 
host and lead to a decrease of the desired final product. 
Microbial production of curcuminoids is still at an early stage and is limited by the 
identification of some curcuminoid synthases, while PKS diversity is barely touched. A 
deeper study is extremely important and would allow the identification of novel enzymes 
that catalyze unnatural reactions and consequently produce more unnatural, potentially 
valuable curcuminoids. The huge accumulation of genome information from a variety of 
organisms due to the development of molecular biology techniques and bioinformatic 
prediction of catalytic properties of gene products will allow combination of the best 
enzymes to generate novel biosynthetic pathways for curcuminoids production in several 
organisms. These pathways can one day be used in bacterial therapies for cancer 
treatment. 
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CHAPTER 3 
Heterologous Production of Caffeic Acid from Tyrosine in Escherichia 
coli 
 
Caffeic acid is a plant secondary metabolite and its biological synthesis has attracted 
increased attention due to its beneficial effects on human health. In this study, 
Escherichia coli was engineered for the production of caffeic acid using tyrosine as the 
initial precursor of the pathway. The pathway design included tyrosine ammonia lyase 
(TAL) from Rhodotorula glutinis to convert tyrosine to p-coumaric acid and 4-coumarate 
3-hydroxylase (C3H) from Saccharothrix espanaensis or cytochrome P450 CYP199A2 
from Rhodopseudomonas palustris to convert p-coumaric acid to caffeic acid. The genes 
were codon-optimized and different combinations of plasmids were used to improve the 
titer of caffeic acid. TAL was able to efficiently convert 3 mM of tyrosine to p-coumaric 
acid with the highest production obtained being 2.62 mM (472 mg/L). CYP199A2 
exhibited higher catalytic activity towards p-coumaric acid than C3H. The highest caffeic 
acid production obtained using TAL and CYP199A2 and TAL and C3H was 1.56 mM 
(280 mg/L) and 1 mM (180 mg/L), respectively. This is the first study that shows caffeic 
acid production using CYP199A2 and tyrosine as the initial precursor. This study 
suggests the possibility of further producing more complex plant secondary metabolites 
like flavonoids and curcuminoids. 
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The information presented in this Chapter was submitted to Enzyme and Microbial 
Technology journal: 
Rodrigues J.L., Araújo R.G., Prather K.L.J., Kluskens L.D., Rodrigues L.R. Heterologous 
production of caffeic acid from tyrosine in Escherichia coli (October 2014). 
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3.1 Introduction 
Caffeic acid is a natural phenolic compound derived from the phenylpropanoid pathway 
in plants. Phenylpropanoic acids, especially caffeic acid, have attracted an increased 
attention owing to their valuable properties, including antioxidant (Mori and Iwahashi, 
2009), anti-inflammatory (Chao et al., 2009), anticancer (Prasad et al., 2011), antiviral 
(Ikeda et al., 2011), antidiabetic (Jung et al., 2006) and antidepressive (Takeda et al., 
2002). Due to its pharmaceutical applications there is an established market for caffeic 
acid production. Caffeic acid is mainly obtained by extraction from plants and these 
extraction methods include high temperatures, treatment with petroleum and solvent 
extraction (methanol, ethyl acetate), thus being energy-intensive and environmentally 
unfriendly (Xing et al., 2012). Moreover, the yields obtained are low because it 
accumulates at low levels in plant cells. To meet the phenylpropanoids market needs, it is 
imperative to look for new green and environmental production methods to replace the 
traditional extraction one. One way to achieve high levels of caffeic acid is the production 
via engineered microorganisms, such as Escherichia coli (Furuya et al., 2012; Furuya and 
Kino, 2013; Huang et al., 2013). 
Natural caffeic acid production starts with the deamination of the amino acid 
phenylalanine which is converted to cinnamic acid by phenylalanine ammonia lyase 
(PAL) (Figure 3.1). Then, cinnamic acid is converted to p-coumaric acid by cinnamate-4-
hydroxylase (C4H), and caffeic acid is obtained from p-coumaric acid using 4-coumarate 
3-hydroxylase (C3H). Tyrosine can also be used as a precursor as some PALs also have 
tyrosine ammonia lyase (TAL) activity (Hwang et al., 2003; Miyahisa et al., 2005). Since 
tyrosine already possesses a 4-hydroxyl group, its use is advantageous as it can be 
directly converted to p-coumaric acid, thus decreasing the number of steps to produce 
caffeic acid. Also, using TAL, the C4H enzyme that is essential for caffeic acid 
production in plants and which has not yet been successfully expressed in prokaryotic 
organisms (Watts et al., 2004) is not needed anymore. 
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Figure 3.1. Artificial caffeic acid biosynthetic pathway. The dashed box represents the caffeic acid pathway 
in plants. Inside and outside the box some strategies used to produce caffeic acid in E. coli are illustrated. 
TAL: Tyrosine ammonia lyase; C3H: 4-coumarate 3-hydroxylase; 4HPA3H: hydroxyphenylacetate 3-
hydroxylase; 4CL: 4-coumarate-CoA ligase.  
 
In the last decade several efforts have been conducted to produce caffeic acid using 
microorganisms. Berner et al. (2006) identified sam8 and sam5 genes, encoding TAL and 
C3H involved in caffeic acid biosynthesis in the Actinomycete Saccharothrix espanaensis 
and expressed them in Streptomyces fradiae XKS. After that, these enzymes were used to 
produce caffeic acid in E. coli (Table 3.1). Other bacterial TAL (Rhodobacter capsulatus 
and Rhodotorula glutinis) were also used for the production of p-coumaric acid and 
hydroxyphenylacetate 3-hydroxylase (4HPA3H) from E. coli or Pseudomonas 
aeruginosa, and cytochrome P450 CYP199A2 from Rhodopseudomonas palustris was 
proved to convert p-coumaric acid to caffeic acid with a high yield.  
In this study, the production of caffeic acid from tyrosine or p-coumaric acid is described. 
To convert tyrosine in p-coumaric acid TAL was used from R. glutinis. p-coumaric acid 
was converted to caffeic acid using C3H from S. espanaensis or CYP199A2 from R. 
palustris. Although all these genes have been previously used in the caffeic acid 
production, it is important to mention that, as far as it is known, the caffeic acid 
production from tyrosine using CYP199A2 in the pathway has never been attempted. 
Additionally, in the current study, the titers of caffeic acid obtained using TAL and C3H 
genes were higher than the ones reported in other studies using the same genes. These 
high yields were obtained by using different combinations of plasmids and genetic 
arrangement.
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Table 3.1. Caffeic acid production in Escherichia coli. Genes/organisms used in the caffeic acid biosynthetic pathway, fermentation conditions and titers. 
 
aTAL - tyrosine ammonia lyase; OpTAL - codon-optimized TAL; C3H - 4-coumarate 3-hydroxylase; 4HPA3H - hydroxyphenylacetate 3-hydroxylase; Pdr – putidaredoxin reductase; Pux – palustrisredoxin.  
bIn some studies a tyrosine overproducing strain was used in which: tyrR (tyrosine repressor) and pheA (chorismate mutase / prephenate dehydratase) were deleted (ΔtyrR and ΔpheA) to direct the pathway only to 
tyrosine production;  ppsA (PEP synthase) and tktA (transkelotase) were overexpressed to increase the availability of the two main precursors of aromatic amino acids biosynthesis; and tyrA (chorismate mutase / 
prephenate dehydrogenase) and aroG (3-deoxy-D-arabino-heptulosonate 7-phosphate synthase) gene sequences were modified and the feedback inhibition-resistant derivatives (tyrAfbr and aroGfbr) were 
overexpressed  to remove the transcriptional control mediated by tyrosine and phenylalanine. 
cTYR strain - tyrosine overproducing strain. 
dAn alternative route through p-coumaroyl-CoA and caffeoyl-CoA (Figure 3.1) using 4CL from P. crispus and E. coli endogenous thiosterase was tested to increase the yield but it was not successful. 
Genes – Organismsa,b Fermentation Conditions Titers (mg/L)c Reference 
TAL - S. espanaensis 
C3H - S. espanaensis 
First induction in LB at 37 ºC. After 5 h cells were transferred to M9 medium 
(glucose) at 26 ºC for 36 h 
(not mentioned) 
Choi et al. 
(2011) 
TAL - R. capsulatus 
4HPA3H - E. coli 
ΔtyrR; tyrAfbr-ppsA-tktA-aroGfbr 
M9 medium (glucose and glycerol) at 37 ºC. After induction shake flasks were 
transferred  to 30 ºC for 48 h 
50.2 (TYR strain) 
12.1 (wild-type) 
Lin and Yan 
(2012) 
TAL and opTAL - S. espanaensis  
C3H - S. espanaensis 
ΔtyrR; tyrAfbr- aroGfbr 
First induction in LB at 37 ºC. After 5 h cells were harvested and transferred to 
M9 medium (glucose) at 26 ºC for 36 h in shake flasks 
150 (TAL, TYR strain) 
40 (opTAL,  TYR strain) 
42 (TAL, wild-type) 
14 (opTAL, wild-type) 
Kang et al. 
(2012) 
CYP199A2 (wild-type and mutant 
F185L) - R. palustris 
Pdr - Pseudomonas putida 
Pux - R. palustris 
Potassium phosphate buffer (glucose or glycerol) at 30 ºC in shake flasks. 20 mM 
p-coumaric acid was added.  
510 (wild-type) 
2800 (mutant) 
Furuya et al. 
(2012) 
TAL - R. glutinis 
C3H - S. espanaensis 
ΔpheA ΔtyrR; tyrAfbr-aroGfbr 
MOPS medium (glucose or xylose), synthetic medium (glucose or xylose) or LB 
(glucose or xylose) at 37 ºC for 72 h in test tubes; 
Synthetic medium (glucose) at 37 ºC for 7 days in bioreactor 
88 (LB, glucose, test tube) 
106 (bioreactor) 
Zhang and 
Stephanopoulos 
(2013)
d
 
TAL - R. glutinis 
4HPA3H - E. coli 
ΔpheA; tyrAfbr-ppsA-tktA-aroGfbr 
M9 medium (yeast extract and glycerol, or glucose and glycerol) at 37 ºC for 72 
h in shake flasks. 20 mM p-coumaric acid fed 3 h after induction and 3 mM 
added afterward (wild-type case) 
3820  (wild-type) 
766.68 (TYR strain) 
Huang et al. 
(2013) 
4HPA3H - P. aeruginosa 
Potassium phosphate buffer (glucose or glycerol) at 30 ºC for 24 h in shake 
flasks. 20 mM of p-coumaric acid was added 3 times 
10200 
Furuya and 
Kino (2013) 
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3.2 Materials and Methods 
3.2.1 Bacterial Strains, Plasmids and Chemicals 
E. coli ElectroMAX
TM
 DH10B competent cells (Invitrogen/Life Technologies, Carlsbad, 
CA, USA) were used for molecular cloning and vector propagation. E. coli K-12 
MG1655(DE3) (Nielsen et al., 2010) was used as the host for the expression of genes 
under the control of the T7 promoter.  
P. putida JCM 6157 strain (ATCC 17453, Manassas, VA, USA) and R. palustris 
CGA009 gDNA (ATCC BAA-98) were used to amplify the pdr and pux genes. The 
characteristics of all the strains and plasmids used in this study are described in Table 
3.2. 
L-Tyrosine, p-coumaric acid and caffeic acid were purchased from Sigma-Aldrich 
(Steinheim, Germany), isopropyl β-D-thiogalactopyranoside (IPTG) and Luria-Bertani 
(LB) medium from NZYTech (Lisbon, Portugal) and anhydrotetracycline (aTc) from 
Acros (Geel, Belgium). Glucose (Acros), Na2HPO4 (Scharlau, Sentmenat, Spain), 
MgSO4, KH2PO4 (Riel-deHaën, Seelze, Germany), NH4Cl, NaCl, CaCO3 (Panreac, 
Barcelona, Spain) and thiamine (Fisher Scientific, Loughborough, UK) were used to 
prepare the M9 modified salt medium. The following mineral traces and vitamins were 
supplemented to the M9 medium: FeCl3, ZnCl2, CoCl2, CuCl2, nicotinic acid (Riedel-
deHaën), NaMoO4, H2BO3, pyridoxine, biotin, folic acid (Merck), riboflavin and 
pantothenic acid (Sigma Aldrich). Ampicillin (Applichem, Darmstadt, Germany), 
chloramphenicol, kanamycin (NZYtech) and spectinomycin (Panreac) were used when 
necessary. 
3.2.2 Codon-Optimization and Synthesis of TAL, C3H and CYP199A2  
TAL, C3H and CYP199A2 genes were codon-optimized for E. coli, synthesized and 
cloned in pUC57 vector by GenScript (Piscataway, NJ, USA). In addition to codon-
optimization, the phenylalanine residue at 185 position (F185) of CYP199A2 was 
replaced by leucine (F185L) (Furuya et al., 2012). The DNA sequences of the codon-
optimized genes are provided in Appendix A (Table A1). 
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Table 3.2. Bacterial strains and plasmids used in this study. 
Strains Relevant Genotype Source 
E. coli Electromax 
DH10B 
F
- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 
endA1 araD139  ∆(ara, leu)7697 galU galK λ- rpsL nupG 
Invitrogen 
E. coli K-12 
MG1655(DE3) 
F
-
 λ-  ilvG- rfb-50 rph-1 λ(DE3) 
(Nielsen et al., 
2010) 
P. putida JCM 6157  ATCC 17453 
Genomic DNA  Source 
R. palustris 
CGA009 
 
ATCC BAA-
98D-5 
Plasmids Construct Source 
pETDuet-1 ColE1(pBR322) ori, lacI, double T7lac, Amp
R
 Novagen 
pCDFDuet-1 CloDF13 ori, lacI, double T7lac, Strep
R
 Novagen 
pRSFDuet-1 RSF ori, lacI, double T7lac, Kan
R
 Novagen 
pKVS45 p15A ori, tetR, Ptet, Amp
R
 
(Solomon et 
al., 2012) 
pUC57_TAL pUC57 carrying codon-optimized TAL from R. glutinis GenScript 
pUC57_C3H pUC57 carrying codon-optimized C3H from S. espanaensis GenScript 
pUC57_CYP199A2 pUC57 carrying codon-optimized CYP199A2 from R. palustris GenScript 
pETDuet_TAL pETDuet-1 carrying codon-optimized TAL from R. glutinis This study 
pETDuet_C3H pETDuet-1 carrying codon-optimized C3H from S. espanaensis This study 
pETDuet_TAL_ 
C3H 
pETDuet_TAL carrying codon-optimized C3H from S. 
espanaensis 
This study 
pCDFDuet_TAL pCDFDuet-1 carrying codon-optimized TAL from R. glutinis This study 
pCDFDuet_C3H pCDFDuet-1 carrying codon-optimized C3H from S. espanaensis This study 
pCDFDuet_CYP 
pCDFDuet-1 carrying codon-optimized CYP199A2 from R. 
palustris 
This study 
pCDFDuet_CYP 
(+7aa) 
pCDFDuet-1 carrying codon-optimized CYP199A2 from R. 
palustris with the first 7 amino acids 
This study 
pCDFDuet_TAL_ 
CYP 
pCDFDuet_TAL carrying codon-optimized CYP199A2 from R. 
palustris  
This study 
pCDFDuet_TAL_ 
CYP (+7aa) 
pCDFDuet_TAL carrying CYP199A2 from R. palustris with the 
first 7 amino acids  
This study 
pCDFDuet_TAL_ 
CYP_op 
pCDFDuet-1 carrying codon-optimized TAL from R. glutinis and 
CYP199A2 from R. palustris in an operon 
This study 
pCDFDuet_TAL_ 
CYP(+7aa)_op 
pCDFDuet-1 carrying codon-optimized TAL from R. glutinis and 
CYP199A2 from R. palustris with the first 7 amino acids in an 
operon 
This study 
pKVS45_TAL pKVS45 carrying codon-optimized TAL from R. glutinis This study 
pKVS45_C3H pKVS45 carrying codon-optimized C3H from S. espanaensis This study 
pRSFDuet_TAL pRSFDuet-1 carrying codon-optimized TAL from R. glutinis This study 
pRSFDuet_C3H pRSFDue-1t carrying codon-optimized C3H from S. espanaensis This study 
pKVS45_Pdr_Pux_ 
op 
pKVS45 carrying Pdr from P. putida and Pux from R. palustris in 
an operon 
This study 
pETDuet_Pdr_Pux_ 
op 
pETDuet-1 carrying Pdr from P. putida and Pux from R. palustris 
in an operon 
This study 
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3.2.3 Construction of Plasmids 
The genes encoding TAL and C3H were expressed in E. coli cells using the pETDuet-1, 
pCDFDuet-1, pRSFDuet-1 and pKVS45 vectors (Table 3.2). The gene encoding 
CYP199A2 mutant was cloned in pCDFDuet-1 and CYP199A2 redox partners, pdr and 
pux genes were cloned in an operon in pKVS45 using restriction enzymes. All the 
primers used are summarized in Table 3.3. P. putida gDNA was extracted using Wizard
®
 
Genomic DNA Purification Kit (Promega, Madison, WI, USA) and used as template for 
the amplification of the pux gene. All the plasmid DNA was isolated using QIAprep Spin 
Miniprep Kit (Qiagen, Germantown, MD, USA). The genes used in this study were 
amplified by polymerase chain reaction (PCR) using Q5
®
 Hot Start High-Fidelity DNA 
Polymerase (NEB, Ipswich, MA, USA). DNA fragments were purified from agarose 
using Gel DNA Recovery Kit (Zymo Research, Orange, CA, USA). Plasmid DNA and 
genes were quantified in NanoDrop (ND-1000, Thermo Scientific, Wilmington, DE, 
USA) and digested with the appropriate restriction endonucleases (Table 3.3) (NEB) for 
3 h and purified using DNA Clean and Concentrator Kit (Zymo Research). Ligation was 
performed at room temperature for 1 h with T4 DNA ligase (NEB). Chemical 
transformation (heat shock method) was carried out using E. coli Electromax DH10B 
competent cells. All constructed plasmids herein described (Table 3.2) were verified by 
colony PCR or digestion and confirmed by sequencing (Macrogen, Amsterdam, The 
Netherlands or Genewiz, Cambridge, MA, USA), followed by transformation of E. coli 
K-12 MG1655(DE3). All the kits and enzymes were used according to the instructions 
provided by the manufacturers. TAL and CYP199A2 were also cloned in an operon using 
Phusion DNA Polymerase (NEB) and overlap extension PCR (Horton et al., 1989). The 
ribosome binding site (RBS) chosen was the same as used in pETDuet-1, pCDFDuet-1 
and pRSFDuet-1. Reverse primers of TAL gene were overlapped with forward primers of 
the CYP199A2 gene to introduce the RBS and spacer. Briefly, the TAL and CYP199A2 
genes were amplified and the overlapping strands of these intermediate products used in a 
subsequent PCR and extended to generate the full-length product amplified by flanking 
primers that included restriction enzyme sites for inserting the operon into the plasmid. 
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Table 3.3. Set of primers for PCR amplification (forward and reverse primers – FW and REV). 
Primer name Primer sequencea 
Restriction 
enzyme 
TAL_pET_pCDF_pRSF_FW GGCGCGCCAAATGGCTCCGCGTCCG AscI 
TAL_pET_pCDF_pRSF_REV GCGGCCGCTTATGCCAGCATTTTCAGCAG NotI 
TAL_pKVS45_FW CCTAGGAAGGAGATATACCATGGGCAGCAGCCATCACCATCATCACCACAGCCAGGCTCCGCGTCCG AvrII 
TAL_pKVS45_REV GGATCCTTATGCCAGCATTTTC BamHI 
C3H_pET_FW AGATCTCATGACGATTACCTCTCCGGC BglII 
C3H_pET_REV CTCGAGCGTGCCCGGGTTAATCAG XhoI 
C3H_pKVS45_FW CCTAGGAAGGAGATATACCATGGGCAGCAGCCATCACCATCATCACCACAGCCAGACGATTACCTCTCCGGCA AvrII 
C3H_pKVS45_REV GGATCCTTACGTGCCCGGGTTAATCAG BamHI 
C3H_pCDF_pRSF_FW GGCGCGCCAAATGACGATTACCTCTCCGG AscI 
C3H_pCDF_pRSF_REV AAGCTTTTACGTGCCCGGGTTAATC HindIII 
CYP(+7aa)_pCDF_FW CATATGCATCACCATCATCACCACATGACGACCGCTCCGAGCCT NdeI 
CYP_pCDF_FW CATATGCATCACCATCATCACCACATGCCGGTTACGACG NdeI 
CYP_pCDF_REV CTCGAGTCAGGCCGGGGTC XhoI 
TAL_op_FW GGATCCAATGGCTCCGCGTC BamHI 
TAL_op_REV CGTCATGGTATATCTCCTTTTATGCCAGCATTTTCAGC - 
CYP(+7aa)_op_FW ATAAAAGGAGATATACCATGACGACCGCTC - 
CYP_op_REV AAGCTTTCAGGCCGGGGTC HindIII 
TAL_op2_REV GGCATGGTATATCTCCTTTTATGCCAGCATTTTCAGC - 
CYP_op2_FW ATAAAAGGAGATATACCATGCCGGTTACGACG - 
Pdr_pKVS45_FW CCTAGGAATAATTTTGTTTAACTTTAAGAAGGAGATATAATGAACGCAAACGAC NdeI 
Pdr_pKVS45_REV GAGCTCTCAGGCACTACTCAGTTCAGC SacI 
Pux_pKVS45_FW GGATCCAATAATTTTGTTTAACTTTAAGAAGGAGATATAATGCCCAGTATCACGTTCATTCTT BamHI 
Pux_pKVS45_REV GCATGCTCAGACCTGACGATCCGGAAT SphI 
Pdr_Pux_op_pET_FW GAATTCAATGAACGCAAACGACAAC EcoRI 
Pdr_Pux_op_pET_REV GATATCTCAGACCTGACGATCCG EcoRV 
aStart and stop codons in bold, occasionally the start codon is placed upstream of the His6-tag sequence and no stop codon is included because of the presence of a Strep-tag; restriction sites in 
italic; His6-tag underlined; The ribosome binding site (RBS) and spacer are double underlined; In order for the sequence to remain in frame one or two bases were occasionally added between the 
restriction site and the gene start codon. 
60 | Chapter 3 
 
3.2.4 p-Coumaric and Caffeic Acid Production 
E. coli cells for gene cloning, plasmid propagation, and inoculum preparation were grown 
in LB medium at 37 ºC and under shaking conditions (200 rpm). 
For p-coumaric acid and/or caffeic acid production, cultures were grown at 37 ºC in 50 
mL LB to an optical density at 600 nm (OD600) of 0.4. IPTG and/or aTc were added at the 
same time (unless otherwise specified) at a final concentration of 1 mM and 100 ng/mL, 
respectively, and the culture was incubated for 5 h at 26 ºC. The cells were harvested by 
centrifugation, resuspended in 50 mL of modified M9 minimal salt medium containing 
(per liter): glucose (40 g), Na2HPO4 (6g), KH2PO4 (3g), NH4Cl (1g), NaCl (0.5 g), CaCl2 
(17 mg), MgSO4 (58 mg), thiamine (340 mg) and CaCO3 (5 g) (to control the pH), and 
incubated at 26 ºC for 63 h. Trace elements [FeCl3 (54 mg), ZnCl2 (4 mg), CoCl2 (4 mg), 
NaMoO4 (4 mg), CuCl2 (2 mg) and H2BO3 (1 mg)] and vitamins [riboflavin (0.84 mg), 
folic acid (0.084 mg), nicotinic acid (12.2 mg), pyridoxine (2.8 mg), biotin (0.12 mg) and 
pantothenic acid (10.8 mg)] were also supplemented to the M9 medium. Depending on 
the plasmid(s) present in the strain, 100 μg/mL of ampicillin, 100 μg/mL of 
spectinomycin and/or 50 μg/mL of kanamycin were added. IPTG and/or aTc and 
substrates were added at time 0 of induction in M9 medium (unless otherwise stated): 
tyrosine, 3 mM or p-coumaric acid, 2 mM. Samples of the supernatant (1.5 mL) were 
collected at time 0 and after 15, 24, 43 and 63 h. All the experiments were done in 
triplicate and analyzed by high-performance liquid chromatography (HPLC). 
 
3.2.5 HPLC Analysis of the Products 
HPLC analysis was used to quantify p-coumaric acid and caffeic acid using a system 
from Jasco (Easton, MD, USA) (PU-2080 Plus Pump unit, LG-2080-02 Ternary Gradient 
unit, a DG-2080-53 3-Line Degasser unit, a UV-2075 Plus Intelligent UV/VIS Detector 
unit and AS-2057 Plus Intelligent Sampler unit) and a Grace Alltech Platinum EPS C18 
column (3µm, 150 mm × 4.6 mm) (Grace, Columbia, MD, USA). Mobile phases A and B 
were composed of water (0.1% trifluoroacetic acid) and acetonitrile, respectively. The 
following gradient was used at a flow rate of 1 mL/min: 10 - 20% acetonitrile (mobile 
phase B) for 17 min. Quantification was based on the peak areas of absorbance at 275 nm 
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(tyrosine) and 310 nm (p-coumaric acid and caffeic acid). The retention times of tyrosine, 
p-coumaric acid and caffeic acid were 3.3, 8.0 and 11.8 min, respectively. 
 
3.2.6 Protein Analysis 
E. coli K-12 MG1655(DE3) cells harboring pETDuet-1, pETDuet_TAL, pETDuet_C3H 
and pETDuet_TAL_C3H were grown in LB at 37 ºC to an OD600 of 0.6. IPTG was added 
at a final concentration of 1 mM, and the culture was incubated for 24 h. Samples (10 mL 
culture medium) were taken at times 0, 5 and 24 h. Samples were centrifuged and the 
cells were resuspended in phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 
10 mM Na2PO4, 1.8 mM KH2PO4, pH 7.4) and further disrupted by sonication on ice for 
3 min. After centrifugation the protein concentration from the resulting supernatant was 
determined using Protein Assay Dye Reagent Concentrate (BioRad, Hercules, CA, USA) 
with bovine serum albumin (BSA) (NEB) as a standard. The expression levels of TAL 
and C3H were evaluated through sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS–PAGE). Fifteen to 20 µg of total protein were loaded onto a 4-20% 
Mini-PROTEAN
®
 TGX™ Precast Gels (BioRad). The protein marker used was Precision 
Plus Protein
TM
 Unstained (BioRad). For gel staining, Bio-Safe Coomassie Stain (BioRad) 
was used. 
 
 
3.3 Results and Discussion 
3.3.1 Selection of the Appropriate Enzyme Sources 
TAL was chosen from the red yeast R. glutinis, since it was reported to have the highest 
TAL activity and a low PAL/TAL catalytic activity ratio (Gatenby et al., 2002; Vannelli 
et al., 2007a; Xue et al., 2007a). TAL prefers tyrosine and is therefore favored over PAL 
and C4H, both of which are required to begin the pathway from phenylalanine (Figure 
3.1). This decreases the pathway number of steps and at the same time eliminates the 
issues associated with the use of C4H. C4H is a P450-dependent monooxygenase and the 
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functional expression of plant P450 enzymes is always hard to achieve in bacteria, which 
is mainly due to the absence of cytochrome P450 reductases (CPRs)/redox partners in E. 
coli needed for electron transfer, and to the absence of an endoplasmatic reticulum which 
prevents the efficient translational of the membrane signal modules of microsomal P450 
enzymes (Chapple, 1998). C3H from S. espanaensis was chosen as it is one of the rare 
cytochrome P450 enzymes that was successfully expressed in E. coli (Choi et al., 2011) 
(Table 3.1). CYP199A2 from R. palustris was chosen as it was effectively used in 
previous studies to achieve one of the highest caffeic acid production from p-coumaric 
acid (Furuya et al., 2012). 
 
3.3.2 Production of p-Coumaric Acid from Tyrosine using TAL 
In order to study p-coumaric acid production from tyrosine, codon-optimized TAL was 
cloned in pETDuet-1, pCDFDuet-1, pRSFDuet-1 and pKVS45. Figure 3.2 illustrates p-
coumaric acid production from 3 mM of tyrosine. p-Coumaric acid was also produced 
from endogenous tyrosine in the presence of pCDFDuet_TAL, but in a very low quantity 
compared to conditions with tyrosine supplemented. Since the endogenous tyrosine is not 
enough to produce p-coumaric acid in high concentrations, two strategies can be used, 
namely supplement the medium with tyrosine or engineer E. coli to overproduce tyrosine 
from glucose. p-Coumaric acid production using TAL was found to be highly dependent 
on the plasmid chosen. The highest production obtained was 2.62 mM (472 mg/L) and 
was achieved with pRSFDuet-1, which is a high copy number plasmid. In this case, the 
product yield was 0.87 (mol p-coumaric acid/ mol tyrosine) and the remaining tyrosine 
was presumably used for growth and primary metabolism since no tyrosine was detected 
by HPLC. Figure 3.2B shows the production of p-coumaric acid in the strain harboring 
pRSFDuet_TAL over time (63 h). The results show that the p-coumaric concentration 
increases along time, and this trend was also observed when using other plasmid 
constructions (data not shown). Santos et al. (2011) used a codon-optimized R. glutinis 
TAL with a 80% similarity to the one used in this study. Although both plasmids 
(pETDuet-1 and pTrcHis2B) have a pBR322 origin, they have different promoters, with 
the T7 system being stronger than the trc promoter. The p-coumaric acid production 
obtained using pETDuet_TAL (the lowest production in the current study) was higher 
than that reported by Santos et al. (2011) using pTrcHis2B (104 mg/L – 0.61 mM). They 
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obtained a product yield of 0.23 (mol p-coumaric acid / mol tyrosine) in a E. coli K-12 
MG1655(DE3) strain. From analyzing these results it can be concluded that the R. 
glutinis TAL used in in this study and the expression systems chosen are a very good 
option to produce p-coumaric acid. 
 
 
Figure 3.2. Production of p-coumaric acid using tyrosine ammonia lyase (TAL) from Rhodotorula glutinis 
using different plasmids after 63 h (A) and using pRSFDuet_TAL during 63 h in M9 medium (B). (*) no 
substrate added. 
 
 
3.3.3 Production of Caffeic Acid from p-Coumaric Acid using C3H  
Caffeic acid was produced from p-coumaric acid using S. espanaensis C3H (Figure 3.3). 
C3H, although being a plant cytochrome P450 enzyme, has been successfully expressed 
in E. coli (Choi et al., 2011; Kang et al., 2012; Zhang and Stephanopoulos, 2013). As 
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previously shown in the p-coumaric acid production from tyrosine (Figure 3.2), the 
highest caffeic acid titer was also obtained with the high copy number plasmid 
pRSFDuet-1. The titer obtained was around 0.93 mM (168 mg/L), corresponding to a 
product yield of 0.47 (mol caffeic acid / mol p-coumaric acid). 
 
 
Figure 3.3. Production of caffeic acid using 4-coumarate 3-hydroxylase (C3H) from Saccharothrix 
espanaensis. 
 
3.3.4 Production of Caffeic Acid from Tyrosine using TAL and C3H  
In a second phase of the current study, TAL and C3H were combined to produce caffeic 
acid from 3 mM of tyrosine (Figure 3.4). In a first approach, the genes were cloned 
together in pETDuet-1. When these genes were combined, the production of caffeic acid 
increased. This increase is probably due to the fact that in this case the p-coumaric 
concentration in the medium is lower than when it is added directly, thus reducing the 
toxic effect to the cells as previously described in the literature (Barthelmebs et al., 2001; 
Furuya and Kino, 2013; Huang et al., 2013; Jung et al., 2013; Shin et al., 2011; Watts et 
al., 2006). To confirm that the addition of p-coumaric acid had a toxic effect to the cells, 
p-coumaric acid and tyrosine were added separately to E. coli harbouring pETDuet-1 and 
pETDuet_TAL_C3H. When p-coumaric acid was added, the E. coli cultures had a lower 
growth rate and the OD600 was 10-11% lower than when tyrosine was added (data not 
shown). Moreover, the protein expression was found to be lower. When only TAL was 
cloned in the pETDuet-1 plasmid the expressed protein was clearly visible in the SDS gel 
(~76 kDa) (Figure 3.5). However, when TAL was combined with C3H, protein 
production was not observed, likely due to the metabolic burden imposed on the host cells 
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by the expression of the two proteins in the same plasmid. Although in small amounts, a 
band around 56 kDa corresponding to C3H production could be observed. 
 
 
Figure 3.4. Production of caffeic acid using tyrosine ammonia lyase (TAL) from Rhodotorula glutinis and 
4-coumarate 3-hydroxylase (C3H) from Saccharothrix espanaensis. 
 
Cloning TAL in pCDFDuet-1 and C3H in pETDuet-1 led to results very similar to the 
experiments in which these enzymes were used alone to produce p-coumaric acid or 
caffeic acid, respectively (Figure 3.2A and Figure 3.3). This occurs because the 
expression of TAL when alone in the plasmid is very high (Figure 3.5), leading to high 
production of p-coumaric acid. Consequently, caffeic acid amounts are comparable to the 
ones obtained when p-coumaric acid is added as substrate. Similar results were observed 
with the combination pETDuet_TAL and pCDFDuet_C3H. The production of p-coumaric 
acid was 1.28 mM and caffeic acid was 0.77 mM. Since caffeic acid is produced from p-
coumaric acid, this suggests that in total more than 2 mM of p-coumaric acid was 
produced. When only pETDuet_TAL was used (Figure 3.2A), the maximum p-coumaric 
acid production obtained was 0.9 mM, which demonstrates that tyrosine can be converted 
faster if p-coumaric acid is being converted to the next product. Again it was observed 
that caffeic acid production does not increase (compared to when only C3H is used and 
the substrate is p-coumaric acid) since the p-coumaric acid concentration in the medium 
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is still very high. The combinations pKVS45_TAL/ pCDFDuet_C3H, pCDFDuet_TAL/ 
pKVS45_C3H and pRSFDuet_TAL/ pCDFDuet_C3H showed very similar results. 
 
 
 
Figure 3.5. SDS-PAGE of tyrosine ammonia lyase (TAL) and 4-coumarate 3-hydroxylase (C3H) 
expression in pETDuet-1. TAL is expected around 76 kDa and C3H around 56 kDa. Arrows indicate where 
it is possible to observe the bands of interest. 
 
 
 
The combination pCDFDuet_TAL/pRSFDuet_C3H is very interesting as almost all the p-
coumaric acid produced is converted to caffeic acid. In the end, only around 3 µM of p-
coumaric acid is detected by HPLC and the concentration in time was never higher than 
0.15 mM, meaning that almost all the p-coumaric acid being produced was being 
converted by C3H to caffeic acid. A final caffeic acid concentration of around 1 mM (180 
mg/L) was obtained. This combination enabled the highest yield from tyrosine with an 
additional benefit of having in the end a very low amount of the intermediate p-coumaric 
acid, contrary to what was observed in the other cases. 
Zhang and Stephanopoulos (2013) used codon-optimized TAL from R. glutinis and C3H 
from S. espanaensis to produce caffeic acid. Also, the authors used a tyrosine 
overproducing strain and no tyrosine limitation was observed during the caffeic acid 
production. After several medium optimizations, the highest titer they reported was 106 
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mg/L (Table 3.1), which is 1.7 times lower than the maximum titer obtained in the 
current study. Although those authors used the same plasmid to carry C3H (pRSFDuet-1), 
they used the pTrcHis2B plasmid to carry TAL, which was previously described by 
Santos et al. (2011) and discussed in section 3.3.2. The study presented here reports the 
highest titer of caffeic acid produced so far using the combination of TAL and C3H 
genes. 
 
3.3.5 Production of Caffeic Acid from p-Coumaric Acid using CYP199A2 
Until the recent studies published using 4HPA3H (Furuya and Kino, 2013; Huang et al., 
2013), CYP199A2 gene from R. palustris was reported to produce the highest amounts of 
caffeic acid from p-coumaric acid (Furuya et al., 2012). The results obtained in this study 
with CYP199A2 are summarized in Figure 3.6. CYP199A2 was cloned in pCDFDuet-1 
and its redox partners, Pdr and Pux, were expressed in another plasmid (pKVS45 or 
pETDuet-1) as part of an operon as described before (Furuya and Kino, 2009; Furuya and 
Kino, 2010). The first results obtained with CYP199A2 in the caffeic acid production 
were surprisingly low as compared to the Furuya et al. (2012) report. After analyzing the 
CYP199A2 DNA sequence it was verified that those authors did not use the first 21 bp of 
CYP199A2 to clone the gene. This decision was based on software results that annotated 
the 8
th
 CYP199A2 amino acid (GTG) as a start codon before the sequence was published 
(T. Furuya, personal communication). It was also confirmed that, for example, EasyGene 
1.2b Server (Larsen and Krogh, 2003; Nielsen and Krogh, 2005) identified the 8
th
 amino 
acid as the start codon. Based on this, CYP199A2 was cloned without the first 7 amino 
acids. The production using this new CYP199A2 increased considerably the caffeic acid 
production compared to the original clone (CYP199A2(+7aa)). Additionally, it was found 
that the production was more than 2.7 times higher when the inducer of 
pKVS45_Pdr_Pux_op, aTc, was added 2.5 h after addition of IPTG (to induce 
CYP199A2 expression). The delay of induction can alleviated the metabolic burden of 
several plasmids (Santos et al., 2011; Wu et al., 2013). Since pKVS45 has CYP199A2 
redox partners (Pdr and Pux) and these proteins are only needed after CYP199A2 is 
present in a significant concentration to support its catalytic activity (NADPH- and O2- 
dependent hydroxylation reactions), their expression can be delayed. The results obtained 
with CYP199A2 in this case were better than the ones obtained with C3H adding p-
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coumaric acid or tyrosine as substrate. Nevertheless, to improve the yield and taking into 
consideration that the addition of a high concentration of p-coumaric acid can have a 
detrimental effect on the caffeic acid production, as discussed before, a different feeding 
system was tested: 1 mM of p-coumaric acid was added at time 0 of induction in M9 
medium and 0.5 mM added at 5 h and 24 h. Caffeic acid production increased to 1.72 mM 
(310 mg/L) using this three step feeding. This approach was successfully demonstrated 
before for the production of caffeic acid (Furuya and Kino, 2013; Huang et al., 2013) and 
allowed to obtain a product yield of 0.86 (mol caffeic acid / mol p-coumaric acid). Furuya 
et al. (2012) obtained a maximum yield of 0.75 (mol caffeic acid / mol p-coumaric acid) 
after testing different energy sources. 
 
 
Figure 3.6. Production of caffeic acid from p-coumaric acid using CYP199A2 from Rhodotorula palustris, 
putidaredoxin reductase (Pdr) from Pseudomonas putida and palustrisredoxin (Pux) from R. palustris. 
 
 
Since pKVS45 induction seems to limit caffeic acid production, pETDuet-1, that is 
induced using IPTG similarly to pCDFDuet-1, was chosen to clone the CYP199A2 redox 
(1) pCDFDuet_CYP(+7aa) + pKVS45_PdrPux_op 
(2) pCDFDuet_CYP + pKVS45_PdrPux_op 
(3) pCDFDuet_CYP + pKVS45_PdrPux_op (aTc added 2,5 h later) 
(4) pCDFDuet_CYP + pKVS45_PdrPux_op (aTc added 2,5 h later; p-coumaric acid 
added several times) 
(5) pCDFDuet_CYP + pETDuet_PdrPux_op 
(6) pCDFDuet_CYP + pETDuet_PdrPux_op (p-coumaric acid added several times) 
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partners and evaluate if the caffeic acid production could be increased. However, the 
results obtained with pETDuet-1 were very similar to the ones obtained with pKVS45 
induced at time 0. This result is not surprising since pKVS45 alone, or combined with 
pCDFDuet-1, gave better overall results using TAL and C3H than the pETDuet-1 plasmid 
(Figures 3.2-3.4). 
 
3.3.6 Production of Caffeic Acid from Tyrosine using TAL and CYP199A2 
To produce caffeic acid from tyrosine, TAL and CYP199A2 were combined using 
different approaches, namely together in the same plasmid but in different MCSs (TAL in 
MCS1 and CYP199A2 in MCS2), or in an operon in MCS1 (Figure 3.7). Both 
CYP199A2 sequences were tested and again it was concluded that CYP199A2 starting at 
the 8
th
 amino acid provides better results. The low caffeic acid concentration obtained was 
due to the addition of aTc at time zero of induction. However, even with a low 
concentration, it can be concluded that the genes work slightly better when cloned in 
different MCSs than when cloned in an operon. Thus, this approach was chosen to 
proceed with other tests including pKVS45 later induction with aTc; three phases of p-
coumaric acid addition; and the use of another plasmid to carry CYP199A2 redox 
partners (pETDuet-1). The results obtained were very similar to the ones found with only 
CYP199A2 in the plasmid (Figure 3.6). The expression of TAL in a different plasmid 
(pRSFDuet-1) improved caffeic acid production. The highest caffeic acid production was 
1.56 mM (280 mg/L). According to these results, CYP199A2 with its redox partners 
seems to be a better option than C3H to produce caffeic acid from tyrosine or p-coumaric 
acid. 
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Figure 3.7. Production of caffeic acid using tyrosine ammonia lyase (TAL) from Rhodotorula glutinis, 
CYP199A2 from Rhodopseudomonas palustris, putidaredoxin reductase (Pdr) from Pseudomonas putida 
and palustrisredoxin (Pux) from R. palustris. 
 
 
 
Based on the above discussion, it would be advisable, in the future, to clone CYP199A2 
with its redox partners in different plasmids and combine them with TAL to confirm if 
caffeic acid production can be improved without a high accumulation of the intermediate 
as its accumulation may result in suboptimal production titers. To improve the yield and 
to avoid the need of two separate stages of cultivation for biomass/protein generation and 
caffeic acid production, the use of potassium phosphate buffer (Furuya et al., 2012; 
Furuya and Kino, 2013) or MOPS (Santos et al., 2011; Zhang and Stephanopoulos, 2013) 
with glucose or glycerol should be tested.  
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3.4 Conclusion 
Caffeic acid has for a long time been recognized for its therapeutic properties, which 
makes it an attractive target for metabolic engineering and synthetic biology. A pathway 
for the production of caffeic acid via metabolic engineering approaches was successfully 
designed in E. coli. Different genetic arrangements with two (or four) genes were tested 
to balance the expression of the enzymes and achieve an optimized performance, and 
significantly different levels of caffeic acid production were obtained. The layout of genes 
and operons in the plasmid, as well as the use of different plasmids had an enormous 
impact on gene expression. In addition, codon-optimization when expressing 
heterologous genes in E. coli was considered to improve gene expression. The repeated 
addition of the substrate and the delay in the induction of protein expression also led to an 
increase of the titers by decreasing the toxicity of p-coumaric acid and the metabolic 
burden of heterologous protein expression. 
In conclusion, caffeic acid is a phenylpropanoic acid and its production pathway can be 
used to produce other products of the phenylpropanoid pathway from tyrosine like 
flavonoids, stilbenoids, isoflavonoids and curcuminoids. For the production system to be 
even more economically viable, the use of a tyrosine overproducing strain should be 
considered. 
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CHAPTER 4 
Production of Curcuminoids from Tyrosine by a Metabolically 
Engineered Escherichia coli 
 
Curcuminoids are phenylpropanoids with great pharmaceutical potential. Herein, it is 
reported an engineered artificial pathway in Escherichia coli to produce natural 
curcuminoids. Three 4-coumaroyl-CoA ligase (4CL) enzymes from two different 
organisms and different polyketide synthases (diketide-CoA synthase (DCS), curcumin 
synthase (CURS1) and curcuminoid synthase (CUS)) for the curcuminoids production 
were tested. The best results starting from ferulic acid were obtained with Arabidopsis 
thaliana 4CL1 and Curcuma longa DCS and CURS1, yielding 70 mg/L of curcumin. 
Bisdemethoxycurcumin and demethoxycurcumin were also produced, but in lower 
concentrations, by feeding p-coumaric acid or a mixture of p-coumaric acid and ferulic 
acid, respectively. Additionally, curcuminoids were produced from tyrosine through the 
caffeic acid pathway. To produce caffeic acid, tyrosine ammonia lyase (TAL) from 
Rhodotorula glutinis and 4-coumarate 3-hydroxylase (C3H) from Saccharothrix 
espanaensis were used. Caffeoyl-CoA O-methyltransferase (CCoAOMT) from Medicago 
sativa was used to convert caffeoyl-CoA to feruloyl-CoA. Using caffeic acid, p-coumaric 
acid or tyrosine as a substrate, 3.90 mg/L, 0.26 mg/L and 0.20 mg/L of curcumin were 
produced, respectively. This is the first time DCS and CURS1 were used in vivo to 
produce curcuminoids and that curcumin was produced by feeding tyrosine. It was 
demonstrated that curcumin can be produced using a pathway through caffeic acid. This 
alternative pathway represents a significant improvement in the heterologous production 
of curcuminoids using E. coli. 
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4.1 Introduction 
Curcuminoids are natural phenylpropanoids from the plant Curcuma longa Linn. Its 
rhizome contains a mixture of curcuminoids with curcumin, demethoxycurcumin and 
bisdemethoxycurcumin being the ones present in higher amounts. These compounds 
present in turmeric have long been used in traditional Asian food and medicine. Their 
therapeutic properties include anticancer, anti-inflammatory, anti-oxidant, anti-
Alzeimer’s, anti-HIV and anti-Parkinson (Aggarwal and Sung, 2009; Goel et al., 2008; 
Prasad et al., 2014; Strimpakos and Sharma, 2008). Despite their numerous benefits to 
human health, curcuminoids have poor bioavailability and their natural abundance is low, 
thus making their heterologous biosynthetic production very interesting. 
Recently, curcuminoids were found to be synthesized by type III polyketide synthases 
(PKSs) and additional enzymes from the phenylpropanoid pathway in plants (Ramirez-
Ahumada et al., 2006). The discovery of the curcuminoid synthase (CUS) from Oryza 
sativa by Katsuyama et al. (2008) allowed the production of curcuminoids in a 
microorganism using an artificial pathway in E. coli. In the biosynthetic pathway they 
used phenylalanine ammonia lyase (PAL) from Rhodotorula rubra with tyrosine 
ammonia lyase (TAL) activity to convert the amino acids phenylalanine and tyrosine 
directly to cinnamic acid and p-coumaric acid. 4-coumarate-CoA ligase (4CL) from 
Lithospermum erythrorhizon was used to convert cinnamic acid and p-coumaric acid to 
cinnamoyl-CoA and p-coumaroyl-CoA, respectively, and then to curcuminoids by 
curcuminoid synthase (CUS) from Oryza sativa. Acetyl-CoA carboxylase (ACC) from 
Corynebacterium glutamicum was also overexpressed to increase the intracellular pool of 
malonyl-CoA. The supplementation of amino acids to the medium led to the production 
of bisdemethoxycurcumin and other two curcuminoids, cinnamoyl-p-coumaroylmethane 
and dicinnamoylmethane. The direct supplementation of carboxylic acids, as ferulic acid 
for instance, led to other curcuminoids including curcumin and demethoxycurcumin 
(Katsuyama et al., 2008). By adding two different unnatural carboxylic acids 
simultaneously (analogs of p-coumaric acid), Katsuyama and coworkers also produced 
unnatural curcuminoids (Katsuyama et al., 2010a). Moreover, Wang et al. (2013) 
produced the curcuminoid dicinnamoylmethane by using PALs from Trifolium pratense, 
4CL1 from Arabidopsis thaliana and CUS from O. sativa. After CUS was discovered, 
Katsuyama et al. (2009a) reported that in the C. longa plant, the PKSs used to produce 
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curcuminoids were diketide-CoA synthase (DCS) and curcumin synthase (CURS1). They 
also identified other CURS enzymes (CURS2 and CURS3) with different substrate 
specificities (Katsuyama et al., 2009b). It is important to bear in mind that CUS catalyzes 
both steps that are catalyzed separately by DCS and CURS (Katsuyama et al., 2009a) 
(Figure 4.1). 
 
In this work, curcuminoids production in E. coli using an artificial pathway is described 
(Figure 4.1). Three different 4CL enzymes from two different organisms and different 
PKSs for curcuminoids production (CUS, DCS and CURS1) were tested. Curcumin, 
demethoxycurcumin and bisdemethoxycurcumin were produced by adding ferulic acid 
and/or p-coumaric acid as precursors. To produce curcuminoids, including curcumin, 
from the amino acid tyrosine, caffeic acid had to be produced as an intermediate in the 
pathway. TAL from R. glutinis and 4-coumarate 3-hydroxylase (C3H) from S. 
espanaensis were selected to produce caffeic acid based on the results obtained in 
Chapter 3. Caffeoyl-CoA was converted to feruloyl-CoA by caffeoyl-CoA O-
methyltransferase (CCoAOMT) from Medicago sativa. This alternative pathway allowed, 
for the first time, the production of curcumin from the amino acid tyrosine, thus 
representing an advance in the heterologous production of curcuminoids by E. coli. 
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Figure 4.1. Proposed curcuminoids biosynthetic pathway in E. coli and the reactions catalyzed by the 
enzymes in this study. TAL: tyrosine ammonia lyase; C3H: 4-coumarate 3-hydroxylase; 4CL: 4-coumarate-
CoA ligase; CCoAOMT: caffeoyl-CoA O-methyltransferase; DCS: diketide-CoA synthase; CURS1: 
curcumin synthase; CUS: curcuminoid synthase. 
 
 
 
 
 
 
 
 
78 | Chapter 4 
 
4.2 Materials and Methods 
4.2.1 Bacterial Strains, Plasmids and Chemicals 
E. coli NZY5α competent cells (NZYTech, Lisbon, Portugal) were used for molecular 
cloning and vector propagation and E. coli K-12 MG1655(DE3) (Nielsen et al., 2010) 
was used as the host for the expression of genes under T7 promoter control. The 
characteristics of all the strains and plasmids used in this study are described in Table 
4.1. 
Le4CL, At4CL2, DCS, CURS, CUS and CCoAOMT genes were codon-optimized for E. 
coli, synthesized and cloned in the plasmid vector pUC57 by GenScript (Piscataway, NJ, 
USA) or NZYTech (Lisbon, Portugal). The DNA sequences of the codon-optimized 
genes are provided in Supplementary Material (Table A1). Non-optimized CUS (nCUS) 
and Le4CL (nLe4CL) were synthesized and cloned in pUC57 vector by NZYTech. TAL 
and C3H synthesis was described previously (Chapter 3). pAC_At4CL1 was purchased 
from Addgene (Cambridge, MA, USA). 
L-tyrosine, p-coumaric, caffeic acid, coenzyme A (CoA) sodium salt, adenosine 5′-
triphosphate (ATP) disodium salt hydrate, demethoxycurcumin and 
bisdemethoxycurcumin were purchased from Sigma-Aldrich (Steinheim, Germany), 
ferulic acid from Acros (Geel, Belgium), curcumin from Fisher Scientific 
(Loughborough, UK), isopropyl β-D-thiogalactopyranoside (IPTG) and Luria-Bertani 
(LB) medium from NZYTec and anhydrotetracycline (aTc) from Acros. Glucose (Acros), 
Na2HPO4 (Scharlau, Sentmenat, Spain), MgSO4, KH2PO4 (Riel-deHaën, Seelze, 
Germany), NH4Cl, NaCl, CaCO3 (Panreac, Barcelona, Spain) and thiamine (Fisher 
Scientific, Loughborough, UK) were used to prepare the M9 modified salt medium. The 
following mineral traces and vitamins were supplemented to the M9 medium: FeCl3, 
ZnCl2, CoCl2, CuCl2, nicotinic acid (Riedel-deHaën), NaMoO4, H2BO3, pyridoxine, 
biotin, folic acid (Merck), riboflavin and pantothenic acid (Sigma Aldrich). Ampicillin 
(Applichem, Darmstadt, Germany), chloramphenicol, kanamycin (NZYtech) and 
spectinomycin (Panreac) were used when necessary. 
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Table 4.1. Bacterial strains and plasmids used in this study. 
Strains Relevant Genotype Source 
E. coli NZY5α 
fhuA2Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17 
NZYTech 
E. coli K-12 
MG1655(DE3) 
F
-
 λ-  ilvG- rfb-50 rph-1 λ(DE3) 
(Nielsen et 
al., 2010) 
Plasmids Construct Source 
pETDuet-1 ColE1(pBR322) ori, lacI, double T7lac, Amp
R
 Novagen 
pCDFDuet-1 CloDF13 ori, lacI, double T7lac, Strep
R
 Novagen 
pCOLADuet-1 COLA ori, lacI, double T7lac, Kan
R
 Novagen 
pRSFDuet-1 RSF ori, lacI, double T7lac, Kan
R
 Novagen 
pKVS45 p15A ori, tetR, Ptet, Amp
R
 
(Solomon et 
al., 2012) 
pUC57_At4CL2 pUC57 carrying codon-optimized 4CL2 from A. thaliana GenScript 
pUC57_CCoAOMT pUC57 carrying codon-optimized CCoAOMT from M. sativa  GenScript 
pUC57_Le4CL pUC57 carrying codon-optimized 4CL from  L. erythrorhizon NZYTech 
pUC57_nLe4CL pUC57 carrying not codon-optimized 4CL from  L. erythrorhizon NZYTech 
pUC57_nCUS  pUC57 carrying not codon-optimized CUS from O. sativa NZYTech 
pUC57_CUS pUC57 carrying codon-optimized CUS from O. sativa NZYTech 
pUC57_DCS pUC57 carrying codon-optimized DCS from C. longa NZYTech 
pUC57_CURS1 pUC57 carrying codon-optimized CURS1 from C. longa NZYTech 
pAC_At4CL1 pAC carrying not codon-optimized 4CL1 from A. thaliana 
Addgene  
 (35947) 
pETDuet_TAL pETduet-1 carrying codon-optimized TAL from R. glutinis Chapter 3 
pETDuet_C3H pETduet-1 carrying codon-optimized C3H from S. espanaensis Chapter 3 
pETDuet_TAL_C3H 
pETduet-1 carrying codon-optimized TAL from R. glutinis and 
C3H from S. espanaensis 
Chapter 3 
pKVS45_C3H pKVS45 carrying codon-optimized C3H from S. espanaensis Chapter 3 
pCDFDuet_TAL pCDFDuet-1 carrying codon-optimized TAL from R. glutinis Chapter 3 
pRSFDuet_Le4CL 
pRSFDuet-1 carrying codon-optimized 4CL from  L. 
erythrorhizon 
This study 
pRSFDuet_nLe4CL 
pRSFDuet-1 carrying not codon-optimized 4CL from  L. 
erythrorhizon 
This study 
pRSFDuet_At4CL2 pRSFDuet-1 carrying codon-optimized 4CL2 from A. thaliana This study 
pRSFDuet_At4CL1 pRSFDuet-1 carrying 4CL1 from A. thaliana This study 
pCDFDuet_At4CL1 pCDFDuet-1 carrying 4CL1 from A. thaliana This study 
pRSFDuet_CUS pRSFDuet-1 carrying codon-optimized CUS from O. sativa This study 
pRSFDuet_nCUS pRSFDuet-1 carrying not codon-optimized CUS from O. sativa This study 
pRSFDuet_CURS1 pRSFDuet-1 carrying codon-optimized CURS1 from C. longa This study 
pRSFDuet_DCS pRSFDuet-1 carrying codon-optimized DCS from C. longa This study 
pCDFDuet_DCS pCDFDuet-1 carrying codon-optimized DCS from C. longa This study 
pCOLADuet_ 
CCoAOMT 
pCOLADuet-1 carrying codon-optimized CCoAOMT from M. 
sativa 
This study 
pRSFDuet_ 
CCoAOMT 
pRSFDuet-1 carrying codon-optimized CCoAOMT from M. 
sativa 
This study 
pRSFDuet_At4CL1_
CUS 
pRSFDuet_At4CL1 carrying codon-optimized CUS from O. 
sativa 
This study 
pRSFDuet_At4CL2_
CUS 
pRSFDuet_At4CL2 carrying codon-optimized CUS from O. 
sativa 
This study 
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Table 4.1. Bacterial strains and plasmids used in this study (continuation). 
Plasmids Construct Source 
pCDFDuet_DCS_C
CoAOMT 
pCDFDuet_DCS carrying codon-optimized CCoAOMT from M. 
sativa 
This study 
pRSFDuet_CURS1
_CCoAOMT 
pRSFDuet_CURS carrying codon-optimized CCoAOMT from M. 
sativa 
This study 
pCDFDuet_DCS_T
AL 
pCDFDuet_DCS carrying codon-optimized TAL from R. glutinis This study 
pCDFDuet_DCS_A
t4CL1 
pCDFDuet_DCS carrying 4CL1 from A. thaliana This study 
pCOLADuet_CUR
S1_DCS_op 
pCOLAduet-1 carrying codon-optimized CURS and DCS from C. 
longa in an operon 
This study 
 
 
4.2.2 Construction of Plasmids 
Plasmid DNA (pETDuet-1, pCDFDuet-1, pRSFDuet-1, pCOLADuet-1, pKVS45 and 
pUC57) was isolated using NucleoSpin
® 
Plasmid Miniprep Kit (Macherey-Nagel, Düren, 
Germany). The genes encoding At4CL2, Le4CL, nLe4CL, CUS, nCUS, CURS, DCS, 
CCoAOMT, TAL and C3H were amplified by PCR using KAPA HiFi DNA Polymerase 
enzyme (Kapa Biosystems, Wilmington, MA, USA). DNA fragments were purified from 
agarose using Gel DNA Recovery Kit (Zymo Research, Orange, CA, USA). The plasmid 
DNA and genes were quantified in NanoDrop (ND-1000, Thermo Scientific, Wilmington, 
DE, USA) and were digested using the appropriate restriction endonucleases (Table 4.2) 
(NEB, Ipswich, MA, USA) for 3 h and purified using DNA Clean and Concentrator Kit 
(Zymo Research). Ligation was performed at room temperature for 1 h with T4 DNA 
ligase (NEB). Chemical transformation (heat shock method) was carried out using E. coli 
NZY5α competent cells. All constructed plasmids herein described (Table 4.2) were 
verified by colony PCR or digestion and confirmed by sequencing (Macrogen, 
Amsterdam, The Netherlands). After confirmation E. coli K-12 MG1655(DE3) was 
transformed with the plasmids. All the kits and enzymes were used according to the 
instructions provided by the manufacturers. CURS1 and DCS were also cloned in an 
operon using Phusion DNA Polymerase (NEB) and overlap extension PCR (Heckman 
and Pease, 2007; Horton et al., 1989). The ribosome binding site (RBS) chosen was the 
same as used in pETDuet-1, pCDFDuet-1 and pRSFDuet-1. Reverse primers of CURS1 
gene were overlapped with forward primers of the DCS gene to introduce the RBS and 
spacer. Briefly, the CURS1 and DCS genes were amplified and the overlapping strands of 
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these intermediate products used in a subsequent PCR and extended to generate the full-
length product amplified by flanking primers that included restriction enzyme sites for 
inserting the operon into the plasmid. 
 
Table 4.2. Set of primers for PCR amplification (forward and reverse primers – FW and REV). 
Primer name Primer sequence 
Restriction 
enzyme 
CUS_MCS1_FW GGATCCCATGGCTCCGACCACG BamHI 
CUS_MCS1_REV AAGCTTTTAGTTCACATGGCTCGTGG HindIII 
CUS_MCS2_FW CATATGGCTCCGACCACGA NdeI 
CUS_MCS2_REV CTCGAGTTAGTTCACATGGCTCGTGG XhoI 
Le4CL_FW GGATCCAATGGACACCCAGACCAAAA BamHI 
Le4CL_REV GGCGCGCCTTAGTTGTGAACACCGTTAGCG AscI 
At4CL2_FW GGATCCGATGACCACGCAAGATGTGA BamHI 
At4CL2_REV AAGCTT TCAGTTCATCAGACCATTAGCC HindIII 
At4CL1_MCS1_FW GGATCCGATGGCGCCACAAGAACA BamHI 
At4CL1_MCS1_REV AAGCTTTCACAATCCATTTGCTAGTTTTGC HindIII 
At4CL1_MCS2_FW CATATGATGGCGCCACAAGAACA NdeI 
At4CL1_MCS2_REV CTCGAGTCACAATCCATTTGCTAGTTTTGC XhoI 
CURS1_FW GGATCCTATGGCTAACCTGCACGCTC BamHI 
CURS1_REV GGCGCGCCTTACAGCGGCATAGAACGC AscI 
DCS_FW GGATCCGATGGAAGCTAACGGTTACCG BamHI 
DCS_REV AAGCTTTTAGTTCAGACGGCAAGAGTG HindIII 
CURS1_op_FW CATATGGCTAACCTGCACGC NdeI 
CURS1_op_REV CATTAACGTCCTCCTTTCACAGCGGCATAGAA - 
DCS_op_FW GTGAAAGGAGGACGTTAATGGAAGCTAACGGTTACC - 
DCS_op_REV CCTAGGTCAGTTCAGACGGCAA AvrII 
TAL_MCS2_FW CATATGGCTCCGCGTCC NdeI 
TAL_MCS2_REV CTCGAGTTATGCCAGCATTTTCA XhoI 
CCoAOMT_FW 
CATATGCATCACCATCATCACCACATGGCTACGAATGA
AGACCAG 
NdeI 
CCoAOMT_REV CTCGAGTCATTTAATACGACGACAGATGGT XhoI 
Start and stop codons in bold; restriction sites in italic; His6-Tag underlined; The ribosome binding site (RBS) and spacer are double 
underlined; In order for the sequence to remain in frame one or two bases were occasionally added between the restriction site and the 
gene start codon. 
 
4.2.3 Curcuminoids Production 
E. coli cells for gene cloning, plasmid propagation, and inoculum preparation were grown 
in LB medium at 37 ºC and under shaking conditions (200 rpm). 
For the production of curcuminoids, the cultures were grown at 37 ºC in 50 mL LB to an 
optical density at 600 nm (OD600) of 0.3-0.4. IPTG and/or aTc were added at a final 
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concentration of 1 mM and 100 ng/mL, respectively. The culture was then incubated for 5 
h at 26 ºC. Next, the cells were harvested by centrifugation, suspended, and incubated at 
26 ºC for 63 h in 50 mL modified M9 minimal salt medium containing (per liter): glucose 
(40 g), Na2HPO4 (6g), KH2PO4 (3g), NH4Cl (1g), NaCl (0.5 g), CaCl2 (17 mg), MgSO4 
(58 mg), thiamine (340 mg) and CaCO3 (5 g) (to control the pH). Trace elements [FeCl3 
(54 mg), ZnCl2 (4 mg), CoCl2 (4 mg), NaMoO4 (4 mg), CuCl2 (2 mg) and H2BO3 (1 mg)] 
and vitamins [riboflavin (0.84 mg), folic acid (0.084 mg), nicotinic acid (12.2 mg), 
pyridoxine (2.8 mg), biotin (0.12 mg) and pantothenic acid (10.8 mg)] were also 
supplemented to the M9 medium. Depending on the plasmid(s) present in the strain, 100 
μg/mL of ampicillin, 100 μg/mL of spectinomycin, 30 μg/mL of chloramphenicol and/or 
50 μg/mL of kanamycin were added. aTc and IPTG were added at the same time. 
Substrates were added at time 0 of induction in M9 medium (unless otherwise stated): 
tyrosine (3 mM), p-coumaric acid (2 mM), caffeic acid (1 mM) and ferulic acid (2 mM). 
Supernatant samples (1.5 mL) were collected for the analysis of hydroxycinnamic acids, 
while for curcuminoids 2 mL of culture broth with cells (whole broth) were collected. All 
the experiments were performed in triplicate unless otherwise specified. 
Curcumin was also produced in a bioreactor. First, the culture was grown in LB at 37 ºC 
in 2-L shake flasks, containing 500 mL medium, to an OD600 of 0.3-0.4. IPTG was added 
at a final concentration of 1 mM and the culture was incubated for 5 h at 26 ºC. 
Afterwards, the cells were harvested by centrifugation, transferred to the bioreactor and 
incubated at 26 ºC for 63 h in 2 L modified M9. IPTG and ferulic acid (2 mM) were 
added to the medium together with the cells. To maintain the pH constant, 
orthophosphoric acid (85%) (Riel-deHaën) and ammonium hydroxide (6%) (Panreac) 
were added in the first two experiments. In the third experiment, CaCO3 was used instead. 
4.2.4 Curcuminoids Extraction 
For posterior analysis, 2 mL of whole broth were taken at several points during the 
fermentation and adjusted to pH 3.0 with 6 M HCl. Then, the curcuminoids present in the 
samples were extracted with an equal volume of ethyl acetate. The extraction procedure 
was performed more than once for the cases in which the presence of curcuminoids inside 
the cells after the first extraction was still visible to the naked eye (yellow coloration). 
The extracts were concentrated by solvent evaporation in a fume hood, suspended in at 
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least 200 µL of acetonitrile and then subjected to product analysis by high-performance 
liquid chromatography (HPLC). 
 
4.2.5 HPLC Analysis of the Products 
HPLC analysis was used to quantify p-coumaric acid, caffeic acid, ferulic acid, curcumin, 
demethoxycurcumin and bisdemethoxycurcumin using a system from Jasco (Easton, MD, 
USA) (PU-2080 Plus Pump unit, LG-2080-02 Ternary Gradient unit, a DG-2080-53 3-
Line Degasser unit, a UV-2075 Plus Intelligent UV/VIS Detector unit and AS-2057 Plus 
Intelligent Sampler unit) and a Grace Alltech Platinum EPS C18 column (3µm, 150 mm × 
4.6 mm) (Grace, Columbia, MD, USA). Mobile phases A and B were composed of water 
(0.1% trifluoroacetic acid) and acetonitrile, respectively. For the hydroxycinnamic acids 
quantification, the following gradient was used at a flow rate of 1 mL/min: 10 - 20% 
acetonitrile (mobile phase B) for 16 min. Quantification was based on the peak areas 
obtained at 310 nm for p-coumaric acid, caffeic acid and ferulic acid. The retention times 
of p-coumaric acid, caffeic acid and ferulic acid were 8.0, 11.8 and 13.8 min, 
respectively. For the curcuminoids quantification, a gradient of 40 - 43% acetonitrile 
(mobile phase B) for 15 min and 43% acetonitrile for an additional 5 min was used. The 
curcuminoids were detected at 425 nm and the retention times of bisdemethoxycurcumin, 
demethoxycurcumin and curcumin were 12.4, 13.5 and 14.5 min, respectively. 
 
4.2.6 Protein Analysis 
E. coli K-12 MG1655(DE3) cells harbouring pRSFDuet_At4CL2, pRSFDuet_CUS, 
pRSFDuet_CURS, pRSFDuet_DCS and pRSFDuet_CCoAOMT were grown in LB at 37 
ºC to an OD600 of 0.6. IPTG was added at a final concentration of 1 mM, and the culture 
was incubated for 5 h. Samples (10 mL culture medium) were taken at time 0 and 5 h of 
induction. Samples were centrifuged and the cells were suspended in phosphate-buffered 
saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4, pH 7.4) and 
disrupted by sonication on ice for 3 min. After centrifugation, the protein concentration 
from the resulting supernatant was determined using Protein Assay Dye Reagent 
Concentrate (BioRad, Hercules, CA, USA) and bovine gamma globulin (BSA) (NEB) as 
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a standard. The expression levels of the enzymes were examined using sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS–PAGE) analysis. Fifteen to 20 µg of 
total protein were loaded in 4-20% Mini-PROTEAN
®
 TGX™ Precast Gels (BioRad). The 
protein marker used was Precision Plus Protein
TM
 Unstained (BioRad) and/or 
ColorPlus
TM
 Prestained Protein Ladder Broad Range (NEB). For gel staining, Bio-Safe 
Coomassie Stain (BioRad) was used. The At4CL2 enzyme was purified using Ni-NTA 
Agarose kit (Qiagen, Germantown, MD, USA). In vitro assays were based in the method 
described in Beuerle and Pichersky (2002). Enzyme activity was measured 
spectrophotometrically at room temperature with a 1-mL mixture containing 0.1 M Tris–
HCl, pH 7.5, 2.5 mM ATP, 2.5 mM MgCl2, 100-220 µg of purified At4CL2 protein, 0.5 
mM hydroxycinnamic acids (p-coumaric acid, ferulic acid and caffeic acid) and 0.5 mM 
CoA. Enzymatic reactions were initiated by the addition of CoA. The change in 
absorbance of the reaction mixture was monitored at the wavelengths of 333, 345 and 369 
nm for p-coumaroyl-CoA, feruloyl-CoA, caffeoyl-CoA, respectively (Ehlting et al., 
1999). 
 
4.3 Results and Discussion 
4.3.1 The 4CL Limiting Step – Selection of the Best 4CL Enzyme 
4CL enzymes convert the hydroxycinnamic acids (p-coumaric acid, caffeic acid and 
ferulic acid) to their corresponding CoA esters (p-coumaroyl-CoA, caffeoyl-CoA and 
feruloyl-CoA) (Figure 4.1) with different substrate preferences and specificities. The 
4CL from L. erythrorhizon (Le4CL), previously reported to successfully produce 
curcuminoids (Katsuyama et al., 2010a; Katsuyama et al., 2008), was selected. However, 
it was not possible to observe Le4CL expression on an SDS-PAGE gel, neither to achieve 
curcuminoids production by combining the Le4CL enzyme with CUS or DCS/CURS1. 
The assays started with codon-optimized Le4CL, but due to the negative results non 
codon-optimized Le4CL was also tested. However, functional expression was not 
observed with either version.  
4CL2 from A. thaliana (At4CL2) was then chosen since it had been described to have a 
higher preference and specificity for caffeic acid than the other isozymes from A. thaliana 
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or other species (Ehlting et al., 1999; Schneider, 2005; Schneider et al., 2003; Stuible and 
Kombrink, 2001). This enzyme could be used to produce curcumin from tyrosine using 
caffeic acid as an intermediate (Figure 4.1). The production of curcumin in E. coli was 
previously reported but only by using ferulic acid as a substrate. Additionally, At4CL2 
was also tested in vivo combined with CUS or DCS and CURS1 using p-coumaric acid, 
ferulic acid and also caffeic acid as a substrate. Although it was not possible to produce 
curcuminoids using At4CL2, its expression on a gel was observed (~61 kDa) and 
subsequently purified (Figure 4.2) for further in vitro assays. However, the in vitro assays 
were inconclusive.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Protein gel showing At4CL2 enzyme present in pRSFDuet-1 in cell-free extract (A) or after 
His6-Tag purification (B). At4CL2 is expected to be around 61 kDa. 4CL: 4-coumarate-CoA ligase. 
 
 
Based on the negative results obtained using Le4CL and At4CL2, an alternative 4CL that 
could also be used for the production of curcuminoids, At4CL1, was investigated. 
Recently, this enzyme was successfully used in the production of curcuminoids (Wang et 
al., 2013) and in stilbene and flavonoid biosynthesis (Watts et al., 2006; Watts et al., 
2004). In the current work, this enzyme was tested in vivo with CUS and DCS/CURS1. 
Since the results obtained regarding the production of curcuminoids were positive, all the 
further optimization tests were performed using this 4CL enzyme. 
(A) (B) 
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4.3.2 Production of Curcuminoids using CUS from O. Sativa 
CUS from O. sativa was chosen as the preferred PKS since it was the first PKS reported 
to produce curcuminoids in E. coli (Katsuyama et al., 2010a; Katsuyama et al., 2008) and 
in vitro (Katsuyama et al., 2007c). CUS has the advantage, as mentioned before, of 
catalyzing the three steps that are catalyzed by different PKSs (CURS and DCS) in C. 
longa: (a) condensation of malonyl-CoA with feruloyl-CoA (or other CoA ester) to 
produce diketide-CoA; (b) hydrolysis of diketide-CoA to its corresponding β-keto acid; 
and (c) decarboxylative condensation of the β-keto acid to the second molecule of 
feruloyl-CoA (Figure 4.1). This enzyme would make the production of curcuminoids 
from tyrosine simpler by decreasing the number of enzymes needed for the pathway to 
function. 
Codon-optimized CUS was cloned in pRSFDuet-1 and its expression was confirmed on a 
protein gel (~ 44 kDa) (Figure 4.3). After that, CUS was tested in E. coli with At4CL1 
(pRSFDuet_CUS + pAC_At4CL1) (Figure 4.4). These enzymes produced 
bisdemethoxycurcumin and curcumin when p-coumaric acid and ferulic acid, 
respectively, were added to the culture medium. Ferulic acid and/or feruloyl-CoA seem to 
be the preferred substrates since curcumin is produced in higher amounts. However, 
At4CL1 was reported to prefer p-coumaric acid to ferulic acid (Ehlting et al., 1999) and 
Katsuyama et al. (2007c) also concluded by in vitro experiments that CUS prefers p-
coumaroyl-CoA as a substrate. Therefore, it is not clear the reason behind the higher 
curcumin production in this study. However, in vivo experiments by Katsuyama et al. 
(2008) revealed that the CUS enzyme together with Le4CL produces very similar 
amounts of bisdemethoxycurcumin and curcumin from p-coumaric acid and ferulic acid, 
respectively, although the curcumin concentration obtained was slightly higher. It cannot 
be concluded if the higher concentration of curcumin obtained in vivo in Katsuyama et al. 
(2008) was due to Le4CL substrate specificity, since it is unknown.  
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Figure 4.3. SDS-PAGE gel showing diketide-CoA synthase (DCS), curcumin synthase 1 (CURS1) and 
curcuminoid synthase (CUS) expression in protein lysates at time zero of induction and after 5 h of 
induction. DCS and CURS1 have ~ 43 kDa and CUS has ~ 44 kDa. M: Marker. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Curcuminoids production from p-coumaric acid and ferulic acid using 4-coumarate-CoA ligase 
(4CL1) from Arabidopsis thaliana and curcuminoid synthase (CUS) from Oryza sativa. 
Bisdemethoxycurcumin was also produced from tyrosine using tyrosine ammonia lyase (TAL) from 
Rhodotorula glutinis. 
 
Additionally, the production of curcuminoids at 24 h is significantly lower compared to 
63 h which is in agreement with the results reported by Katsuyama et al. (2008). Also, a 
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(1) Bisdemethoxycurcumin; 2 mM p-coumaric acid 
(2) Bisdemethoxycurcumin; 1 mM p-coumaric acid + 1 mM p-coumaric acid at 24 h 
(3) Bisdemethoxycurcumin; 3 mM tyrosine 
(4) Curcumin; 2 mM ferulic acid 
(5) Curcumin; 1 mM ferulic acid  + 1 mM ferulic acid at 24 h 
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yellow color of the culture medium could only be observed after 24 h. This color is due to 
the increase of curcuminoids inside the cells. The production of curcuminoids, even at 
very low amounts could be easily detected after 63 h (Figure 4.5, A and B) by the 
observation of some cells that adhered to the walls of the shake flasks. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Curcuminoid production can be observed by the yellow/orange color of the cells. 
Bisdemethoxycurcumin (A, C) and curcumin (B, D) were produced using p-coumaric and ferulic acid as 
substrates, respectively. Two different combinations of PKS enzymes were tested: CUS (A, B) and CURS1 
and DCS (C, D). When curcuminoids are not produced the culture medium remains white
 
(E). CUS: 
curcuminoid synthase; CURS1: curcumin synthase 1; DCS: diketide-CoA synthase. 
 
To improve curcuminoids production, p-coumaric acid and ferulic acid were 
supplemented to the culture medium in two steps: 1 mM at time 0 of induction and 1 mM 
after 24 h of induction. This stepwise approach was tested because of the possible toxicity 
of p-coumaric and ferulic acids to the cells (Barthelmebs et al., 2001; Furuya and Kino, 
2013; Huang et al., 2013; Jung et al., 2013; Shin et al., 2011; Watts et al., 2006), and also 
because this strategy improved the production of caffeic acid in Chapter 3. However, in 
this case the two-step feeding was shown to be counterproductive, i.e. the production 
(E) 
(B) (A) 
(C) (D) 
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decreased which means that the slow process of curcuminoids production requires all the 
substrate available at the beginning of the fermentation to achieve a high production. 
Bisdemethoxycurcumin was also produced from tyrosine using TAL from R. glutinis 
(cloned in pCDFDuet_TAL), At4CL1 and CUS. The production was very similar to that 
obtained in the experiment in which p-coumaric acid was added in two steps, which 
probably means that the low production/concentration of p-coumaric acid in the first 24 h 
affects the production of bisdemethoxycurcumin. The production of p-coumaric acid at 63 
h was around 1500 µM, thus suggesting that the TAL enzyme was highly functional. To 
try to improve curcuminoids production At4CL1 was cloned alone in pCDFDuet-1 and 
with CUS in pRSFDuet-1, however no curcuminoids production could be observed. 
Since it was not possible to obtain the curcuminoids production  expected using CUS, it 
was decided to test if non codon-optimized CUS, which was successfully used by 
Katsuyama et al. (2008), could give better results. However, using this non codon-
optimized CUS it was impossible to see curcuminoids production or its expression. 
Taking this into account, it was concluded that the codon-optimization led to a more 
functional CUS expressed by E. coli and that codon-optimization should be carefully 
studied maybe using other algorithms in order to further improve the results. 
4.3.3 Production of Curcuminoids using DCS and CURS1 from C. longa 
CURS1 and DCS were also chosen to test the curcuminoids production due to the 
promising results previously reported in vitro (Katsuyama et al., 2009a; Katsuyama et al., 
2009b; Katsuyama et al., 2011). Although these two genes were successfully expressed in 
E. coli and the enzymes were used to produce several curcuminoids, including curcumin, 
DCS and CURS1 were never tested in vivo. CURS1 was named curcumin synthase due to 
its pronounced preference for feruloyl-CoA (Katsuyama et al., 2009a). Moreover, other 
CURSs were identified. CURS2 was also reported to prefer feruloyl-CoA and CURS3 
favored both feruloy-CoA and p-coumaroyl-CoA (Katsuyama et al., 2009b). Since 
curcumin has been reported to possess, in some systems, a higher therapeutic value than 
the other curcuminoids (Ahsan et al., 1999), CURS1 was chosen as it has the highest 
turnover rate towards feruloyl-CoA, as well as the highest difference between the 
catalytic efficiency towards feruloyl-CoA and p-coumaroyl-CoA. 
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Codon-optimized DCS and CURS1 were cloned in pRSFDuet-1 and their protein 
expression was also confirmed on a protein gel (Figure 4.3). The protein expression of 
DCS and CURS (42.90 kDa) was very high; hence in vivo production was further tested. 
Figure 6 illustrates the curcumin production from ferulic acid using pAC_At4CL1, 
pCDFDuet_DCS and pRSFDuet_CURS1. The production with these enzymes was very 
high, 188 µM (70 mg/L) after 63 h. Besides, the culture medium showed a dark orange 
color (Figure 4.5D), thus suggesting the production of curcuminoids. A higher 
concentration (113 mg/L) was reported by Katsuyama et al. (2008) using Le4CL, CUS 
and ACC. It is important to note that ACC can be very important to obtain high 
curcuminoids titers, in particular if there is a limitation of malonyl-CoA in the cells. 
However, comparing the results from Katsuyama et al. (2008) and Wang et al. (2013), it 
can be concluded that a high production of curcuminoids can also be obtained without 
ACC overexpression. Katsuyama et al. (2008), when using R. rubra PAL, Le4CL, CUS 
and ACC and adding phenylalanine or cinnamic acid obtained around 107 mg/L or 84 
mg/L of dicinnamoylmethane, respectively; while Wang et al. (2013) by using T. 
pratense PAL, At4CL1 and CUS and adding phenylalanine obtained 360 mg/L of 
dicinnamoylmethane – 3.4 times higher dicinnamoylmethane concentration than 
Katsuyama et al. (2008) without the need of using overexpressed ACC to increase the 
malonyl-CoA pool in E. coli. 
The addition of substrate (ferulic acid) was also tested at three different time points, 
namely 1 mM at time zero of induction in M9 medium, 0.5 mM at 5 h and an additional 
0.5 mM 24 h after induction. As previously observed (Figure 4.4), the curcuminoids 
production was also very low with multiple additions compared to adding all the ferulic 
acid at time zero of induction. Also, it was tested whether curcuminoids production was 
limited by low CaCO3 concentrations. CaCO3 is added to the M9 medium to aid pH 
maintenance during extended cultivation. During that time, when the production of 
curcuminoids is high, the CaCO3 precipitate decreases but it does not dissolve 
completely. Since the amount of CaCO3 used in the experiments was 5 times lower than 
other research groups used for caffeic acid, flavonoids and curcuminoids production 
(Choi et al., 2011; Kang et al., 2012; Katsuyama et al., 2010a; Katsuyama et al., 2008; 
Miyahisa et al., 2005; Wang et al., 2013), the CaCO3 concentration could be limiting the 
production of curcuminoids in some way, for example by affecting malonyl-CoA 
availability. Malonyl-CoA can be produced from acetyl-CoA and CO2 using endogenous 
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ACC. By increasing CaCO3 concentration, CO2 pool would also increase and maybe this 
would increase the production of curcumin. However, by tripling the initial CaCO3 
concentration, the curcuminoid production decreased considerably (Figure 4.6). 
Therefore, CaCO3 should not be used in such concentration at least in the conditions of 
this study. 
 
 
 
 
Figure 4.6. Curcumin production from ferulic acid using 4-coumarate-CoA ligase (4CL1) from Arabidopsis 
thaliana and diketide-CoA synthase (DCS) and curcumin synthase 1 (CURS1) from Curcuma longa. 
 
To understand if the amount of cells (OD600) at the time of induction in LB influenced the 
production of curcuminoids, the cultures were induced at different OD600 values (Figure 
4.7). We found that, although the cells should be induced early, induction should not be 
too early since it can impose a metabolic burden on the host strain associated with protein 
overexpression. The addition of IPTG at an OD600 of 0.4 yielded the highest production 
titer, suggesting that induction should be performed at an OD600 of 0.3-0.4. Moreover, the 
production by inducing the cells in LB and then in M9 at 37 ºC, instead of 26 ºC, was also 
tested. As expected the production of curcumin at 37 ºC was residual. Low temperatures, 
around 26-30 ºC, should be used for optimal enzyme synthesis and curcuminoids 
production. 
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Figure 4.7. Effect of IPTG induction at different OD600 values and effect of induction temperature on the 
production titers of curcumin using ferulic acid as substrate and 4-coumarate-CoA ligase (4CL1) from 
Arabidopsis thaliana and diketide-CoA synthase (DCS) and curcumin synthase 1 (CURS1) from Curcuma 
longa. 
 
 
Additionally, the effect of adding p-coumaric acid as a substrate, or a mixture of p-
coumaric acid and ferulic acid in the production of other curcuminoids was also evaluated 
(Figure 4.8A). The amount of bisdemethoxycurcumin produced was very low compared 
to curcumin, albeit 5 times higher than that obtained when CUS was used instead of DCS 
and CURS1. The addition of both substrates enabled the production of 
bisdemethoxycurcumin, demethoxycurcumin and curcumin. Curcumin was produced at 
the highest concentration (0.59 µM), followed by demethoxycucumin, due to the 
preference of feruloy-CoA as a substrate, compared to p-coumaroyl-CoA. 
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Figure 4.8. Curcuminoids production from tyrosine, p-coumaric acid and ferulic acid using 4-coumarate-
CoA ligase (4CL1) from Arabidopsis thaliana and diketide-CoA synthase (DCS) and curcumin synthase 1 
(CURS1) from Curcuma longa (A). Bisdemethoxycurcumin was also produced from tyrosine using 
tyrosine ammonia lyase (TAL) from Rhodotorula glutinis and curcumin was produced using a different 
plasmid configuration (B).  
 
 
Bisdemethoxycurcumin could also be produced from tyrosine, although in very small 
amounts (Figure 4.8B), i.e. almost 10 times lower than when p-coumaric acid is added. 
Since multiple plasmids may impose a metabolic burden on the host strain, At4CL1 was 
cloned in pCDFDuet-1 with DCS. However the curcumin production was extremely low 
comparing to that obtained when At4CL1 was in the pAC plasmid. CURS1 and DCS 
were also cloned as an operon in pCOLADuet-1. Nonetheless, no production of 
curcuminoids was observed. 
 
4.3.4 Production of Curcumin in a Bioreactor using DCS and CURS1 from C. longa 
The production of curcumin was further evaluated in a 2-L (working volume) bioreactor. 
As far as is known, this is the first time curcumin (or other curcuminoid) was produced in 
(1) 2 mM p-coumaric acid; pAC_At4CL1 + pCDFDuet_DCS + pRSFDuet_CURS1 
(2) 1mM p-coumaric acid + 1mM ferulic acid; pAC_At4CL1 + pCDFDuet_DCS + pRSFDuet_CURS1 
(3) 3 mM tyrosine; pETDuet_TAL + pAC_At4CL1 + pCDFDuet_DCS + pRSFDuet_CURS1  
(4) 2 mM ferulic acid; pCDFDuet_DCS_At4CL1 + pRSFDuet_CURS1 
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a bioreactor with E. coli. The induction in LB was performed in 2-L shake flaks 
containing 500 mL of medium. After 5 h of protein synthesis in LB, cells were transferred 
to M9 medium in the bioreactor. The initial OD600 in the bioreactor was ~1.0. Two 
experiments were performed where the pH was controlled using orthophosphoric acid and 
ammonium hydroxide instead of CaCO3. Since the curcumin concentration obtained after 
63 h was 3 times lower than that obtained in shake flasks, it was checked whether the use 
of CaCO3 to control the pH could improve the results. However, no significant 
improvement could be observed. Figure 4.9 shows the three independent experiments 
conducted for the production of curcumin in the bioreactor. Curcumin production was 
still increasing after 63 h and the bioreactor was visibly orange (Figure 4.9C). However, 
even after 111 h, this production was 2.3 times lower than that obtained in shake flasks. It 
is believed that the production of curcumin in bioreactor can be optimized. The fact that 
the first step in LB was done in 2-L shake flaks with 25% working volume, instead of 250 
mL flasks with 20% working volume, can influence the production since the space 
available for aeration was lower than in the smaller scale. Also, following transfer to the 
bioreactor, the cells probably need more time to adapt to the M9 medium and to the 
bioreactor conditions (e.g. agitation, aeration). Aeration and agitation rate (that can cause 
shear stress) must be further tested and optimized. Additionally, the culture medium 
should also be optimized since the two-step fermentation strategy, although feasible at 
laboratory scale, will become much more difficult and expensive in large-scale 
fermentations.  
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Figure 4.9. Curcumin production from ferulic acid in a bioreactor using 4-coumarate-CoA ligase (4CL1) 
from Arabidopsis thaliana and diketide-CoA synthase (DCS) and curcumin synthase 1 (CURS1) from 
Curcuma longa. Curcumin production during 111 h (A) and bioreactor at time zero of induction (B) and 
after 63 h (C). 
 
4.3.5 Production of Curcuminoids using Caffeic Acid as a Precursor or Intermediate 
CCoAOMT from M. sativa catalyzes the methylation of caffeoyl-CoA, its preferred 
substrate, to feruloyl-CoA and it was chosen since it has already been expressed in E. coli  
(Inoue et al., 1998). CCoAOMT (~27 kDa) was successfully expressed in E. coli (Figure 
4.10). CCoAOMT was used to produce curcumin from caffeic acid. After At4CL1 
converts caffeic acid to caffeoyl-CoA, CCoAOMT converts caffeoyl-CoA to feruloyl-
CoA which DCS and CURS1 can convert to curcumin. At4CL1 showed some specificity 
for caffeic acid and CCoAOMT was found to be functional since curcumin was produced 
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in vivo using these enzymes (Figure 4.11). However, the curcumin concentration 
obtained was low as compared with the production from ferulic acid. This lower 
production is probably due to the At4CL1 specificity. The enzyme shows a much higher 
preference for ferulic acid than for p-coumaric acid and caffeic acid. However, At4CL1 
seems to have a higher preference for caffeic acid than for p-coumaric acid since the 
production of curcumin from caffeic acid and bisdemethoxycurcumin from p-coumaric 
acid (Figure 4.8A) was very similar although more steps are required to obtain curcumin. 
Different approaches to clone CCoAOMT were tested. CCoAOMT cloned in 
pRSFDuet_CURS1 leads to a significant production of curcuminoids while if cloned in 
pCDFDuet_DCS the production is residual. Consequently, the first approach was chosen 
to attempt the production of curcuminoids from tyrosine. 
 
Figure 4.10. Protein gel showing caffeoyl-CoA O-methyltransferase (CCoAOMT) enzyme present in 
pRSFDuet-1 in cell-free extract. CCoAOMT is expected around 27 kDa. 
 
 
 
 
 
Figure 4.11. Curcumin production from caffeic acid using caffeoyl-CoA O-methyltransferase (CCoAOMT) 
from Medicago sativa, 4-coumarate-CoA ligase (4CL1) from Arabidopsis thaliana and diketide-CoA 
synthase (DCS) and curcumin synthase 1 (CURS1) from Curcuma longa. 
 
(1) pAC_At4CL1 + pCDFDuet_DCS + 
pRSFDuet_CURS1_CCoAOMT 
(2) pAC_At4CL1 + pCDFDuet_DCS_ 
CCoAOMT + pRSFDuet_CURS1 
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Curcuminoids production, including curcumin, was obtained from p-coumaric acid and 
tyrosine by using caffeic acid as an intermediate (Figure 4.12). When p-coumaric is used 
as a precursor, the production of curcuminoids is higher than when using tyrosine. Indeed, 
this was expected since, as the number of intermediates increases, the production of 
curcuminoids decreases, due to the loss of product in each step of the pathway. When p-
coumaric acid is used as a substrate, bisdemethoxycurcumin is the curcuminoid produced 
in higher concentrations, followed by demethoxycurcumin. This occurs probably because, 
due to the high concentration of p-coumaric acid added, p-coumaroyl-CoA is present in a 
higher concentration than feruloyl-CoA, thus being more available to produce a higher 
concentration of bisdemethoxycurcumin and demethoxycurcumin. Also, pKVS45_C3H 
enabled a higher concentration of caffeic acid than pETDuet_C3H, as it was observed 
previously (Chapter 3). Consequently, a higher caffeic acid concentration allowed the 
production of more curcumin. When tyrosine is used as substrate, the caffeic acid 
concentration obtained is lower, and the p-coumaric acid concentration produced is also 
lower than that maintained when it is added as a precursor. Although p-coumaric is 
present in a higher concentration than caffeic acid, At4CL1 seems to prefer caffeic acid 
over p-coumaric acid and consequently, curcumin is produced in higher amounts than 
bisdemethoxycurcumin. The concentration of the asymmetric curcuminoid 
(demethoxycurcumin) is higher than the concentration obtained of the symmetric 
curcuminoids (curcumin and bisdemethoxycurcumin). The system using TAL and C3H in 
the same plasmid (pETDuet_TAL_C3H) works better than cloning TAL in 
pCDFDuet_DCS. In the latter case, low expression levels of TAL seems to be the cause, 
as was found for CCoAOMT (Figure 4.11), since the p-coumaric acid production was 
low and consequently the caffeic acid production was also low, thus leading to a lower 
production of curcuminoids. 
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Figure 4.12. Curcuminoid production from p-coumaric acid and tyrosine using caffeic acid as an 
intermediate and using tyrosine ammonia lyase (TAL) from Rhodotorula glutinis, 4-coumarate 3-
hydroxylase (C3H) from Saccharothrix espanaensis, caffeoyl-CoA O-methyltransferase (CCoAOMT) from 
Medicago sativa, 4-coumarate ligase (4CL1) from Arabidopsis thaliana and diketide-CoA synthase (DCS) 
and curcumin synthase 1 (CURS1) from Curcuma longa. In (A) bisdemethoxycurcumin, 
demethoxycurcumin and curcumin production are shown while in (B) p-coumaric acid and caffeic acid are 
reported. 
 
At4CL1 was reported to have a high affinity for p-coumaric acid, followed by caffeic acid 
and a very low specificity for ferulic acid (Ehlting et al., 1999), which seems to be 
contradicted by the obtained results. According to Katsuyama et al. (2008), CURS1 has a 
higher preference for feruloyl-CoA than for p-coumaroyl-CoA. DCS preference for p-
coumaric acid or ferulic acid is unknown, although it is established that its affinity for 
malonyl-CoA is high (Katsuyama et al., 2009a). CUS was reported to prefer p-
coumaroyl-CoA as a substrate (Katsuyama et al., 2007c), which contradicts the obtained 
results as well. All these issues make it difficult to control the curcuminoids production 
ratios, whereby more information about the catalytic properties of all the enzymes 
involved in the curcuminoids biosynthetic pathway is required. The production levels can 
also be improved by balancing different expression levels. Imbalances can lead to over- 
or underproduction of enzymes and accumulation of intermediate metabolites which may 
result in suboptimal titers. 
 
(1) p-coumaric acid; pKVS45_C3H + pRSFDuet_CURS1_CCoAOMT + pCDFDuet_DCS + pAC_At4CL1 
(2) p-coumaric acid; pETDuet_C3H + pRSFDuet_CURS1_CCoAOMT + pCDFDuet_DCS + pAC_At4CL1 
(3) tyrosine; pETDuet_TAL_C3H + pRSFDuet_CURS1_CCoAOMT + pCDFDuet_DCS + pAC_At4CL1 
(4) tyrosine; pETDuet_C3H + pRSFDuet_CURS1_CCoAOMT + pCDFDuet_DCS_TAL + pAC_At4CL1 
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4.4 Conclusion 
Since there is an increasing interest in curcumin and other curcuminoids due to their 
several recognized beneficial effects, synthetic biology and metabolic engineering 
constitute good approaches to improve their availability. In this study, CUS was used to 
produce the three main curcuminoids in C. longa, namely bisdemethoxycurcumin, 
demethoxycurcumin and curcumin. However, the amount of curcuminoids produced with 
CUS was lower than the expected. The low titers may be due to use of plant enzymes in 
the pathway, which usually are poorly stable in prokaryotes even with codon-optimization 
owing to the lack of specific protein folding chaperones and post-translational 
modifications. 4CL was identified as a limiting step in the production of curcuminoids. 
Indeed, three different 4CL were studied; Le4CL, At4CL2 and At4CL1, but only At4CL1 
allowed the production of curcuminoids. To increase the curcuminoids production, 
CURS1 and DCS from C. longa were used and the production of curcumin was 
surprisingly higher than expected, especially taking into account the results obtained with 
CUS. This is the first report that demonstrates that these two enzymes can be used 
efficiently to produce curcuminoids in E. coli and provide high production titers. 
Although a high production of curcumin was achieved, the ACC requirements should be 
evaluated to confirm if malonyl-CoA is limiting the production of curcuminoids. In 
addition, CURS1 and DCS together with At4CL1 were used to produce curcumin in a 
bioreactor. The curcuminoids production in a bioreactor has never been reported before, 
and although it was lower than the one obtained in shake flasks, the results are promising 
and can be further optimized. Likewise, as far as is known, this is the first report on the 
production of curcumin from tyrosine through the production of caffeic acid as an 
intermediate. Although up to now the production of curcuminoids from tyrosine is low 
and the curcuminoids ratio difficult to control, this alternative pathway successfully led to 
the production of curcumin from tyrosine. It is believed that further optimization 
strategies of the proposed pathway will lead to the production of curcumin and other 
curcuminoids through de novo synthesis by using a tyrosine overproducing strain. 
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CHAPTER 5 
Selection of Escherichia coli Heat Shock Promoters toward their 
Application as Stress Probes 
 
The mechanism of heat shock response of Escherichia coli can be explored to program 
novel biological functions. In this study, the strongest heat shock promoters were 
identified by microarray experiments conducted at different temperatures (37 ºC and 45 
ºC, 5 min). The promoters of the genes ibpA, dnaK and fxsA were selected and validated 
by RT-qPCR. These promoters were used to construct and characterize stress probes 
using green fluorescence protein (GFP). Cellular stress levels were evaluated in 
experiments conducted at different shock temperatures during several exposure times. It 
was concluded that the strength of the promoter is not the only relevant factor in the 
construction of an efficient stress probe. Furthermore, it was found to be crucial to test 
and optimize the ribosome binding site (RBS) in order to obtain translational efficiency 
that balances the transcription levels previously verified by microarrays and RT-qPCR. 
These heat shock promoters can be used to trigger in situ gene expression of newly 
constructed biosynthetic pathways.  
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5.1 Introduction 
The heat shock response (HSR) is an essential and universal mechanism to protect cells 
(Lindquist, 1986). This mechanism is induced by a variety of stress conditions including 
physicochemical factors such as heat shock, complex metabolic processes and 
metabolically harmful substances (Arsène et al., 2000; Zhao et al., 2005) like heavy 
metals (Lindquist and Craig, 1988). The stress factors increase the level of denatured 
proteins, resulting in a biological activity change that can be damaging. In Escherichia 
coli exposed to heat shock conditions, there is an increase of the σ32 transcription factor 
(Grossman et al., 1984) that allows RNA polymerase to recognize the heat shock gene 
promoters. Consequently, the expression of heat shock proteins (HSP) increases 
(Lindquist, 1986; Zhao et al., 2005). Most HSP are chaperones and proteases (Arsène et 
al., 2000). Chaperones aid misfolded and unfolded proteins to fold correctly. Proteases 
degrade the proteins that chaperones cannot fold correctly, thus ensuring that problems 
created by stress conditions are minimized (Madigan et al., 2009). The E. coli HSR 
mechanism is, as in other organisms, very complex. When temperature increases up to 42 
ºC, a cascade of events with several key players is initiated. Despite several scientific 
efforts (El-Samad et al., 2005; Genevaux et al., 2007; Georgopoulos, 2006; Guisbert et 
al., 2004; Ito and Akiyama, 2005; Janaszak et al., 2007; Janaszak et al., 2009; Yura and 
Nakanigashi, 1999), some steps of this process have still not been completely elucidated. 
In the past decade numerous studies have been carried out using DNA microarrays to 
unravel the HSR of E. coli (Nonaka et al., 2006; Rasouly et al., 2009; Richmond et al., 
1999; Wade et al., 2006; Zhao et al., 2005). These studies evaluated different control and 
shock temperatures, exposure times and gene expression induction methods (temperature 
increase, σ32 transcription factor increase, IPTG) leading to the identification of several 
repressed and overexpressed heat shock related genes. Three of the most highly expressed 
heat shock genes are ibpB, ibpA and dnaK (Nonaka et al., 2006; Rasouly et al., 2009; 
Richmond et al., 1999; Wade et al., 2006; Zhao et al., 2005). However, gene expression 
and induction ratios obtained in these studies proved to be difficult to compare, mainly 
due to the different parameters tested.  
The heat shock promoters can be exploited for designing biological systems where a 
temperature shift can be used to trigger the expression of a particular gene or set of genes 
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and to build new biological functions and complex artificial systems that do not occur in 
nature (Khalil and Collins, 2010; Rodrigues and Kluskens, 2011). Induction methods like 
temperature shift are safe, easy to implement and administer (culture handling and 
contamination risks are minimized) and less expensive (Valdez-Cruz et al., 2010). For 
instance, the HSR in E. coli has been studied with a special focus on its potential use as a 
biosensor (transcriptional biosensing). For that purpose, the HSP promoters (dnaK, grpE, 
lon, clpB, ibpAB, clpPX, fxsA) have been fused to several reporter genes: lux (Ben-Israel 
et al., 1998; Sagi et al., 2003; Van Dyk et al., 1994), gfp (Aertsen et al., 2004; Cha et al., 
1999; Nemecek et al., 2008; Sagi et al., 2003) and luc (Kraft et al., 2007) that allowed 
detecting the activation of the HSR by the fast occurrence of light. These biosensors 
enabled the detection of pollution by metals, solvents and other chemicals. Furthermore, 
they also helped to identify HSP promoters activated by different types of stress and the 
overload exerted in E. coli by the production of recombinant proteins. The HSP 
promoters can further have a significant role in another important field of synthetic 
biology, namely in engineering bacteria and virus for therapeutic applications (Shankar 
and Pillai, 2011), like vaccines (Garmory et al., 2003) and gene delivery vectors (Drabner 
and Guzmán, 2001). Besides sensing environmental pollution, it is feasible to program 
bacteria to sense the tumor environment and selectively release a drug to kill cancer cells 
(Anderson et al., 2006; Shankar and Pillai, 2011).  
This study aims to identify the strongest heat shock promoters in E. coli to be used in 
synthetic biology approaches to reprogram organisms and trigger the expression of novel 
biomolecular components, networks and pathways. The promoter’s strength was 
evaluated using microarray data and was further validated by quantitative RT-PCR (RT-
qPCR) and by the construction and characterization of stress probes. 
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5.2 Materials and Methods 
5.2.1 Media and Strains 
E. coli K-12 MG1655 (The Coli Genetic Stock Center - CGSC#: 6300, New Haven, CT, 
USA) was grown in LB (Luria-Bertani) medium (tryptone 1% (w/v), yeast extract 0.5% 
(w/v), sodium chloride 1% (w/v)) (Panreac, Barcelona, Spain) at 37 ºC/30 ºC and 200 
rpm in shake flasks and in a 2 L stirred tank bioreactor (Autoclavable Benchtop 
Fermenter Type RALF, Bioengineering, AG, Wald, Switzerland) (section 5.2.3). Pre-
inocula were prepared from frozen glycerol stocks and incubated overnight (~12 h) in LB 
at 37 ºC/30 ºC and 200 rpm. Both shake flasks and bioreactor were inoculated with 1% of 
inoculum. Biomass was monitored in a spectrophotometer at an optical density at 600 nm 
(OD600). The cell concentrations at which the heat shock should be applied were 
determined using biomass calibration curves. Samples were collected over time for RNA 
extraction or fluorescence measurements. 
5.2.2 Heat Shock Probes Construction 
GFP (mut3b) was amplified by PCR from pSB1A2-GFP (Cormack et al., 1996). The 
promoters were amplified from E. coli gDNA extracted using the Wizard
®
 Genomic 
DNA Purification Kit (Promega, Madison, WI, USA). Q5
®
 Hot Start High-Fidelity DNA 
Polymerase (NEB, Ipswich, MA, USA) was used to amplify GFP and all the promoters 
used. The heat shock promoter sequences were obtained from the NCBI (The National 
Center for Biotechnology Information) database. The RBS was calculated using the 
software RBS Calculator v1.1 (Salis, 2011). GFP and all the promoters were cloned using 
restriction enzymes and DNA T4 ligase (NEB, Ipswich, MA, USA). GFP was cloned in 
MCS1 of pETduet (Novagen, Darmstadt, Germany), between the BamHI and AscI site. 
After cloning GFP, the T7 promoter was replaced by each of the three heat shock 
promoters (selected after microarrays data treatment) that were cloned between the SphI 
and BamHI site. The SacI site was added downstream of the SphI site to aid colony 
screening. E. coli ElectroMAX
TM
 DH10B competent cells (F
- mcrA ∆(mrr-hsdRMS-
mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 endA1 araD139  ∆(ara, leu)7697 galU galK λ- 
rpsL nupG) (Invitrogen/Life Technologies, Carlsbad, CA, USA) were transformed with 
the ligation mixture. Colonies were screened by plasmid digestion, confirmed by 
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sequencing (Genewiz, Cambridge, MA, USA) and E. coli K-12 MG1655(DE3) 
competent cells were transformed with the plasmid containing the gene or promoter of 
interest. Primers (Sigma-Aldrich, St. Louis, MO, USA) and restriction enzyme sites are 
listed in Table 5.1. 
 
Table 5.1. Set of primers for PCR amplification used in GFP and heat shock promoters for stress probe 
construction (forward and reverse primers – FW and REV). 
Primer Name Primer sequence 
Restriction 
Enzymes 
GFPmut3b_FW GGATCCAATGCGTAAAGGAGAAGAACT BamHI 
GFPmut3b_REV GGCGCGCCTTATTATTTGTATAGTTCATCCATGCC AscI 
ibpA_FW GCATGCGAGCTCAAAATAACATCATCATTACGTCG SphI, SacI 
ibpA_REV GGATCCTCCTTAATAGTTCGCTCGTACGATGTAAAAATGGGTCTG BamHI 
dnaK_FW GCATGCGAGCTCATGCCTTGGCTGCGATT SphI, SacI 
dnaK_REV GGATCCTCCTCGTCTATTCCGACTCCTATTCGGTCATCATGTGGT BamHI 
fxsA_FW GCATGCGAGCTCGAGGATTTCTACCGTAATCTG SphI, SacI 
fxsA_REV 
GGATCCTCCCGATCCGTCGTGCTTTCTTTAGCTTATATTGTGGTCA
TTAG 
BamHI 
 
5.2.3 Heat Shock Experiments 
Shake flasks were placed in an incubator at 37 ºC and 200 rpm. Bacterial growth was 
monitored by OD600. Heat shock was applied at a cell concentration of 5 to 6 × 10
8 
cells 
per mL, a concentration obtained after approximately 7.5 h of growth. Control flasks were 
kept at 37 ºC, while the ones corresponding to the heat shock assay were immersed in a 
water bath at 45 ºC for 5 min. Samples were taken before heat shock and after 5 min of 
heat shock. These experiments were conducted six-fold (two for microarray analysis and 
four for RT-qPCR analysis). 
 In order to fully characterize the transcriptional profiles of the heat shock genes, two 
experiments were conducted in a 2-L bioreactor (1 L of LB medium) at 200 rpm, 30% of 
dissolved oxygen, and at different control (30 ºC and 37 ºC) and heat shock temperatures 
(45 ºC and 50 ºC) during different exposure times and different heating rates (Figure 
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5.1.). A very high heat shock temperature (50 ºC) was chosen to observe the differences 
during and after heat shock under more lethal conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Temperature profiles tested in the bioreactor experiments: (A) 37 ºC → 45 ºC → 37 ºC and (B) 
30 ºC → 50 ºC → 30 ºC. The letters A to W represent points where samples were collected for RNA 
extraction. 
 
The experiments with the heat shock probes containing GFP were also performed in 
shake flasks and the heat shock was applied in a water bath at 45 and 50 ºC for 5 or 10 
min. In each experiment 5 flasks were permanently held at 30 or 37 ºC (control) and 5 
flasks were subjected to the corresponding heat shock temperature for 5-10 min. Each 
culture flask contained one of the five following plasmids: T7promoter_pETduet (empty), 
T7promoter_pETduet_GFPmut3b, ibpApromoter_pETduet_GFPmut3b, dnaKpromoter_ 
pETduet_GFPmut3b, fxsApromoter_pETduet_GFPmut3b. Ampicillin (Applichem, 
Darmstadt, Germany) was added at a final concentration of 100 µg/mL. For the plasmids 
with a T7 promoter, 0.1 mM IPTG was added at induction time zero. Each experiment 
was conducted three times at different experimental conditions (heat shock temperature 
and/or duration). 
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5.2.4 RNA Extraction and DNase Treatment 
All samples collected for microarrays and RT-qPCR analysis were immediately stabilized 
with the RNAprotect Bacteria Reagent (Qiagen, Germantown, MD, USA) and the pellets 
were maintained at -80 ºC. 
RNA extraction for microarray analysis was conducted using the RNeasy® Protect 
Bacteria Mini Kit (Qiagen), following the manufacturer’s guidelines. The Qiagen RNase-
free DNase Set (Qiagen) was used to eliminate any DNA contamination from the 
samples.  
RNA extraction for RT-qPCR analysis was performed by the phenol-chloroform method 
followed by ethanol precipitation, and then the addition of DEPC (Diethylpyrocarbonate) 
(Sigma-Aldrich) treated water (Khodursky et al., 2003). To eliminate any DNA 
contamination from these samples, the Turbo DNA-free
TM
 Kit (Ambion/Applied 
BioSystems/Life Technologies, Carlsbad, CA, USA) was used according to the 
manufacturer’s guidelines. 
RNA concentration and quality were determined using a NanoDrop spectrophotometer 
(ND-1000, Thermo Scientific, Wilmington, DE, USA). RNA purity levels were estimated 
by the A260/A280 and A260/A230 ratios. Furthermore, RNA integrity was evaluated by 
running a 1.5% (w/v) agarose gel electrophoresis loaded with 5 μL of RNA sample. 
 
5.2.5 Microarrays 
Genetic expression levels of samples grown in shake flasks were analyzed by microarray 
experiments (two control samples – CA and CB - and two heat shock samples – TA and 
TB). Total RNA samples were sent to an Affymetrix (Santa Clara, CA, USA) core facility 
(Instituto Gulbenkian de Ciência, Oeiras, Portugal) where quality-control analysis was 
carried out using the Bioanalyzer 2100 (Agilent Technologies, Waldbronn, Germany). All 
microarray steps (cDNA synthesis with appropriate random primers (Invitrogen/Life 
Technologies, P/N 48190-011, Carlsbad, CA, USA), cDNA fragmentation and labeling 
through incorporation of biotinylated ribonucleotide analogs (ddUTP-biotin), 
hybridization to the GeneChip® E. coli Genome 2.0 Array (Affymetrix, Santa Clara, CA, 
USA), staining with streptavidin- phycoerythrin and scanning) were done according to 
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Affymetrix protocols. The GeneChip® includes approximately 10000 probe sets for all 
20366 genes present in four strains of E. coli, including the K-12 MG1655 used in this 
study. 
 
5.2.6 RT-qPCR 
The primers used for specific amplification (Invitrogen) are described in Table 5.2 and 
were designed using the Primer 3 program (Rozen and Skaletsky, 1999). The size of all 
amplicons was between 100 and 105 base pairs. Reverse Transcriptase (RT) reaction was 
performed in a MyCycler™ Personal Thermal Cycler (BioRad, Hercules, CA, USA) and 
the iScriptTM Select cDNA Synthesis kit (BioRad, Hercules, CA, USA) was used 
according to the manufacturer’s instructions, except that the reaction volume used was 10 
μL. The final RNA template concentration in the cDNA synthesis reaction was 0.05 
μg/μL, and was calculated using the RNA concentrations as determined by NanoDrop. 
The reverse primers used in the RT reaction are also described in Table 5.2. 
 
Table 5.2. Set of primers used in RT (reverse primers - REV) and qPCR amplification (forward and reverse 
primers – FW and REV). 
 
Gene name Primer name Primer Sequence  
dnaK 
dnaK_FW AATCGAACTGTCTTCCGCTC 
dnaK_REV TTCGCACGAGTCACTTTGAT 
ibpA 
ibpA_FW ACAAAAAGAGCGCACCTATCT 
ibpA_REV CAGGTTAGCACCACGAACA 
fxsA 
fxsA_FW CGGCGGAGATGATTAAAAGT 
fxsA_REV CGGCGGCAATAAAAGTAGA 
rrsA - 16S 
16S_FW TAGCGGTGAAATGCGTAGAG 
16S_FW TAATCCTGTTTGCTCCCCAC 
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qPCR was used to evaluate the transcription levels of the heat shock genes that were 
selected from the microarray experiments. qPCR was carried out in a CFX96 Real-Time 
PCR Detection System (BioRad, Hercules, CA, USA) using SsoFastTM EvaGreen® 
Supermix (BioRad, Hercules, CA, USA) as specified by the manufacturer, except that the 
reaction volume used was 10 μL. Primer efficiency and correlation values (R2) were 
determined by the CFX Manager Software (Biorad, Hercules, CA, USA). The cDNA 
dilution used in the qPCR experiments was 1/80. No-reverse transcriptase controls, in 
which RNA instead of cDNA was used, were included to evaluate the presence of any 
gDNA. Three and two technical replicates were performed for each biological replicate 
from flask and bioreactor heat shock experiments, respectively.  
 
5.2.7 Microarrays Data Treatment 
Analysis of the microarray data was conducted using three different software programs 
(Expression Console®, dChip and SAM - Significance Analysis of Microarrays). The 
Expression Console
®
 software (Affymetrix) was used to analyze the raw data from the 
four arrays (CA, CB, TA and TB) and assess the need for data pre-treatment (background 
correction, normalization and summarization). For data pre-treatment three different 
algorithms (RMA - Robust Multichip Average, PLIER - Probe Logarithmic Intensity 
Error Estimation and MAS5 - MicroArray Suite 5) were used. dChip software (Li and 
Wong, 2003) was used for data pre-treatment and to filter the genes in order to obtain the 
most expressed ones during heat shock conditions. In this case, the algorithm used for 
data pre-treatment was MBEI (Model Based Expression Index). For background 
correction the MM (MisMatch) probes where used to correct PM (Perfect Match) probes 
(PM/MM difference), and normalization was carried out using the invariant set method. 
Subsequently, data were filtered according to the name "MG1655," since the GeneChip® 
also includes three other pathogenic E. coli strains and several intergenic regions that are 
not relevant for the purpose of the current work. Figure 5.2 illustrates the roadmap of the 
microarrays data treatment. 
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Figure 5.2. Roadmap of the microarrays data treatment. 
 
The genes were also filtered according to their dispersion coefficient in various samples 
(σ/?̅?) and to the percentage of presence of the gene in the four above-mentioned arrays. 
The ratio of standard deviation and mean of gene expression values across all samples 
should be greater than a certain threshold (0.5 < σ/?̅? <10). The more variable a gene is 
across samples, the larger this ratio will be. Nevertheless, if a gene is mostly absent across 
samples, this ratio can be large due to a small mean. For these reasons, the gene should be 
present in more than 40% of the arrays (i.e. at least in two arrays). Following these 
procedures, 703 genes were found to verify the filtering criteria. 
 The filtered genes were used to compare the different samples and to identify the 
differentially expressed genes. These genes were selected according to their induction 
ratio ((𝑇𝐴 + 𝑇𝐵) (𝐶𝐴 + 𝐶𝐵)⁄ > 1.2 or  (𝐶𝐴 + 𝐶𝐵) (𝑇𝐴 + 𝑇𝐵)⁄ > 1.2) and absolute 
difference between the samples ((𝑇𝐴 − 𝐶𝐴 + 𝑇𝐵 − 𝐶𝐵)/2 > 100 or (𝐶𝐴 − 𝑇𝐴 + 𝐶𝐵 −
𝑇𝐵)/2 > 100). The t-test for paired samples was performed for each gene identified and 
a p-value lower than 0.05 was assumed to obtain significant results (Cui and Churchill, 
2003). The differentially expressed genes were grouped by hierarchical clustering 
strategies to evaluate the different expression profiles. 
The genes identified by the dChip program as differentially expressed (189 
genes) were subsequently tested in the SAM (Significance Analysis of Microarrays) 
program (S-test) (http://statweb.stanford.edu/~tibs/SAM/). The "two-class paired" test 
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(two groups, and one-to-one pairing between a member of group A and a corresponding 
member of group B) was chosen with the following parameters: number of permutations 
= 5000 (at least 1000 permutations are recommended for accurate estimates) and Δ = 1 
(delta parameter is used to adjust the false positive rate, that can be decreased at the cost 
of missing true positives, or increased at the cost of obtaining more false negatives. The 
number of significant genes and the number of false significant genes will decrease with 
increasing delta values) (Dziuda, 2010). 
 
5.2.8 RT-qPCR Data Treatment 
RT-qPCR data were analyzed using the 2
-ΔΔC
T method described by Livak and 
Schmittgen (2001). In this method, the amount of mRNA for a target gene is normalized 
to an endogenous control and relative to a calibrator or arbitrary control condition. The 
housekeeping rrsA gene, encoding the 16S RNA, was used as an endogenous control to 
normalize the differences in total RNA quantity (Dong et al., 2008; Kobayashi et al., 
2006). RT-qPCR values were obtained for each gene for both control and heat shock 
conditions. Afterwards, data were normalized with the 16S CT value and subsequently the 
expression value of each gene under the control conditions (Livak and Schmittgen, 2001): 
Equation 1:  ΔΔCT= (CT,heat-shock gene-CT,16S) Heat Shock – (CT,heat-shock gene-CT,16S) Control  
 
Finally, the expression level for each heat shock gene (E
-ΔC
T) and the induction ratio (E
-
ΔΔC
T) were calculated. E represents the real calculated efficiency value for each set of 
primers, which was very close to 100% (97.8%-100.8%). 
 
5.2.9 Fluorescence Measurements and Data Treatment 
The GFP assay was performed by measuring fluorescence intensity with a fluorescence 
spectrometer (Infinite 200
®
 PRO, Tecan) at an excitation wavelength of 485 nm and an 
emission wavelength of 535 nm. The measurements were performed in Nunc-Immuno
™
 
MicroWell
™
 96 well polystyrene black plates (Nunc/Thermo Scientific, Rochester, NY, 
USA) with 300 µL of culture sample resuspended in phosphate-buffered saline (PBS: 137 
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mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4, pH 7.4). The software used in 
the analysis was the i-Control
TM
 version 1.9.17.0 (Tecan, Morrisville, NC, USA). The 
specific fluorescence intensity (SFI) is calculated by dividing the raw fluorescence 
intensity by the OD600 and allows comparison of samples with different OD600 at time 
zero. 
 
5.3 Results and Discussion  
5.3.1 Differential Expression of HSP Genes and Identification of the Strongest HSP 
Promoters using Microarrays 
The microarray results of the heat shock experiments conducted in flasks at different 
temperatures (held constant at 37ºC relative to incubation at 45 ºC for 5 min) allowed 
identifying the strongest heat shock promoters (i.e. the most highly expressed genes). 
After the heat shock, the percentage of transcripts considered present increases slightly 
(~2%) and the transcripts considered absent decrease proportionally. This means that the 
heat shock led to an increase of the expression of some genes, some of which are possibly 
not transcribed under normal growth conditions.  
These heat shock promoters were identified after the data pre-treatment (background 
correction and normalization, see section 5.2.7). E. coli K-12 MG1655 genes were 
selected from all the genes present in the Affymetrix array and were further filtered and 
compared to the criteria mentioned before (Figure 5.2). These criteria allowed to only 
select genes with low variation between the replicates and that are differentially expressed 
comparing to the control sample. Based on the different criteria, 189 genes were selected 
and classified as differentially expressed. These differentially expressed genes were then 
hierarchically clustered. As shown in Figure 5.3A, the tree is divided in two main 
branches, displaying underexpressed (upper branch) and overexpressed genes (lower 
branch). All replicates (CA and CB, TA and TB) demonstrate a great affinity with each 
other (Figure 5.3B) with a Spearman coefficient near 1. When comparing the two 
conditions (control and heat shock) the coefficient is near -1, demonstrating that there is a 
significant difference in gene expression between the samples. 
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(A) (B)  
 
 
Figure 5.3. Hierarchical clustering of 189 genes whose expression is significantly altered following heat 
shock induction (A) and Spearman correlation matrix (B). The red color in the hierarchical clustering 
represents expression levels above the average of gene expression in all samples, the white color represents 
an average expression, and the blue color represents expression levels below average. 
 
Afterwards, these 189 genes were subjected to the t-test and only 56 were considered as 
being significantly transcribed. However, t-test is not satisfactory when used in the 
analysis of data from microarrays with few replicates (as is the case of this work) since it 
is difficult to estimate the variance (Cui and Churchill, 2003). Thus, adapted t-test, for 
example, S-test, should be used because it prevents the selection of genes with small 
changes as significant genes and it uses the values of the replicates to estimate the 
percentage of genes identified by chance (FDR - False Discovery Rate). Using the S-test, 
from the 189 genes identified as differentially expressed by dChip program, only 128 
were considered significant with an FDR equal to 0%. The q-value, which is the lowest 
FDR at which a gene is described as significantly regulated, was also 0.  
Table 5.3 shows the 34 genes that were found to be the most expressed due to the heat 
treatment (45 ºC, 5 min) and which simultaneously fulfilled the comparison criteria. In 
Figure 5.3B, these genes can be found in the branch called "TA Expression ~ TB 
Expression." The microarray results obtained in the current work are consistent with 
others reported in the literature (Nonaka et al., 2006; Rasouly et al., 2009; Richmond et 
al., 1999; Wade et al., 2006; Zhao et al., 2005). 
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Table 5.3. Heat shock genes induction ratio, expression values (average of two biological replicates) and t- 
and S-test results. 
Gene code 
Blattner  
Gene 
Induction 
Ratios  
Expression values 
t-test  
dChip 
S-test 
SAM 
Number Test/Control Control Test t p- value S 
1762978_s_at b3686 ibpB 224.76 22.55 5071.54 8.25 0.08 8.39 
1769060_s_at b3687 ibpA* 55.68 106.34 5917.71 8.95 0.07 9.05 
1765041_s_at b1322 ycjF 23.82 62.22 1473.74 14.38 0.04 13.55 
1768270_s_at b1321 ycjX* 21.77 102.70 2230.95 24.86 0.03 24.53 
1766244_s_at b3635 mutM* 21.1 42.90 907.10 5.10 0.12 4.92 
1762193_s_at b3685 yidE 21.09 21.95 463.43 2.29 0.26 2.23 
1765416_s_at b1380 ldhA* 20.12 113.35 2282.35 15.42 0.04 14.83 
1760394_s_at b1594 mlc* 18.78 70.46 1324.72 3.83 0.16 3.76 
1763446_s_at b4140 fxsA* 16.89 104.78 1742.74 95.73 0.01 134.67 
1761819_s_at b0473 htpG* 13.02 347.16 4469.62 27.21 0.02 28.35 
1766513_s_at b0492 ybbN* 11.15 215.08 2397.06 7.33 0.09 7.18 
1761806_s_at b3401 hsp33 9.89 138.25 1365.18 8.22 0.08 7.93 
1760965_s_at b1829 htpX* 9.82 379.64 3742.23 16.26 0.04 15.99 
1763516_s_at b1060 yceP* 9.44 224.83 2117.17 6.75 0.09 6.60 
1764871_s_at b2592 clpB* 9.17 548.94 4955.68 48.22 0.01 679.74 
1761621_s_at b3498 prlC* 9.17 176.66 1609.55 10.99 0.06 10.54 
1763737_s_at b3594 yibA* 9.01 41.95 376.25 3.78 0.16 3.54 
1761422_s_at b3400 yrfH* 8.66 292.95 2517.09 10.39 0.06 10.14 
1768615_s_at b3497 yhiQ 8.29 135.89 1127.29 5.65 0.11 5.46 
1764204_s_at b3292 zntR 8.24 187.82 1541.54 72.42 0.01 155.46 
1766949_s_at b3932 hslV* 8.07 416.46 3351.77 44.71 0.01 46.65 
1768518_s_at b4143 groEL 7.90 743.13 5831.04 37.87 0.02 55.53 
1763357_s_at b0014 dnaK* 7.59 814.09 6120.95 24.91 0.03 28.07 
1769019_s_at b0015 dnaJ 7.08 559.61 3946.50 23.26 0.03 23.91 
1767479_s_at b1593 ynfK 7.08 35.13 246.56 4.01 0.16 3.60 
1764894_s_at b4142 groES* 6.79 772.53 5188.85 25.73 0.03 148.96 
1767623_s_at b0439 lon* 6.76 604.83 4079.96 18.37 0.04 19.04 
1762240_s_at b3931 hslU 6.58 518.63 3370.51 24.98 0.03 30.41 
1764710_s_at b3293 yhdN* 6.42 369.45 2377.17 38.28 0.02 40.39 
1767508_s_at b1814 sdaA* 6.37 536.85 3429.90 7.25 0.09 7.13 
1764062_s_at b1379 hslJ 6.30 162.79 1016.68 21.90 0.03 19.99 
1768300_s_at b0016 yi81_1 5.74 374.36 2133.52 23.63 0.03 22.85 
1768989_s_at b1280 yciM 5.64 217.00 1218.50 18.14 0.04 17.24 
1759242_s_at b0630 lipB 5.61 220.41 1235.10 64.04 0.01 70.13 
Genes marked with "*" represent the ones that are directly downstream of the σ32 factor dependent promoters. The list presented is 
ordered according to the average rate of induction (Test/Control) of the genes. q-value was 0 for all the genes. In bold it is possible to 
observe the promoters chosen for posterior validation. 
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5.3.1.1 Selection of the Appropriate Heat Shock Promoters to Trigger Gene 
Expression 
In metabolic engineering it is very important to choose the right promoter(s) since many 
rate-limiting steps may exist in the pathways and accumulation of intermediate 
metabolites may occur. Therefore, after constructing a novel pathway(s), the expression 
levels of all the components should be orchestrated to allow fine-tuning of expression 
levels and optimization of metabolic fluxes (Khalil and Collins, 2010). For this reason, it 
is essential to construct libraries of engineered tandem promoters with varying strengths 
(Alper et al., 2005; Ellis et al., 2009; Jensen and Hammer, 1998). Depending on the 
envisaged purpose for the use of HSP promoters, several options can be considered to 
make an appropriate choice. For example, if building engineered bacteria to overexpress a 
given compound is foreseen, the promoter of choice will depend essentially on the 
product concentration needed and its toxicity to the cell, since a low concentration may 
not be sufficient for the intended purpose, but too high a concentration can damage the 
cells. Table 5.3 illustrates three main situations when considering the genes placed 
directly downstream of the promoters (*): high induction rate and high expression level 
during heat shock (ibpA, ycjX, ldhA); high induction rate but low expression during heat 
shock (mutM, mlc, fxsA) when compared to the expression levels of other genes; and 
medium induction rate and high expression level (clpB, dnaK, groES, lon). 
 
5.3.1.1.1 High Induction Rate and High Expression Level  
If the aim is to achieve a very high concentration of a given compound, the chosen 
promoter has to allow a rapid induction of gene expression, but also a high expression. In 
this study (Table 5.3) and in several of the microarray-based studies to identify E. coli 
heat shock genes, it was found that ibpA and ibpB were the two most induced genes, with 
a consistently higher induction rate for ibpB (Caspeta et al., 2009; Richmond et al., 1999; 
Zhao et al., 2005). These genes, along with yidE gene, belong to the same transcription 
unit and the σ32 promoter-dependent is upstream of the ibpA gene. Moreover, ibpA 
expression is higher than ibpB expression, both under normal growth conditions and after 
heat shock treatment. This suggests that the high induction rate of ibpB is not due to a 
higher expression compared to the gene ibpA, but to its low expression at 37°C (control 
conditions). Therefore, at 37 ºC the ibpB gene is poorly expressed, possibly due to the 
short half-life of the σ32 factor, while under heat shock conditions, due to an increase in 
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denatured proteins, the half-life of σ32 increases and the ibpB gene is transcribed similarly 
to the ibpA gene. Hence, despite the high induction rate of the ibpB gene, one can 
conclude that the promoter upstream of the ibpA gene is by far the one that allows a more 
pronounced expression of the HSP genes (Caspeta et al., 2009). As can be seen in Table 
5.3, the strongest promoter following the ibpA gene promoter is the promoter upstream 
the operon comprising ycjX, ycjF and tyrR. These three genes have been reported to be 
σ32 dependent in all microarray studies conducted so far. The ldhA gene, encoding the 
enzyme D-lactate dehydrogenase, was also identified by several authors as a heat shock 
gene (Richmond et al., 1999; Wade et al., 2006; Zhao et al., 2005). The difference in hslJ 
gene expression, present in the same transcription unit, is not so evident in the current 
results but remains significant. 
 
5.3.1.1.2 High Induction Rate but Moderate Expression Level during Heat Shock 
If a fast expression induction and, at the same time, a more moderate expression is 
required after heat shock, then mutM, mlc, fxsA and prlC promoters can be used. These 
genes have been reported in several studies as heat shock genes, their functions are well-
known and their promoters have been properly identified (Nonaka et al., 2006; Shin et al., 
2001; Tsui et al., 1996; Zhao et al., 2005). However, in the current work the expression 
values obtained for mutM and mlc gene duplicates are very different and not conclusive, 
which can be clearly seen by the t- and S-test results (Table 5.3). The same occurs with 
the yibA gene which was only been identified as heat shock gene by Zhao et al. (2005) 
and Wade et al. (2006), although the sequence of its promoter has not been defined. Thus, 
if a rapid induction and a lower gene expression are required, then the fxsA and prlC 
promoters would be a preferable choice.  
 
5.3.1.1.3 Medium Induction Rate and High Expression Level 
The promoters associated with other genes with a relatively high induction ratio and 
expression, such as htpG, ybbN, htpX, yceP, clpB, yrfH, hslV, dnaK, groES, lon, yhdN and 
sdaA, can also be considered as strong promoters and therefore may be used in the 
construction of engineered bacteria. However, it is necessary to take into account that the 
lower induction rate in these cases is primarily due to a high expression of genes in 
control samples. Thus, it is necessary to evaluate any implications that the possible 
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expression of these genes could have on the applications envisaged before the heat shock 
treatment occurs. If the production/expression of the compound/gene before heat shock 
induction leads to misleading/undesirable results, then these promoters should not be 
used. As can be observed in Table 5.3, dnaK has the highest expression at 45 ºC, 
followed very closely by ibpA. Although they have similar expression levels under heat 
shock conditions, the dnaK induction rate is much smaller than that of ibpA. DnaK is one 
of the most reported chaperones and belongs to the DnaK system, together with the DnaJ 
(known to assist the DnaK chaperone) and GrpE proteins (nucleotide exchanger factor). 
In the absence of stress, these proteins have an important role in the regulation of the 
stability of the σ32 transcription factor, and in the maintenance and restoration of the 
homeostatic balance. As for the ybbN, htpX, yceP, yrfH, hslV, yhdN and sdaA genes, it is 
known that all of them are also associated with σ32 controlled promoters (Chuang et al., 
1993; Cowing et al., 1985; Kornitzer et al., 1991; Nonaka et al., 2006; Zhao et al., 2005). 
The two htpG genes and clpB, groES and lon genes have σ32-dependent promoters but 
they are also controlled by σ54 and σ70 transcription factors. Therefore, the possibility that 
the high ratio and expression levels in this study are due to the higher affinity of the other 
factors to the promoter cannot be ruled out. Nevertheless, since the binding sites of the 
two factors are superimposed, the use of these promoters with possibly more affinity for 
other transcription factors is not necessarily a disadvantage, since both factors can 
hypothetically bind during heat shock induction, which in turn could lead to a high gene 
expression. 
 
5.3.2 Validation by RT-qPCR of the Differential Expression of HSP Genes 
Validation by quantitative RT-PCR (RT-qPCR) of the overexpression of some of these 
HSP genes identified by microarrays, for example ibpA, fxsA and dnaK, is required before 
using their promoters to trigger a gene or a biosynthetic pathway by heat. For RT-qPCR 
validation, flask experiments were conducted twice in duplicate using the same 
temperatures and exposure time as for the microarray studies (Figure 5.4). Furthermore, 
several experiments were conducted in a bioreactor at different heat shock temperatures, 
during different exposure times and at different heating rates in order to fully characterize 
the transcriptional profiles of the selected heat shock genes (Figure 5.5). 
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Figure 5.4. Gene expression profiles (A) and fold change (B) during the temperature up-shift from 37 to 45 
ºC in flask. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Gene expression profiles (A, B) and fold changes (C, D) during up-shift from 37 to 45 ºC (A, 
C) and 30 to 50 ºC (B, D) and subsequent down-shift in bioreactor. 
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Figure 5.4A shows the relative expression of the three selected genes (ibpA, dnaK, fxsA) 
with respect to the rrsA gene in the two sample types (control and heat shock). A different 
expression of the heat shock genes could be observed when comparing the control with 
the heat shock sample. In the case of the heat shock genes it was found that the gene 
expression is lower in the control, which was foreseen since the heat shock transcripts are 
lower at 37 ºC. Comparison of the three heat shock genes shows that the dnaK gene 
possessed the highest expression in heat shock conditions. However, this gene also 
showed the highest expression in normal growth conditions, which in turn contributes to a 
lower induction ratio (Figure 5.4B). The ibpA gene showed the highest induction ratio, 
since it has a high expression in heat shock conditions but a low expression at 37 ºC. The 
fxsA gene showed a moderate expression under heat shock conditions when compared to 
the other two heat shock genes, as expected. 
As can be observed in Figure 5.5 the expression profiles of the three heat shock genes 
obtained in the bioreactor are very similar. The expression increases when temperature 
up-shift starts and maximum expression occurs when the culture medium reaches 45 ºC 
(Point D, Figure 5.5A) and 50 ºC (Point O, Figure 5.5B). After reaching the maximum 
temperature, the gene expression starts to decrease until a new stationary state is reached 
due to bacterial adaptation to heat. Also, following the temperature down-shift to the 
original temperatures, 37 ºC (Point I, Figure 5.5A) and 30 ºC (Point T, Figure 5.5B), the 
heat shock gene expression almost returns to its original basal level. During adaptation, to 
establish the homeostatic balance, σ32 transcription factor is degraded by proteases, such 
as FtsH. This occurs due to the chaperones negative modulation mechanism, in which 
they regulate their own synthesis by controlling the activity, stability and synthesis of the 
σ32 transcription factor. The HSR at 45 ºC was found to be in accordance with previous 
studies conducted at 42 ºC (Nagai et al., 1991; Rasouly et al., 2009; Tilly et al., 1989). In 
contrast, the heat shock response at 50 ºC was more prolonged, which was expected since 
it is more lethal to the cells and it is more difficult for the cells to adapt. 
From the analysis of the expression profiles represented in Figure 5.5A and Figure 5.5B, 
it is possible to conclude that the ipbA gene had a higher fold change, since in normal 
growth conditions (37 ºC)  it is less expressed than dnaK gene, and at heat shock 
temperatures it reaches levels similar to the ones observed for the dnaK gene. As 
expected, the fxsA gene showed a moderate expression. These results are in accordance 
with the ones obtained in the flasks experiments. Figure 5.5C and Figure 5.5D show the 
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genes fold change for the two experiments after normalization of the data. The gene 
expression is higher in the experiment conducted at the lethal temperature (50 ºC) as for 
this temperature, the heat shock genes’ transcription is controlled by the transcription 
level of the rpoH gene. The rpoH gene encodes the σ32 transcription factor. The rpoH 
gene transcription is controlled by different transcription factors depending on the 
temperature. At 30 ºC or 37 ºC, the rpoH gene transcription is controlled by three σ70 
transcription factor dependent promoters (Erickson et al., 1987). In heat shock conditions 
around 42-45 ºC, the transcription of the rpoH gene does not increase significantly. In 
these cases, the increase of σ32, and consequently the expression of the heat shock genes, 
is due to the de-repression of rpoH gene translation. However, in lethal heat shock 
conditions (greater than 45 ºC) the HSR is also controlled at the rpoH transcription level. 
When the cells are maintained at these elevated temperatures a balanced growth is no 
longer possible, the HSP are essentially the only proteins to be synthesized (Raina et al., 
1995) and the HSR remains elevated until the cells begin to die, unless the temperature 
decreases (Erickson et al., 1987; Guisbert et al., 2004; Nagai et al., 1991; Yamamori et 
al., 1978). 
 
5.3.3 Construction of Heat Shock Inducible Stress Probes using GFP 
Since the aim was to identify the strongest heat shock promoters that can trigger a 
biosynthetic pathway as a result of a temperature increase, besides the transcription levels 
study, it is also important to study and optimize the protein translation to obtain high 
protein expression. To study the protein translation, the HSP promoter elements were 
fused to the gfp reporter gene. This strategy has been applied in the past by Cha et al. 
(1999), where the heat shock response of E. coli resting cells was quantified by dnaK, 
clpB, and rpoH GFP promoter probes. In their experiment they used chemical (addition of 
IPTG, acetic acid, ethanol, phenol, antifoam or salt) and physical stresses (heat shock or 
nutrient limitation) to induce GFP expression. Gill et al. (1998) and Seo et al. (2003) also 
fused GFP to rpoH, clpB and dnaK promoters to monitor the toxic effect of dithiothreitol 
addition and compare the cellular stress levels of four strains caused by temperature up-
shift, respectively. Lu et al. (2003), Lu et al. (2005) and Messaoudi et al. (2013) 
constructed oxidative stress probes by fusing the promoters of several oxidative stress 
gene promoters with GFP. Other stress probe strategies have also been used. Heat shock 
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promoters were fused to β-galactosidase (lacZ) and to bioluminescent luciferase 
bioreporters (lux and luc) in several studies to investigate the toxicity of heterologous 
protein expression and other compounds (Bianchi and Baneyx, 1999a; Bianchi and 
Baneyx, 1999b; Kotova et al., 2010; Kraft et al., 2007; Lesley et al., 2002; Pérez et al., 
2007; Van Dyk et al., 1994). In this study the gfp reporter gene was used because of its 
small size, minimal toxicity, high stability and ease of use (March et al., 2003). 
The use of stress probes with the HSP promoters fused to gfp helped to study how 
efficient the promoter sequences and the original heat shock RBS are in the translation of 
a gene. Different experiments were done with different control (30 ºC and 37 ºC) and heat 
shock (45 ºC and 50 ºC) temperatures and different heat shock duration (5 and 10 min). 
Figure 5.6 shows the fluorescence results obtained for the above mentioned experiments. 
As observed before, the dnaK promoter allows the highest expression after heat shock 
treatment, but the induction ratio is not as high as for ibpA since the dnaK expression at 
37 ºC is already very high and in most cases even higher than ibpA expression after heat 
shock conditions. The fxsA promoter showed less GFP expression, corroborating the 
microarrays and RT-qPCR results. Comparing the two heat shock temperatures tested (45 
and 50 ºC) it can be concluded that the highest temperature allows a higher promoter 
response and consequently, a higher GFP expression. However, the fluorescence level at 
50 ºC depends on the initial temperature (30 and 37 ºC). In general, an initial lower 
temperature (30 ºC) that corresponds to less basal fluorescence also corresponds to lower 
specific fluorescence intensity at 50 ºC. The SFI obtained with the original T7 promoter 
(data not shown) was around 33000 and the fluorescence reached the steady state in about 
2–3 h (37-30 ºC experiments) and remained stable until the end of the experiment. As 
expected, the T7 promoter is a better option as the expression obtained is higher and more 
stable. However, the use of IPTG has some disadvantages, such as cost and toxicity, and 
limited utility for in situ gene expression. The lower stability of the mRNA when using 
heat shock promoters can be overcome by adding sequences to form stem-loop at its 5’ 
and 3’ untranslated regions (UTRs) (Chen et al., 1991; Higgins et al., 1993). This 
prolongs the half-life of a normally unstable mRNA by presumably interfering with 
RNase binding. 
These results (Figure 5.6) were obtained after studying four different promoter sequences 
(Appendix B, Tables B1-B3). The first heat shock promoter sequences used to replace 
the T7 promoter were obtained from gDNA amplification of the -50 region until the start 
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codon (ATG) of the heat shock gene. The TATA box regions, transcription initiation site, 
RBS and translation initiation site of the native proteins were used for GFP regulation. 
The only promoter that showed a significant increase in GFP fluorescence after heat 
shock was dnaK. In order to improve the expression of GFP, the promoter sequence from 
the -150 region to the heat shock gene ATG was amplified, toward the inclusion of some 
possible existing binding sites for transcription activator proteins present in the region 
upstream of the core promoter, referred as the upstream (UP) element (Ross et al., 1993). 
The new sequences did not result in an effective improvement of the GFP expression 
level. Therefore, the promoter sequence from the -150 region to the +21 nucleotides from 
the three heat shock genes was amplified. Several authors (Bianchi and Baneyx, 1999a; 
Bianchi and Baneyx, 1999b; Pérez et al., 2007) have reported good results when 
including the first 21 nucleotides of the ibpA open reading frame in a lacZ gene fusion. 
However, fluorescence did not improve and therefore the experiments were repeated and 
samples were analyzed by RT-qPCR. The preliminary results showed a significant 
increase of gfp transcription after heat shock which allowed to conclude that the lack of 
fluorescence after heat shock induction was not related to the promoter strength but to the 
translational efficiency (data not shown). To overcome this issue, the RBS Calculator 
v1.1 (Salis, 2011) software was used. Twenty N nucleotides (any base calculated by the 
software) were added to the RBS constraints, followed by GGATCC, which corresponds 
to the BamHI site. The target translation initiation rate (TIR) was set to 20000 for the 
three cases. With these new constructions, it was possible to observe an increase of 
fluorescence in the fxsA and ibpA stress probes. However, the fluorescence for the fxsA 
probe was higher than for ibpA, which was not expected according to the previously 
observed mRNA levels. The TIR determined using the RBS Calculator for the heat shock 
gene promoters in the E. coli genome presented the following relation: ibpA~2.5 ×
dnaK ~ 21.2 × fxsA (Appendix B, Table B1). To obtain GFP expression results more 
similar to the ones of the heat shock genes in the genome, the RBS Calculator was used. 
After running the software for 8 h, a relation closer to the TIR in the genome was found, 
namely ibpA~1.6 ×  dnaK ~14.9 ×  fxsA, where fxsA construction possessed the same 
translation initiation rate as the one used in the previous constructions (19000). These 
newly determined RBS were then used to obtain the results gathered in Figure 5.6.  
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Figure 5.6. Specific fluorescence intensity after heat shock in E. coli MG1655(DE3) transformed with 
pETduet_GFPmut3b plasmids with different promoters: ibpA promoter (), dnaK promoter () and fxsA 
promoter () (control – 37 or 30ºC), ibpA promoter (■), dnaK promoter (●) and fxsA promoter (▲) (heat 
shock – 45 or 50ºC). The three biological replicates for each experiment were performed in different days. 
The fluorescence values in the figures on the right correspond to the maximum values obtained for each 
case (1 h after heat shock induction). 
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5.4 Conclusion 
Synthetic biology finds applications in several fields, such as biosensing (pollution 
detection), therapeutics (drug discovery/target identification, therapeutic 
delivery/treatment), and production of biofuels, pharmaceuticals and novel biomaterials 
(construction/optimization of biosynthetic pathways, programming novel functionality 
and materials). For these applications, new biological devices and systems to regulate 
gene expression and metabolite pathways are required. Furthermore, external control and 
triggers for such devices and systems can be designed using adequate gene promoter 
strategies. Most promoters commonly used in heterologous protein expression are 
inducible promoters. Chemical inducers can be expensive at laboratory or pilot-plant 
scales and are often toxic, thus their presence in either the final product or in waste 
effluents is highly undesirable and requires their disposal/elimination. These restrictions 
are particularly important in food, pharmaceutical-grade proteins and other products 
intended for human use, such as therapeutic products. Induction methods having a 
thermo-regulated expression system with heat shock promoters are even more important 
for in vivo applications which rely on an external stimulus to the body. The heat shock 
promoters identified in this study can be used in the construction of new therapeutic 
bacteria, in which the biosynthetic pathway of a therapeutic agent will be inserted and 
whose expression will be triggered in situ by heat, emitted by laser therapy or ultrasound. 
The expression obtained with these heat shock promoters will most likely not reach the 
same level as the one obtained with other stronger promoters such as T7; however, in situ 
delivery will likely not require expression levels as high as those necessary in bioreactors. 
In addition, the promoter sequences can be optimized as demonstrated by the approach 
herein reported using RBS optimization to improve the translation efficiency and to reach 
the desired response and obtain the expected results in the production of novel genes or 
pathways. Overall, a heat shock approach would be easier to implement and administer 
and will be safer since no chemicals are involved. 
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CHAPTER 6 
Heat-Triggered Production of Curcuminoids in Escherichia coli – a Step 
towards New Bacterial Therapies for Cancer Treatment 
 
Caffeic acid and curcuminoids are compounds with great therapeutic potential, including 
anticancer properties. In this study, caffeic acid and curcumin were produced in 
Escherichia coli. Their production was induced by heat shock (50 ºC for 10 min) using 
the dnaK heat shock promoter. The ribosome binding site (RBS) used was tested and 
further optimized for each gene for efficient translation. Caffeic acid was successfully 
produced from tyrosine or p-coumaric acid using tyrosine ammonia lyase (TAL) from 
Rhodotorula glutinis, 4-coumarate 3-hydroxylase (C3H) from Saccharothrix espanaensis 
or cytochrome P450 CYP199A2 from Rhodopseudomonas palustris. The highest caffeic 
acid production was 80 µM. Regarding curcumin, 1 µM was produced using 4-
coumarate-CoA ligase (4CL1) from Arabidopsis thaliana, diketide-CoA synthase (DCS) 
and curcumin synthase 1 (CURS1) from Curcuma longa. Stronger RBSs and/or different 
induction conditions should be further evaluated to optimize those production levels. 
Herein it was demonstrated that the production of caffeic acid and curcumin in E. coli can 
be triggered by heat, suggesting its potential for the development of new bacterial 
therapies combined with laser or ultrasound treatments. 
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6.1 Introduction 
For decades, Escherichia coli has been the host of choice for the expression of 
recombinant proteins in high quantities and low production costs. In large-scale 
production, chemical inducers, such as IPTG, can be expensive and toxic (Makrides, 
1996; Su et al., 1990) and their presence in waste effluents or in the final product must be 
eliminated, especially in the production of  pharmaceutical-grade proteins and other 
products intended for human use (Menart et al., 2003). Constitutive promoters or 
promoters induced by starvation of an essential nutrient, or by shift in a physical or 
physicochemical factor, such as temperature or pH, allow an inducer-free environment for 
heterologous protein expression (Keasling, 2012). Thermal induction in E. coli is carried 
out by increasing the temperature (usually 37 ºC) to 42 ºC or higher for a certain period 
and then, shifting it down (Caspeta et al., 2013; Caulcott and Rhodes, 1986; Srivastava et 
al., 2005; Tabandeh et al., 2004; Valdez-Cruz et al., 2010; Velez et al., 2013; Wang et al., 
2012b; Wu et al., 2010). The thermal induction strategy has the potential of reducing the 
fermentation cost since expensive chemicals or special media are not required. In 
addition, it simplifies the downstream processing since culture handling and 
contamination risks are minimized (Gupta et al., 1999; Valdez-Cruz et al., 2010). All 
these aspects are very important when producing therapeutic recombinant proteins at an 
industrial scale (Valdez-Cruz et al., 2010). One of the weakest points of thermo-inducible 
promoters that should be considered is the heat transfer limitations of large-scale 
bioreactors since the larger the volume, the lower the heating rate is. Nevertheless, it was 
shown that the slow heating rates represent an advantage in the production of 
heterologous proteins (Caspeta et al., 2009). 
Induction by heat shock can also be very advantageous in therapeutic approaches, for 
example in bacterial therapies. These therapies can be used combined with laser or 
ultrasound treatments and temperature increase would trigger the production in situ of the 
desired compounds. Over the last years, several therapeutic agents have been reported for 
cancer treatment. For example, caffeic acid and curcuminoids were shown to have 
countless beneficial effects on human health, including anticancer activities (Prasad et al., 
2011; Prasad et al., 2014), thus highlighting the importance of their biosynthetic 
production. An engineered bacterium able to produce these compounds when exposed to 
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heat can be further explored in the future as a bacterial therapy combined with thermal 
treatments.  
Caffeic acid and curcuminoids were previously produced in E. coli harboring artificial 
biosynthetic pathways (Chapters 3 and 4), as illustrated in Figure 6.1. Moreover, the 
dnaK heat shock promoter was used with a synthetic ribosome binding site (RBS) and the 
green fluorescence protein (GFP) to design and construct stress probes, which were 
further used to evaluate the promoter strength (Chapter 5; Rodrigues et al., 2014). In this 
study, the heat shock induction system was coupled to the artificial biosynthetic pathways 
leading to the production of caffeic acid and curcumin. The dnaK promoter and two 
different synthetic RBSs with different strengths were used. The results gathered in this 
study demonstrate that the caffeic acid and curcumin production in E. coli can be 
triggered by heat and that synthetic biology techniques can help to improve their 
production. This effort represents the first step towards the potential future use of these 
compounds in bacterial therapies.  
 
 
Figure 6.1. Caffeic acid (A) and curcumin biosynthetic pathway (B). TAL: Tyrosine ammonia lyase; C3H: 
4-coumarate 3-hydroxylase; 4CL: 4-coumarate-CoA ligase; DCS: diketide-CoA synthase; CURS1: 
curcumin synthase 1. 
 
(A) 
(B) 
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6.2 Materials and Methods 
6.2.1 Bacterial Strains, Plasmids and Chemicals 
E. coli NZY5α competent cells (NZYTech, Lisboa, Portugal) were used for molecular 
cloning and vector propagation and E. coli K-12 MG1655(DE3) (Nielsen et al., 2010) 
was used as host. E. coli K-12 ER2925 (NEB, Ipswich, MA, USA) competent cells were 
used whenever restriction endonucleases sensitive to E. coli K-12 methylation patterns 
were required. Table 6.1 summarizes the characteristics of all strains and plasmids used. 
Synthesis and amplification of TAL, C3H, CYP199A2, Pdr, Pux, At4CL1, DCS and 
CURS1 was previously described (Chapters 3 and 4). 
L-tyrosine, p-coumaric and caffeic acid were purchased from Sigma-Aldrich (Steinheim, 
Germany); ferulic acid from Acros (Geel, Belgium); curcumin from Fisher Scientific 
(Loughborough, UK) and Luria-Bertani (LB) medium from NZYTech (Lisbon, Portugal). 
Glucose (Acros), Na2HPO4 (Scharlau, Sentmenat, Spain), MgSO4, KH2PO4 (Riel-deHaën, 
Seelze, Germany), NH4Cl, NaCl, CaCO3 (Panreac, Barcelona, Spain) and thiamine 
(Fisher Scientific, Loughborough, UK) were used to prepare the M9 modified salt 
medium. The following mineral traces and vitamins were supplemented to M9 Medium: 
FeCl3, ZnCl2, CoCl2, CuCl2, nicotinic acid (Riedel-deHaën), NaMoO4, H2BO3, 
pyridoxine, biotin, folic acid (Merck), riboflavin and pantothenic acid (Sigma Aldrich). 
Ampicillin (Applichem, Darmstadt, Germany), chloramphenicol, kanamycin (NZYtech) 
and spectinomycin (Panreac) were used when necessary. 
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Table 6.1. Bacterial strains and plasmids used in this study. 
Strains Relevant Genotype Source 
E. coli NZY5α 
fhuA2Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
NZYTech 
E. coli K-12 
MG1655(DE3) 
F
-
 λ- ilvG- rfb-50 rph-1 λ(DE3) 
(Nielsen et 
al., 2010) 
E. coli K-12 ER2925 
ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA 
dcm-6 hisG4 rfbD1 R(zgb210::Tn10)TetS endA1 rpsL136 
dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 hsdR2 
NEB 
(E4109) 
Plasmids Construct Source 
pETDuet-1 ColE1(pBR322) ori, lacI, double T7lac, Amp
R
 Novagen 
pCDFDuet-1 CloDF13 ori, lacI, double T7lac, Strep
R
 Novagen 
pRSFDuet-1 RSF ori, lacI, double T7lac, Kan
R
 Novagen 
pUC57_TAL pUC57 carrying codon-optimized TAL from R. glutinis GenScript 
pUC57_C3H pUC57 carrying codon-optimized C3H from S. espanaensis GenScript 
pUC57_CYP199A2 
pUC57 carrying codon-optimized CYP199A2 from R. 
palustris 
GenScript 
pUC57_DCS pUC57 carrying codon-optimized DCS from C. longa NZYTech 
pUC57_CURS1 pUC57 carrying codon-optimized CURS1 from C. longa NZYTech 
pAC-At4CL1 pAC carrying 4CL1 from A. thaliana 
Addgene 
(35947) 
pCDFDuet_TAL pCDFDuet-1 carrying codon-optimized TAL from R. glutinis Chapter 3 
pCDFDuet_CYP 
pCDFDuet-1 carrying codon-optimized CYP199A2 from R. 
palustris 
Chapter 3 
pETDuet_Pdr_Pux_op 
pETDuet-1 carrying Pdr from P. putida and Pux from R. 
palustris in an operon 
Chapter 3 
pCDFDuet_RBS1_TAL pCDFDuet_TAL carrying dnaK promoter and RBS1 This study 
pRSFDuet_RBS1_TAL 
pRSFDuet-1 carrying codon-optimized TAL from R. glutinis, 
dnaK promoter and RBS1 
This study 
pCDFDuet_RBS1_CYP pCDFDuet_CYP carrying dnaK promoter and RBS1 This study 
pCDFDuet_RBS1_C3H 
pCDFDuet-1 carrying codon-optimized C3H from S. 
espanaensis, dnaK promoter and RBS1 
This study 
pRSFDuet_RBS1_C3H 
pRSFDuet-1 carrying codon-optimized C3H from S. 
espanaensis, dnaK promoter and RBS1 
This study 
pETDuet_RBS1_Pdr_ 
Pux_op 
pETDuet-1 carrying Pdr from P. putida and Pux from R. 
palustris in an operon, dnaK promoter and RBS1 
This study 
pCDFDuet_RBS2_TAL 
pCDFDuet-1 carrying codon-optimized TAL from R. glutinis, 
dnaK promoter and RBS2 
This study 
pRSFDuet_RBS2_TAL 
pRSFDuet-1 carrying codon-optimized TAL from R. glutinis, 
dnaK promoter and RBS2 
This study 
pCDFDuet_RBS2_C3H 
pCDFDuet-1 carrying codon-optimized C3H from S. 
espanaensis, dnaK promoter and RBS2 
This study 
pRSFDuet_RBS2_C3H 
pRSFDuet-1 carrying codon-optimized C3H from S. 
espanaensis, dnaK promoter and RBS2 
This study 
pRSFDuet_RBS1_ 
CURS1 
pRSFDuet-1 carrying codon-optimized CURS1 from C. longa, 
dnaK promoter and RBS1 
This study 
pCDFDuet_RBS1_DCS 
pCDFDuet-1 carrying codon-optimized DCS from C. longa, 
dnaK promoter and RBS1 
This study 
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6.2.2 Design of the dnaK Promoter and RBS 
The dnaK heat shock promoter sequence used was obtained from the NCBI (National 
Center for Biotechnology Information) and previously described in Rodrigues et al. 
(2014) (Chapter 5). This promoter and the ribosome binding sites (RBS) replaced the T7 
promoter and the RBSs of the plasmids from Novagen (Figure 6.2, Table 6.1). The RBSs 
were designed using the software RBS Calculator v1.1 (Salis, 2011). RBS1 was 
previously designed in Rodrigues et al. (2014) (Chapter 5). RBS2 (Table 6.2) was 
designed to improve TAL and C3H expression. Translation Initiation Rate (TIR) for TAL 
was set to 180000. 
 
 
 
Figure 6.2. Strategy used in this study to replace the T7 promoter by the dnaK promoter. 
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Table 6.2. dnaK promoter and RBSs sequences and set of primers for promoter and genes PCR 
amplification (forward and reverse primers –FW and REV). 
DNA feature DNA sequence
a
 
Restriction 
enzyme 
dnaK promoter 
ATGCCTTGGCTGCGATTCATTCTTTATATGAATAAA
ATTGCTGTCAATTTTACGTCTTGTCCTGCCATATCG
CGAAATTTCTGCGCAAAAGCACAAAAAATTTTTGC
ATCTCCCCCTTGATGACGTGGTTTACGACCCCATTT
AGTAGTCAACCGCAGTGAGTGAGTCTGCAAAAAAA
TGAAATTGGGCAGTTGAAACCAGACGTTTCGCCCC
TATTACAGACTCACAACCACATGATGACCGAATA 
PfoI, EcoNI, 
SphI 
RBS1 GGAGTCGGAATAGACGAGGA BamHI, NdeI 
RBS2 TCTACCTAAGGA   BamHI 
Primer name Primer sequence
b
 
Restriction 
enzyme 
C3H _FW GGCGCGCCAAATGACGATTACCTCTCCGG AscI 
C3H _REV AAGCTTTTACGTGCCCGGGTTAATC HindIII 
C3H_ FW2 GGATCCAATGACGATTACCTCTCCGG BamHI 
TAL_FW GGATCCAATGGCTCCGCGTCC BamHI 
TAL_REV GCGGCCGCTTATGCCAGCATTTTCAGCAG NotI 
Pdr_Pux_op_pET_FW GAATTCAATGAACGCAAACGACAAC EcoRI 
Pdr_Pux_op_pET_REV GATATCTCAGACCTGACGATCCG EcoRV 
CURS1_FW GGATCCTATGGCTAACCTGCACGCTC BamHI 
CURS1_REV GGCGCGCCTTACAGCGGCATAGAACGC AscI 
DCS_FW GGATCCGATGGAAGCTAACGGTTACCG BamHI 
DCS_REV AAGCTTTTAGTTCAGACGGCAAGAGTG HindIII 
dnaK_RBS1_pCDF_FW CCTGCATTAGGGAGCTCATGCCTTGGCTGCGATT EcoNI, SacI 
dnaK_RBS1_pRSF_FW TCCGGGAGCATGCATGCCTTGGCTGCGATT PfoI, SphI 
dnaK_RBS1_pET_FW GCATGCGAGCTCATGCCTTGGCTGCGATT SphI, SacI 
dnaK_RBS1_pCDF_pR
SF _pET_REV1 
GGATCCTCCTCGTCTATTCCGACTCCTATTCGGTCAT
CATGTGGT 
BamHI 
dnaK_RBS1_pCDF_RE
V2 
CATATGTCCTCGTCTATTCCGACTCCTATTCGGTCAT
CATGTGGT 
NdeI 
dnaK_RBS2_pCDF_FW CCTGCATTAGGCTCGAGATGCCTTGGCTGCGATT EcoNI, XhoI 
dnaK_RBS2_pRSF_FW TCCGGGACTCGAGATGCCTTGGCTGCGATT PfoI, XhoI 
dnaK_RBS2_pCDF_pR
SF_REV 
GGATCCTCCTTAGGTAGATATTCGGTCATCATGTGG
TTGT 
BamHI 
a The restriction site and the base(s) between the restriction site and ATG were included in the ribosome binding site (RBS) and 
introduced in the computation as constraints for the design; b Start and stop codons in bold; restriction sites in italic – dnaK promoter 
FW primer has two restriction sites, one to clone, other to aid colony screening; dnaK promoter underlined; RBS and spacer are double 
underlined; In some cases between the restriction site and the gene start codon one or two bases were added for the sequence to be in 
frame. 
 
6.2.3 Construction of the Plasmids 
The dnaK promoter with RBS1 was cloned in the plasmids pCDFDuet_TAL and 
pCDFDuet_CYP previously constructed (Chapter 3). For the other constructions the 
dnaK promoter and RBS1/RBS2 were first cloned in an empty plasmid, and only 
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afterwards the genes TAL, C3H, Pdr_Pux_operon, CURS1 and DCS were cloned. This 
approach was adopted to avoid digestion of the genes by the restriction enzymes required 
to clone the promoter. A restriction site in the FW primer was used to assist the colony 
screening. The primers are summarized in Table 6.2. 
Plasmid DNA was isolated using NucleoSpin
® 
Plasmid Miniprep Kit (Macherey-Nagel, 
Düren, Germany). The genes were amplified by PCR using KAPA HiFi DNA Polymerase 
enzyme (Kapa Biosystems, Wilmington, MA, USA). DNA fragments were purified from 
agarose using Gel DNA Recovery Kit (Zymo Research, Orange, CA, USA). Plasmid 
DNA and genes were quantified in NanoDrop (ND-1000, Thermo Scientific, Wilmington, 
DE, USA) and were digested with the appropriate restriction endonucleases (Table 6.2) 
(NEB) for 3 h and purified using DNA Clean and Concentrator Kit (Zymo Research). 
Ligation was performed at room temperature for 1 h with T4 DNA ligase (NEB). 
Chemical transformation (heat shock method) was carried out using E. coli NZY5α or E. 
coli K-12 ER2925 competent cells. All constructed plasmids herein described (Table 6.1) 
were verified by colony PCR or digestion and confirmed by sequencing (Macrogen, 
Amsterdam, The Netherlands). After confirmation E. coli K-12 MG1655(DE3) was 
transformed with the plasmids. All the kits and enzymes were used according to the 
instructions provided by the manufacturers.  
 
6.2.4 Caffeic acid and Curcumin Production 
E. coli cells for gene cloning, plasmid propagation, and inoculum preparation were grown 
in LB medium at 37 ºC and under shaking conditions (200 rpm). 
For caffeic acid and curcuminoids production cultures were grown at 37 ºC in 50 mL LB 
to an optical density at 600 nm (OD600) of 0.3-0.4. After that, a heat shock at 50 ºC for 10 
min was performed in a shaking water bath to induce gene expression. Next, the culture 
was incubated for 5 h at 26 or 37 ºC.  
The cells were harvested by centrifugation, suspended, and incubated at 26 or 37 ºC for 
63 h in 50 mL modified M9 minimal salt medium containing (per liter): glucose (40 g), 
Na2HPO4 (6g), KH2PO4 (3g), NH4Cl (1g), NaCl (0.5 g), CaCl2 (17 mg), MgSO4 (58 mg), 
thiamine (340 mg) and CaCO3 (5 g) (to control the pH). Trace elements [FeCl3 (54 mg), 
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ZnCl2 (4 mg), CoCl2 (4 mg), NaMoO4 (4 mg), CuCl2 (2 mg) and H2BO3 (1 mg)] and 
vitamins [riboflavin (0.84 mg), folic acid (0.084 mg), nicotinic acid (12.2 mg), pyridoxine 
(2.8 mg), biotin (0.12 mg) and pantothenic acid (10.8 mg)] were supplemented to the 
medium. Depending on the plasmid(s) present in the strain, 100 μg/mL of ampicillin, 100 
μg/mL of spectinomycin, 30 μg/mL of chloramphenicol and/or 50 μg/mL of kanamycin 
were added. Shake flasks were incubated for 30 min at 26 ºC or 37 ºC to stabilize the 
initial temperature and then they were immersed in a shaking water bath at 50 ºC. After 
10 min under this temperature, the shake flasks were placed back in the incubator at 26 ºC 
or 37 ºC. Substrates were added at time 0 of induction in M9 medium (unless otherwise 
stated): tyrosine (3 mM), p-coumaric acid (2 mM) and ferulic acid (2 mM). Supernatant 
samples (1.5 mL) were collected for the analysis of caffeic acid, while for curcumin 2 mL 
of culture broth with cells (whole broth) were collected. All the experiments were 
conducted in triplicate.  
6.2.5 Curcumin Extraction 
For subsequent curcumin analysis, 2 mL of whole broth was adjusted to pH 3.0 with 6 M 
HCl. Then, curcumin was extracted with an equal volume of ethyl acetate. The extracts 
were concentrated by solvent evaporation in a fume hood, suspended with 200 µL of 
acetonitrile and subjected to product analysis by high-performance liquid chromatography 
(HPLC). 
6.2.6 HPLC Analysis of Products 
HPLC analysis was used to quantify p-coumaric acid, caffeic acid, ferulic acid and 
curcumin using a system from Jasco (Easton, MD, USA) (PU-2080 Plus Pump unit, LG-
2080-02 Ternary Gradient unit, a DG-2080-53 3-Line Degasser unit, a UV-2075 Plus 
Intelligent UV/VIS Detector unit and AS-2057 Plus Intelligent Sampler unit) and a Grace 
Alltech Platinum EPS C18 column (3µm, 150 mm × 4.6 mm) (Grace, Columbia, MD, 
USA). Mobile phases A and B were composed of water (0.1% trifluoroacetic acid) and 
acetonitrile, respectively. For hydroxycinnamic acid quantification the following gradient 
was used at a flow rate of 1 mL/min: 10 - 20% acetonitrile (mobile phase B) for 16 min. 
Quantification was based on the peak areas of 310 nm for p-coumaric acid, caffeic acid 
and ferulic acid. The retention times of p-coumaric acid, caffeic acid and ferulic acid were 
8.0, 11.8 and 13.8 min, respectively. For curcumin quantification, a gradient of 40 - 43% 
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acetonitrile (mobile phase B) for 15 min and 43% acetonitrile for more 5 min was used. 
Curcumin was detected at 425 nm of absorbance and the retention time 14.5 min. 
 
6.3 Results and Discussion 
6.3.1 Caffeic Acid Production using dnaK Heat Shock Promoter 
Caffeic acid was produced using tyrosine ammonia lyase (TAL) from R. glutinis that 
converts tyrosine to p-coumaric acid. To convert p-coumaric acid to caffeic acid, 4-
coumarate 3-hydroxylase (C3H) from S. espanaensis or cytochrome P450 CYP199A2 
from R. palustris were used. CYP199A2 only converts p-coumaric acid efficiently to 
caffeic acid in the presence of its redox partners, Pux and Pdr. The expression of caffeic 
acid genes was triggered by heat shock (50 ºC, 10 min).  The strategy used was based on 
previous results regarding the production of caffeic acid (Chapter 3). The plasmids 
pCDFDuet-1 and pRSFDuet-1 were chosen since they allowed obtaining the highest p-
coumaric acid and caffeic acid production. As expected, pRSFDuet-1 plasmid carrying 
the heat shock promoter enabled a higher p-coumaric acid and caffeic acid production 
than the pCDFDuet-1 plasmid (Figure 6.3). When TAL and C3H were combined, the 
production of caffeic acid was higher when C3H is cloned in pCDFDuet-1 and TAL in 
pRSFDuet-1. This was not in accordance to the results obtained before (Chapter 3, 
Figure 3.4). When T7 promoters were used the highest caffeic acid production obtained 
was when TAL was cloned in pCDFDuet-1 and C3H in pRSFDuet-1 and almost all the p-
coumaric acid produced was converted to caffeic acid. 
The results obtained with CYP199A2 in pCDFDuet-1 and Pdr and Pux redox partners in 
pETDuet-1 were also not in accordance with what was observed before (Chapter 3, 
Figures 3.3 and 3.6), since Pdr and Pux expression in pETDuet-1 using heat shock 
promoters led to a higher caffeic acid concentration than in the C3H strategy. All these 
discrepancies between the results obtained with the T7 promoter and the dnaK promoter 
imposed a cautious study of the dnaK promoter constructs and the RBS strength, which 
are discussed later on. 
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Figure 6.3. Caffeic acid production using the dnaK promoter and RBS1. TAL: Tyrosine ammonia lyase; 
C3H: 4-coumarate 3-hydroxylase; CYP: cytochrome P450 CYP199A2. 
 
 
In general, the production levels obtained using a heat shock induction were very low, as 
compared to the results obtained when using isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and the T7 promoter (Chapter 3), which was expected considering that the T7 
promoter is stronger than the dnaK one. In the previous study (Chapter 5; Rodrigues et 
al., 2014), the expression of the dnaK promoter was studied and it was demonstrated that 
testing and optimizing the RBS is crucial to improve the translational efficiency. In this 
study, the experiments started by using the dnaK promoter and RBS that previously 
showed the best performance with GFP expression. A strong RBS with high translation 
initiation rate (TIR) led to high translation efficiency. This efficiency is completely 
dependent on the spacer length between the Shine–Dalgarno (SD) sequence and the AUG 
codon, as well as the beginning of the downstream coding DNA sequence (CDS) 
(Makrides, 1996). All RBS sequence should be designed to minimize the formation of 
mRNA secondary structure. Although the TIR of the synthetic RBS was high when GFP 
expression was considered (TIR = 175751.22), it was found to be extremely low for TAL 
(TIR = 0.42) or C3H (TIR = 558.5) expression. This could explain why the p-coumaric 
acid production was very low when compared to the caffeic acid production, which was 
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exactly the opposite that was found in Chapter 3 (Figure 3.2 and 3.3). Regarding the 
difference in production using different plasmids, since TIR is equal in both pCDFDuet-1 
and pRSFDuet-1, but pRSFduet-1 is a higher copy plasmid, this plasmid gave higher p-
coumaric acid and caffeic acid productions.  
The results obtained when CYP199A2 and its redox partners were used to produce caffeic 
acid can also be explained by the TIR. Although the TIR value of 5372.9 in CYP199A2 
expression was not very high when compared to GFP expression, it was significantly 
higher when compared to TAL or even C3H expression. Also, TIR was high in Pdr and 
Pux operon (TIR = 5813.16). This could explain why caffeic acid production was higher 
when using CYP199A2 and Pdr and Pux redox partners in pETDuet-1. When p-coumaric 
acid was not added to the culture medium and needed first to be produced using TAL, the 
caffeic acid production decreased significantly since the amount of p-coumaric acid 
available was very low and not sufficient as the result of the very low TAL TIR. 
In order to improve the p-coumaric acid and caffeic acid production, a new RBS (RBS2) 
was designed using RBS Calculator software. This new RBS showed a TIR = 118277.07 
for TAL, and a TIR = 82516.14 for C3H. Several spacer lengths were tested for C3H but 
it was not possible to find a higher TIR value. As illustrated in Figure 6.4, this new RBS 
led to an improvement of the acids production. The p-coumaric acid production increased 
up to 40 times and caffeic acid up to 7 times. The highest caffeic acid titer was 80 µM 
(14.41 mg/L). This increase occurs for two reasons: C3H TIR from RBS1 was higher than 
the TAL TIR, enabling higher caffeic acid concentration using RBS1, and C3H TIR from 
RBS2 was lower than the TAL TIR. As expected, caffeic acid production using C3H in 
pRSFDuet-1 and TAL in pCDFDuet-1 was found to be the best option to produce caffeic 
acid, as no p-coumaric acid limitation due to low translation efficiency of TAL occurred. 
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Figure 6.4. Caffeic acid production using dnaK promoter and RBS2. TAL: Tyrosine ammonia lyase; C3H: 
4-coumarate 3-hydroxylase; CYP: cytochrome P450 CYP199A2. 
 
 
The dnaK promoter with RBS2 was not cloned and tested for CYP199A2 since 
satisfactory results could be obtained with RBS1. However, caffeic acid production was 
tested with TAL in pRSFDuet-1 using the new RBS in combination with CYP199A2 and 
its redox partners. Using this combination, caffeic acid production was almost as high as 
that obtained by adding p-coumaric acid directly and using only CYP199A2 and its redox 
partners (Figure 6.3). These results suggest that caffeic acid production was probably 
improved due to the higher availability of p-coumaric acid.  
Although p-coumaric and caffeic acids production improved by using stronger RBSs, the 
production levels obtained were still lower than those obtained using the T7 promoters. It 
is also important to note that these results were obtained after induction at 50ºC for 10 
min. In the future, and in addition to the assessment of other RBSs, other induction times, 
heat shock temperatures, temperature up-shift profiles and post-induction temperatures 
should be tested. This can enable more or less protein expression and consequently, more 
or less product formation, as was found in previous results (Chapter 5; Rodrigues et al., 
2014). Also, oscillatory induction should be considered since it has shown to be more 
effective, as it leads to longer productive times that result in higher titers (Caspeta et al., 
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2013). In addition, this strategy reduces the drawbacks associated with the use of high 
temperature, such as formation of inclusion bodies, acetate overproduction, decreased 
growth rate, plasmid instability, proteolytic susceptibility and metabolic stress caused by 
heterologous protein production and heat shock (Lamotte et al., 1996; Menart et al., 
2003). 
 
6.3.2 Curcumin Production using the dnaK Heat Shock Promoter 
Curcumin was produced using 4-coumarate-CoA ligase (4CL1) from A. thaliana and 
diketide-CoA synthase (DCS) and curcumin synthase 1 (CURS1) from C. longa. This 
strategy was based on previous results (Chapter 4). As for the caffeic acid production, 
the expression of curcumin genes was triggered by heat (50 ºC, 10 min). The dnaK 
promoter with RBS1 was cloned in pCDFDuet-1 and pRSFDuet-1 that harbored DCS and 
CURS1, respectively. In the case of 4CL1, the lac promoter of pAC was not replaced 
since it is a constitutive promoter unlike T7 promoter, so there was no need to add 
expensive and toxic additives like IPTG. In addition, the 4CL step was considered the 
bottleneck of the curcuminoids production (Chapter 4) since it was very difficult to find 
an efficient 4CL. The 4CL1 from A. thaliana was only efficient in the pAC plasmid. 
Thus, the original lac promoter was maintained. 
Figure 6.5 shows curcumin production induced by heat shock. Curcumin production was 
very low compared to that obtained using the T7 promoter, however this was expected 
since the dnaK promoter is weaker than T7, and the obtained TIRs were not as high as 
required. In the DCS case, TIR was 8312.53, while in the CURS1 case it was 9095.44. 
Although the curcumin production was low compared to the levels obtained by chemical 
induction, it reached 1 µM and a yellow color, thus confirming the occurrence of 
curcuminoids production. This is very promising as it has been proven that curcumin 
administration combined with ultrasound treatments leads to a 87% cytotoxicity with only 
10 µM of curcumin (Wang et al., 2011a). In the studies from Lin et al. (2012) and Wang 
et al. (2012a), 10 to 15 µM of curcumin was also found to be effective. Therefore, this 
suggests that curcumin can induce cancer cells destruction at concentrations that can 
possibly be produced by bacteria. Besides, these concentrations can easily be achieved 
and even improved in the future, by testing heat shock promoters with stronger RBSs. 
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Figure 6.5. Curcumin production using the dnaK promoter and RBS1. 
 
 
Curcumin production was higher when the flasks were incubated at 26 ºC instead of at 37 
ºC after the heat shock. When no heat shock was performed, only 0.1 µM of curcumin 
was obtained at 26 ºC and no curcumin was detected by HPLC at 37 ºC (data not shown) 
Since the dnaK promoter allows higher expression at 37 ºC than 30 ºC (Chapter 5; 
Rodrigues et al., 2014), and bearing in mind that if bacterial therapies are envisaged the 
body temperature is around 37ºC, this temperature was first chosen as the incubation 
temperature in this work instead of 26 ºC. However, as expected, the curcuminoids 
production at the higher temperature was very low (Figure 6.5). These results suggest 
that the curcuminoids production is greatly influenced by temperature. Moreover, at 37 ºC 
it was found that this production was also very low when T7 promoters were used 
(Chapter 4). The best results at 26 ºC are probably due to an improved solubility of the 
recombinant proteins as a consequence of a decrease of aggregation and inclusion-body 
formation (Correa and Oppezzo, 2011). This residual curcuminoids production at body 
temperature can be a drawback in bacterial therapies as after the heat shock caused by 
ultrasounds, the cells temperature will gradually decrease again to 37 ºC, thus leading to a 
low curcuminoids production. However, these results can be improved using stronger 
RBSs and different heat shock induction strategies since the curcumin concentrations 
required to have a therapeutic effect are not very high. 
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The addition of ferulic acid can also be a disadvantage since it is not a substrate naturally 
produced by E. coli from simple carbon sources, representing an extra cost. Hence, for in 
vivo and in situ strategies, curcumin (and other curcuminoids) should be produced from 
the amino acid tyrosine using a pathway through caffeic acid production as previously 
demonstrated (Chapter 4). Unlike ferulic acid, tyrosine is readily available from glucose 
and its concentration can be increased by using a tyrosine overproducing strain (Kang et 
al., 2012; Kim et al., 2013). Another important drawback that must be considered if 
bacterial therapies are envisaged is the use of antibiotics. The use of resistant bacteria in 
therapies represents an even greater problem than using chemical inducers, like IPTG, 
since antibiotics must be used to eliminate bacteria quickly and effectively if necessary. 
Therefore, the genes that compose the artificial biosynthetic pathway should be integrated 
in the chromosome to avoid any issues related to antibiotic-resistant genes. Also, the 
proteins produced for bacterial therapies should be easily transcribed and translated by 
bacteria and should be secreted (Swofford et al., 2014). Curcuminoids, unlike 
hydroxycinnamic acids, take more time to be produced in significant amounts probably 
due to the several enzymatic steps needed for their production and this should be 
considered when designing a bacterial therapy strategy. Regarding secretion, curcumin 
needs to be extracted from E. coli cells after its production and this can be easily achieved 
through strategies already used in bacterial therapies. For instance, the E. coli strain can 
be an auxotrophic for diaminopimelic acid (DAP) that is usually present in the 
peptidoglycan layer of the cell wall, and its deficiency impairs the cell wall synthesis and 
therefore, the bacteria undergoes lysis (Critchley et al., 2004; Grillot-Courvalin et al., 
1998). This will allow the release of the curcumin inside the tumor or near it. 
 
6.4 Conclusions 
Caffeic acid and curcuminoids were successfully produced in E. coli using heat shock 
induction. Also, it was demonstrated that the strength of the RBS needs to be considered 
when designing a biosynthetic pathway. Higher TIR values generally allow higher 
production. The RBS different strengths can help in the fine tuning of the pathway by 
controlling/limiting the production of intermediate compounds. Besides testing different 
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RBSs, to increase the production, different heat shock induction strategies can be tested. 
Although curcumin titer was not very high, it is almost in the range required for 
therapeutic applications as bacterial therapies combined with laser and ultrasound 
therapies. 
Caffeic acid and curcumin production induced by heat is a process still in its infancy and 
many improvements are required. However, these results represent the first steps towards 
the future use of these compounds in bacterial therapies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER 7 
General Conclusions and Recommendations for Future Work 
 
In this chapter the main conclusions of this thesis are drawn. Also, some general 
recommendations for further research in this field are presented. Detailed conclusions and 
suggestions are given in each chapter.  
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7.1 General Conclusions  
The main objective of this thesis was to design and construct a new biosynthetic pathway 
for the production of curcuminoids in Escherichia coli. Its potential use in a bacterial 
therapy combined with laser or ultrasound therapies to treat cancer was also addressed.  
Curcuminoids were produced for the first time using a new biosynthetic pathway that 
used caffeic acid as an intermediate. The first experimental work described in this thesis 
consisted of optimizing caffeic acid production. Different levels of caffeic acid 
production were obtained by testing alternate combinations of plasmids and genetic 
arrangements.  With these combinations it was possible to balance the expression of the 
enzymes and to achieve an optimized performance without a high accumulation of the 
intermediate, as its accumulation may result in suboptimal production titers. Tyrosine 
ammonia lyase (TAL) efficiently converted tyrosine to p-coumaric acid and CYP199A2 
exhibited higher catalytic activity towards p-coumaric acid than 4-coumarate 3-
hydroxylase (C3H). This was the first report on caffeic acid production using CYP199A2 
and tyrosine, as the initial precursor, and the highest concentration obtained using this 
substrate was 280 mg/L. Additionally, the titers of caffeic acid obtained in this study 
using TAL and C3H genes (180 mg/L) were higher than the ones reported in other studies 
using the same genes. This pathway can be further integrated in other pathways to 
produce more complex plant secondary metabolites. 
After validating the first steps of the pathway where caffeic acid is produced, 
curcuminoids production was tested from carboxylic acids to optimize its final steps. 
Three 4-coumarate-CoA ligase (4CL) enzymes were tested from two different organisms 
and different polyketide synthases (PKSs): curcuminoid synthase (CUS), diketide-CoA 
synthase (DCS) and curcumin synthase 1 (CURS1). The 4CL was identified as the 
limiting step in the production of curcuminoids. Indeed, Le4CL, At4CL2 and At4CL1 
were studied, and only At4CL1 allowed curcuminoids production. CUS also demonstrated 
very low catalytic efficiency. The low titers obtained may be due to the use of plant 
enzymes, which usually are poorly stable in prokaryotes even after codon-optimization. 
DCS and CURS1, on the contrary, were found to produce high concentration of curcumin 
from ferulic acid (70 mg/L). Bisdemethoxycurcumin and demethoxycurcumin were also 
produced, but in lower concentrations, by feeding p-coumaric acid or a mixture of p-
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coumaric acid and ferulic acid, respectively. CURS1 and DCS together with At4CL1 were 
also used to produce curcumin in a bioreactor. The curcuminoids production in a 
bioreactor has never been reported before, and although it was lower than the one 
obtained in shake flasks, the results are promising and can be further optimized.  
Curcuminoids were also produced from tyrosine through the caffeic acid pathway. To 
produce caffeic acid, TAL and C3H were used since this pathway involves fewer 
enzymes. Caffeoyl-CoA O-methyltransferase (CCoAOMT) converted caffeoyl-CoA to 
feruloyl-CoA. Using caffeic acid, p-coumaric acid or tyrosine as a substrate, 3.90 mg/L, 
0.26 mg/L and 0.20 mg/L of curcumin were produced, respectively. This was the first 
report that curcumin was produced in E. coli without the direct supplementation of ferulic 
acid to the culture medium. This alternative pathway where curcumin can be produced 
through caffeic acid represents a significant improvement in the heterologous production 
of curcuminoids using E. coli.  
In order to trigger the in situ gene expression of the biosynthetic pathway, the mechanism 
of heat shock response of E. coli was studied and E. coli heat shock promoters were 
identified by microarray experiments conducted at different temperatures. It was 
concluded that the identified heat shock promoters can have different types of strengths 
due to distinct induction ratios and expression after heat shock. Thus, the promoters 
should be selected taking into account the fine-tuning and optimization of the metabolic 
fluxes of the pathway, and also the final application of the pathway (for example 
industrial or therapeutic). The promoters of the genes ibpA, dnaK and fxsA were selected 
due to their different strengths. Afterwards, they were successfully validated by RT-qPCR 
and used to construct and characterize stress probes using green fluorescence protein. In 
this work it was demonstrated that testing and optimizing the ribosome binding site 
(RBS) is important to obtain a translational efficiency that balances the transcription 
levels previously verified by microarrays and RT-qPCR, to obtain the expected results in 
the production of novel genes or pathways.  
Finally, caffeic acid and curcumin were successfully produced in E. coli using heat shock 
induction from the dnaK promoter. Once again, RBS optimization was found to be 
important to obtain an efficient translation of the genes. By increasing the RBS strength, 
p-coumaric and caffeic acid production increased significantly. TAL, C3H or CYP199A2 
and its redox partners were used to produce p-coumaric and caffeic acids, and the highest 
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caffeic acid titer was 14.41 mg/L. As expected, even the highest titer was lower than 
those obtained using chemical induction in this study, though equivalent to that obtained 
in some other reported experiments using chemical induction. Curcumin production 
reached 0.37 mg/L using At4CL1, DCS and CURS1 and ferulic acid as substrate. 
Although the titer is not very high, it is supposedly within the range required to exert a 
therapeutic effect when applied as a bacterial therapy combined with laser and ultrasound 
treatments.  
In this work, DCS and CURS1 were used in vivo for the first time to produce 
curcuminoids. This is also the first work that demonstrated the construction of a 
biosynthetic pathway for curcumin production from tyrosine. Caffeic acid and curcumin 
production in E. coli induced by chemicals or heat is a process still in its infancy and 
many improvements are required. However, these results are very promising and 
represent the first steps towards their industrial heterologous production or their future 
use in bacterial therapies. 
 
7.2 Suggestions for Future Work  
Although the present work brings new insights to the heterologous production of 
curcuminoids, contributing with a new biosynthetic pathway, additional research is still 
needed. Some of the suggestions that should be taken into consideration for future 
investigations are described below. 
 Codon bias was considered in this study since rare codons in E. coli are often 
abundant in heterologous genes, especially plant genes, and the expression of those 
genes can lead to erroneous or incomplete translation. Although codon-optimization 
was used, this subject should be carefully studied by using other algorithms to further 
improve the results obtained with some genes. In addition, plant enzymes are 
generally poorly stable in prokaryotes even after codon-optimization, mainly due to 
the lack of specific protein folding chaperones and post-translational modifications. It 
is also possible that some rare codons are necessary to provoke a pause in the 
ribosome processing which allows the correct folding of the protein. These stability 
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issues can be solved for example by co-expression of additional chaperones to aid in 
the protein folding. 
 The enzymes At4CL1 and CUS should be characterized in vitro since the results 
obtained in this study do not corroborate the results previously published relative to 
their substrate specificities. More information is needed about their catalytic 
properties to be easier to control the curcuminoids production ratios. Also, other 
genes, like CURS2 and CURS3, should be tested to evaluate if an improvement in 
the curcuminoids production can be achieved. New genes encoding potential type III 
PKS curcumin/curcuminoid synthases, such as WtPKS1, WtPKS2 and ClPKS1, also 
need to be studied and characterized through in vitro and in vivo assays. Since 4CL 
represents the limiting step of curcuminoids production, alternatives for 4CLs with 
known specificities should also be tested.  
 Although it was possible to achieve a high production of curcumin, it would be 
interesting to study curcuminoids production using overexpressed ACC enzyme to 
evaluate if increasing intracellular malonyl-CoA pool leads to an increase of the 
curcuminoids titer. Other strategies used to increase acetyl-CoA production or 
malonate synthase and transportation can also be considered to increase malonyl-
CoA availability. 
 So far, curcuminoids production involves two separate cultivation steps to 
compensate the metabolic burden associated with protein overexpression and poor 
growth observed in minimal medium. Although this strategy is feasible at laboratory 
scale, in a bioreactor the separation of biomass is much more difficult and expensive, 
thus new strategies ought to be tested. Robust strains able to produce curcuminoids in 
a single medium still have to be developed. The use of potassium phosphate buffer or 
MOPS with glucose or glycerol should be tested since they presented good results in 
the production of similar compounds. 
 In the future, the development of E. coli tyrosine overproducing strains capable of 
converting glucose or other simple carbon sources to curcuminoids represents an 
important strategy for the engineering process.  
 In this work, it became obvious that the layout of the genes and operons in the 
plasmid, as well as the use of different plasmids had an enormous impact on gene 
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expression. However, all this information serves only as a starting point to study gene 
expression and protein functionality because, in the future, the pathway should be 
integrated into the genome. This can dramatically influence the expression level of 
the heterologous genes. However, the promoter and RBS strength can be adapted, as 
well as the stability of the mRNA and the resulting protein. This genome integration 
is important when eliminating the need to use antibiotics that are not desirable in the 
waste effluents or in products intended for human use. The use of antibiotics in 
bacterial therapies is even less desired since these may be required to eliminate the 
bacteria when necessary. 
 When E. coli is considered as a host for the in situ production of curcuminoids in 
bacterial therapies, other RBSs, induction times, oscillatory inductions, heat shock 
temperatures, temperature up-shift profiles and post-induction temperatures should 
be tested to obtain higher titers or to replicate the human body conditions. In the 
future, the two pathways still have to be connected to produce curcuminoids from 
tyrosine using heat shock. In addition to produce curcuminoids, E. coli should have 
the ability to invade mammalian cells and then undergo lysis to release the 
curcuminoids. 
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Appendix A: DNA Sequences of the Codon-Optimized Genes 
The DNA sequences of the codon-optimized genes used in this study (TAL, C3H, CYP199A2, CCoAOMT, At4CL1, At4CL2, CUS, DCS 
and CURS1) are in Table A1. These genes were synthesized in GenScript and NZYTech and sequenced. 
Table A1. Gene sequences of TAL, C3H, CYP199A2, Le4CL1, At4CL2, CCoAOMT, CUS, DCS and CURS1 with codon-optimization. 
Gene Sequence 
TAL 
(Rhodotorula 
glutinis) 
ATGGCTCCGCGTCCGACCTCGCAATCCCAAGCTCGCACCTGCCCGACCACCCAAGTTACCCAAGTTGACATCGTTGAAAAAATGCTGGCGGCGCCGACCGATTCGACGCTGG
AACTGGACGGCTATAGCCTGAACCTGGGTGATGTGGTTTCTGCAGCACGTAAAGGTCGTCCGGTGCGTGTTAAAGATTCAGACGAAATTCGCTCGAAAATCGATAAAAGCGT
GGAATTTCTGCGTAGCCAGCTGAGCATGTCTGTTTACGGCGTCACCACGGGTTTCGGCGGTTCAGCCGATACCCGCACGGAAGACGCCATTTCGCTGCAGAAAGCACTGCTG
GAACATCAACTGTGCGGCGTGCTGCCGAGCTCTTTTGATAGCTTCCGCCTGGGCCGTGGTCTGGAAAACTCTCTGCCGCTGGAAGTCGTGCGTGGTGCAATGACCATCCGTGT
TAATTCCCTGACGCGCGGTCATTCAGCTGTCCGTCTGGTTGTCCTGGAAGCGCTGACCAACTTTCTGAATCACGGTATTACGCCGATCGTGCCGCTGCGTGGTACCATTAGTG
CATCCGGTGATCTGAGCCCGCTGTCTTATATTGCAGCTGCGATCTCTGGCCACCCGGACAGTAAAGTTCATGTGGTTCACGAGGGTAAAGAAAAAATCCTGTACGCCCGTGA
AGCTATGGCGCTGTTCAACCTGGAACCGGTCGTGCTGGGCCCGAAAGAAGGCCTGGGTCTGGTGAATGGTACGGCTGTTTCAGCGTCGATGGCCACCCTGGCACTGCATGAT
GCCCACATGCTGAGCCTGCTGAGCCAGTCTCTGACCGCGATGACGGTCGAAGCGATGGTGGGCCATGCAGGTAGCTTTCATCCGTTCCTGCACGATGTGACCCGTCCGCACC
CGACGCAGATTGAAGTTGCAGGCAACATCCGCAAACTGCTGGAAGGTAGCCGTTTTGCGGTGCATCACGAAGAAGAAGTGAAAGTGAAAGATGACGAAGGCATTCTGCGCC
AGGATCGTTATCCGCTGCGTACCAGTCCGCAATGGCTGGGTCCGCTGGTCTCCGACCTGATTCATGCCCACGCAGTGCTGACCATCGAAGCGGGTCAGAGTACCACGGATAA
CCCGCTGATTGACGTGGAAAATAAAACCTCTCATCACGGCGGTAACTTTCAAGCCGCAGCTGTTGCCAATACGATGGAAAAAACGCGCCTGGGCCTGGCACAGATCGGTAA
ACTGAATTTCACCCAACTGACGGAAATGCTGAACGCAGGCATGAATCGTGGTCTGCCGAGCTGCCTGGCAGCAGAAGATCCGAGTCTGTCCTATCATTGTAAAGGCCTGGAC
ATTGCAGCTGCGGCCTACACCTCTGAACTGGGTCATCTGGCGAACCCGGTTACCACGCACGTCCAGCCGGCTGAAATGGCGAACCAAGCCGTGAATTCCCTGGCACTGATCT
CAGCTCGTCGCACCACGGAATCGAATGATGTCCTGAGCCTGCTGCTGGCGACCCATCTGTATTGTGTTCTGCAGGCTATTGACCTGCGCGCGATCGAATTTGAATTCAAAAA
ACAGTTTGGCCCGGCTATTGTGAGCCTGATCGATCAACACTTCGGCTCTGCCATGACCGGTAGTAACCTGCGTGACGAACTGGTGGAAAAAGTTAATAAAACGCTGGCCAAA
CGCCTGGAACAGACCAACAGTTACGATCTGGTGCCGCGTTGGCATGACGCATTTTCCTTCGCAGCTGGTACGGTTGTCGAAGTTCTGAGTTCCACCTCACTGTCGCTGGCGGC
CGTCAATGCCTGGAAAGTGGCAGCTGCGGAAAGTGCAATTTCCCTGACCCGCCAAGTGCGTGAAACGTTTTGGTCAGCAGCATCGACGTCATCGCCGGCACTGAGCTATCTG
TCTCCGCGCACCCAAATTCTGTACGCTTTTGTTCGTGAAGAACTGGGCGTCAAAGCGCGTCGCGGCGATGTTTTCCTGGGTAAACAGGAAGTGACCATCGGTAGTAATGTTTC
CAAAATCTATGAAGCTATCAAAAGCGGTCGTATCAATAATGTGCTGCTGAAAATGCTGGCATAA 
C3H 
(Saccharothrix 
espanaensis) 
ATGACGATTACCTCTCCGGCACCGGCTGGTCGCCTGAACAATGTCCGCCCGATGACGGGTGAAGAATACCTGGAATCCCTGCGTGACGGCCGTGAAGTGTATATTTACGGTG
AACGCGTCGATGACGTGACCACGCATCTGGCGTTCCGCAACAGCGTTCGTTCTATCGCCCGCCTGTATGATGTCCTGCACGACCCGGCATCCGAAGGTGTTCTGCGTGTCCCG
ACCGATACGGGTAATGGTGGTTTTACCCATCCGTTTTTCAAAACGGCGCGTAGCTCTGAAGACCTGGTGGCGGCCCGTGAAGCCATTGTCGGCTGGCAACGCCTGGTGTATG
GCTGGATGGGTCGTACCCCGGATTACAAAGCAGCGTTTTTCGGTACGCTGGACGCTAACGCGGAATTTTATGGCCCGTTCGAAGCCAATGCACGTCGCTGGTATCGTGATGC
ACAGGAACGCGTTCTGTACTTCAACCATGCTATCGTTCACCCGCCGGTCGATCGTGACCGTCCGGCTGATCGTACCGCAGACATTTGCGTCCATGTGGAAGAAGAAACGGAT
TCAGGCCTGATCGTGTCGGGTGCCAAAGTGGTTGCAACCGGTTCTGCTATGACGAACGCGAATCTGATTGCCCACTATGGTCTGCCGGTTCGCGATAAAAAATTTGGCCTGG
TGTTCACCGTTCCGATGAACAGTCCGGGTCTGAAACTGATCTGTCGTACCTCCTATGAACTGATGGTGGCCACGCAGGGCTCACCGTTTGATTACCCGCTGAGTTCCCGCCTG
GATGAAAATGACAGCATTATGATCTTTGATCGTGTTCTGGTCCCGTGGGAAAACGTTTTCATGTACGACGCAGGCGCGGCCAATAGCTTTGCTACCGGCTCTGGTTTCCTGGA
ACGCTTTACCTTCCATGGTTGCACGCGTCTGGCAGTGAAACTGGATTTTATTGCAGGCTGTGTTATGAAAGCTGTGGAAGTTACCGGCACCACGCACTTCCGCGGTGTTCAGG
CGCAAGTCGGCGAAGTGCTGAACTGGCGTGATGTCTTTTGGGGTCTGTCGGACGCTATGGCGAAAAGTCCGAATTCCTGGGTGGGCGGTAGCGTTCAGCCGAACCTGAATTA
TGGCCTGGCCTACCGCACCTTTATGGGCGTGGGTTATCCGCGTATTAAAGAAATTATCCAGCAAACGCTGGGCTCTGGTCTGATCTACCTGAACTCATCGGCAGCTGATTGGA
AAAATCCGGACGTTCGCCCGTATCTGGATCGTTACCTGCGCGGCAGTCGTGGTATTCAGGCAATCGATCGTGTCAAACTGCTGAAACTGCTGTGGGACGCAGTGGGTACCGA
ATTCGCAGGTCGTCATGAACTGTATGAACGCAACTACGGCGGTGATCACGAAGGTATTCGTGTGCAGACCCTGCAAGCCTATCAGGCAAATGGTCAAGCGGCCGCACTGAA
AGGCTTTGCGGAACAGTGTATGTCGGAATATGACCTGGATGGCTGGACCCGCCCGGACCTGATTAACCCGGGCACGTAA 
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Table A1. Gene sequences of TAL, C3H, CYP199A2, Le4CL1, At4CL2, CCoAOMT, CUS, DCS and CURS1 with codon-optimization (continuation). 
Gene Sequence 
CYP199A2  
(Rhodopseudomonas 
palustris) 
ATGACGACCGCTCCGAGCCTGATGCCGGTTACGACGCCGTCTCAACATGGTGCTGGTGTGCCGCATCTGGGTATCGACCCGTTCGCACTGGATTATTTTGCAGACCCGT
ACCCGGAACAGGAAACGCTGCGTGAAGCGGGTCCGGTGGTTTATCTGGATAAATGGAACGTTTACGGCGTCGCCCGCTATGCAGAAGTGTACGCGGTTCTGAATGATC
CGCTGACCTTTTGCAGCTCTCGTGGCGTGGGTCTGTCAGACTTCAAAAAAGAAAAACCGTGGCGCCCGCCGTCGCTGATTCTGGAAGCTGATCCGCCGGCACATACGC
GTACCCGTGCTGTCCTGTCAAAAGTGCTGTCGCCGGCGACCATGAAACGTCTGCGCGATGGTTTTGCGGCCGCAGCTGATGCCAAAATCGACGAACTGCTGGCACGTG
GCGGTAACATTGATGCTATCGCGGACCTGGCCGAAGCATATCCGCTGTCAGTTTTTCCGGATGCCATGGGTCTGAAACAGGAAGGCCGCGAAAATCTGCTGCCGTACG
CTGGTCTGGTCCTGAACGCATTCGGTCCGCCGAATGAACTGCGTCAGAGCGCCATTGAACGCTCTGCACCGCATCAGGCGTATGTTGCGGAACAGTGCCAACGTCCGA
ACCTGGCACCGGGCGGTTTTGGTGCATGTATTCACGCATTCTCCGATACGGGCGAAATCACCCCGGAAGAAGCTCCGCTGCTGGTGCGTAGTCTGCTGTCCGCCGGTCT
GGACACCACGGTGAACGGTATCGCAGCAGCAGTTTACTGCCTGGCCCGCTTTCCGGATGAATTCGCTCGTCTGCGTGCGGACCCGAGCCTGGCCCGTAATGCATTTGA
AGAAGCAGTTCGCTTCGAATCTCCGGTCCAGACGTTTTTCCGTACCACGACCCGCGATGTCGAACTGGCTGGTGCGACCATTGGCGAAGGTGAAAAAGTGCTGATGTT
TCTGGGCAGCGCAAATCGTGACCCGCGTCGCTGGGATGACCCGGATCGTTATGACATCACGCGCAAAACCAGTGGTCATGTTGGCTTCGGTTCCGGCGTTCACATGTG
TGTCGGTCAACTGGTGGCGCGTCTGGAAGGTGAAGTCGTGCTGGCTGCACTGGCACGTAAAGTGGCAGCAATTGAAATCGCAGGCCCGCTGAAACGCCGTTTTAACAA
TACCCTGCGTGGTCTGGAAAGCCTGCCGATTCAACTGACCCCGGCCTGA 
4CL 
(Lithospermum 
erythrorhizon) 
ATGGACACCCAGACCAAAACCGACCAGAAAGACATCATCTTCCGTTCTAAACTGCCGGACATCTACATCCCGAAACACCTGCCGCTGCACTCTTACTGCGGTGAAAAC
ATCTCTCAGTTCTCTTCTCGTCCGTGCCTGATCAACGGTTCTAATGATCGTGTATACACCTACGCAGAAGTTGAAATCACCTCTCGTAAAGTTGCTGCTGGTCTGCACAA
ACACGGTATCAAACAGACCGAAACCATCATGCTGCTGCTGCCGAACTGCCCGGAATTCGTTTTCGCTTTCCTGGGTGCTTCTTACATCGGTGCTGTTTCTACCACCGCT
AACCCGTTCTTCACCTCTTCTGAAATCATCAAACAGGCTAAAGCTTCTAAAACCAAACTGATCATCACCGTTTCTACCACCGTTCCGAAACTGAAAGACTTCTCTCAGG
AAAACCACGTTAAAATCATGTGCATCGACGACAAAATCGACGGTTGCCTGCACTTCTCTTCTGACCTGGAAAACTCTGACGAAACCACCCTGCCGGACGTTGAAATCC
GTCCGGACGACGTTGTTGCTCTGCCGTACTCTTCTGGTACCACCGGCCTGCCGAAAGGTGTTATGCTGACCCACAAAGGTCTGGTTACCTCTGTTGCTCAGCAGGTTGA
CGGTGACAACGCTAACCTGTACATGCACCACGAAGACGTTGTTATGTGCACCCTGCCGCTGTTCCACATCTACTCTATGAACTCTATCCTGCTGTGCGGTCTGCGTGTT
GGTGCTGCTATCCTGCTGATGCACAAATTCGAAATCGTTACCTTCCTGGAACTGATCCAGCGTTACAAAGTTACCATCGGTCCATTCGTTCCGCCGATCGTTCTGGCTAT
CGCTAAATCTAACGTTGTTGACCAGTACGACCTGTCTACCGTTCGTACCGTTATGTCTGGTGCTGCTCCGCTGGGTTCTGAACTGGAAGACGCTGTTCGTGCTAAATTCC
CGAACGCTAAACTGGGTCAGGGTTACGGTATGACCGAAGCTGGTCCGGTTCTCGCTATGTGCCTGGCGTTCGCTAAAGAACCATTCGAAATCAAATCTGGTGCTTGCG
GTACCGTTGTTCGTAACTCTGAAATGAAAATCATCGACACCGAAACCGGCGCTTCTCTGCCGCGTAACCAGTCTGGTGAAATCTGCATCCGTGGTGACCAGATCATGA
AAGGTTACCTGAACGACCCGGAAGCTACCGAACGTACCATCGACAAAGAAGGTTGGCTGCACACCGGCGACATCGGTTACATCGACGACGACGACGAACTGTTCATC
GTTGACCGTCTGAAAGAACTGATCAAATACAAAGGTTTCCAGGTTGCTCCGCCGGAACTGGAAGCTCTGCTGGTTCCACATCCGAACGTAAGCGACGCTGCTGTTGTT
TCTATGAAAGACGAAGGTGCTGGTGAAGTTCCGGTTGCTTTCGTTGTTCGTTCTAACGGTTCTACCACCACCGAAGACGAAATCAAACAGTTCGTTTCTAAACAGGTTA
TCTTCTACAAACGTATCAACCGTGTTTTCGGTGTTGACTCTATCCCGAAATCTCCGTCTGGTAAAATCGTTCGTAAAGACCTGCGTGCTAAACTGGCTGCTCGTTTCCTG
AACGGTCCAACCACCAACGTTGTTCCGAACGGTGGTAACGTTGCTAAAGACAACGTTCCAAATGGTGTAAGCAACGGTGTTTCTAAAGCTAACGGTGGTGTTGCTAAA
GAAGGTGTTGCTAACGGTGTTCCGACCGACGGTGACTACGGTGTTGCTACCAAAGGTGTTGCTAACGGTATCTCTAACGGTGTTTACAAACAGGTTTCTAACGGTGTTG
TTTCTAACGGTGTTGCTAACGGTATCGTTTCTAACGGTATCGCTAACGGTGTTCACAACTAA 
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Table A1. Gene sequences of TAL, C3H, CYP199A2, Le4CL1, At4CL2, CCoAOMT, CUS, DCS and CURS1 with codon-optimization (continuation). 
Gene Sequence 
4CL2 
(Arabidopsis 
thaliana) 
ATGACCACGCAAGATGTGATTGTGAATGACCAGAATGACCAGAAACAGTGTAGTAATGATGTGATTTTTCGTAGCCGCCTGCCGGACATTTATATCCCGAACCATCTGCCGC
TGCACGATTACATCTTCGAAAACATCTCTGAATTCGCGGCCAAACCGTGCCTGATTAACGGTCCGACCGGCGAAGTGTATACGTACGCGGATGTTCATGTCACCTCTCGTAAA
CTGGCAGCTGGTCTGCATAACCTGGGCGTTAAACAGCACGATGTGGTTATGATCCTGCTGCCGAATAGTCCGGAAGTCGTGCTGACCTTTCTGGCGGCCTCCTTCATTGGCGC
AATCACCACGTCAGCTAACCCGTTTTTCACCCCGGCGGAAATTTCGAAACAAGCAAAAGCTAGCGCAGCTAAACTGATCGTGACGCAGTCGCGCTACGTTGATAAAATCAAA
AACCTGCAAAACGACGGTGTTCTGATTGTCACCACGGATAGCGACGCCATCCCGGAAAATTGCCTGCGTTTTTCTGAACTGACCCAGAGTGAAGAACCGCGCGTGGATTCTA
TTCCGGAAAAAATCAGTCCGGAAGACGTTGTCGCCCTGCCGTTCAGCTCTGGTACCACGGGCCTGCCGAAAGGCGTGATGCTGACCCATAAAGGTCTGGTGACGTCAGTTGC
ACAGCAAGTTGATGGCGAAAACCCGAATCTGTATTTTAACCGTGATGACGTTATCCTGTGCGTCTGGCCGATGTTCCACATTTACGCACTGAATTCCATCATGCTGTGTTCACT
GCGTATTGGTGCTACCATTCTGATCATGCCGAAATTTGAAATTACGCTGCTGCTGGAACAGATCCAACGCTGTAAAGTGACCGTTGCCATGGTGGTTCCGCCGATTGTGCTGG
CGATCGCCAAAAGTCCGGAAACGGAAAAATATGATCTGAGTTCCGTCCGTATGGTGAAATCTGGTGCGGCCCCGCTGGGCAAAGAACTGGAAGACGCAATTAGTGCTAAAT
TTCCGAACGCAAAACTGGGCCAGGGTTACGGTATGACCGAAGCAGGTCCGGTGCTGGCAATGTCGCTGGGTTTTGCGAAAGAACCGTTCCCGGTTAAAAGCGGTGCATGCGG
TACCGTCGTGCGTAACGCCGAAATGAAAATTCTGGACCCGGACACGGGTGATTCCCTGCCGCGTAATAAACCGGGTGAAATTTGTATCCGCGGCAACCAGATCATGAAAGGT
TATCTGAATGATCCGCTGGCAACCGCTAGCACGATTGATAAAGACGGTTGGCTGCATACCGGTGATGTCGGCTTTATTGATGACGATGACGAACTGTTCATCGTGGACCGCCT
GAAAGAACTGATTAAATACAAAGGCTTTCAGGTGGCGCCGGCCGAACTGGAAAGCCTGCTGATTGGTCACCCGGAAATCAATGATGTTGCGGTTGTCGCCATGAAAGAAGA
AGACGCAGGCGAAGTCCCGGTGGCTTTCGTGGTTCGTTCAAAAGATTCGAACATTAGCGAAGACGAAATCAAACAGTTTGTTTCCAAACAAGTCGTGTTCTATAAACGCATC
AACAAAGTCTTTTTCACCGATTCAATCCCGAAAGCGCCGAGCGGTAAAATCCTGCGTAAAGATCTGCGTGCCCGTCTGGCTAATGGTCTGATGAACTGA 
CCoAOMT 
(Medicago 
sativa) 
ATGGCTACGAATGAAGACCAGAAACAGACGGAATCAGGCCGCCACCAAGAAGTCGGTCACAAATCACTGCTGCAATCAGATGCGCTGTATCAGTACATTCTGGAAACGAGC
GTCTTTCCGCGTGAACATGAAGCTATGAAAGAACTGCGCGAAGTGACCGCGAAACACCCGTGGAACATCATGACCACGAGCGCTGATGAAGGCCAATTCCTGTCTATGCTG
CTGAAACTGATTAACGCGAAAAATACCATGGAAATCGGCGTGTATACGGGTTACAGCCTGCTGGCAACCGCACTGGCAATTCCGGAAGACGGTAAAATTCTGGCCATGGAT
ATCAACAAAGAAAACTACGAACTGGGCCTGCCGGTTATCAAAAAAGCCGGTGTCGACCATAAAATCGATTTTCGTGAAGGCCCGGCACTGCCGGTTCTGGACGAAATGATC
AAAGATGAGAAAAACCATGGTAGTTACGATTTCATCTTCGTCGATGCGGACAAAGATAACTATCTGAATTACCACAAACGCCTGATTGACCTGGTCAAAGTGGGCGGTGTGA
TCGGCTATGATAACACGCTGTGGAATGGTTCCGTGGTTGCACCGCCGGACGCACCGCTGCGTAAATACGTGCGTTATTACCGCGATTTCGTTCTGGAACTGAATAAAGCTCT
GGCGGTTGATCCGCGCATTGAAATCTGTATGCTGCCGGTGGGTGACGGTATTACCATCTGTCGTCGTATTAAATGA 
CUS 
(Oryza sativa) 
ATGGCTCCGACCACGACGATGGGTTCCGCTCTGTATCCGCTGGGTGAAATGCGCCGTAGTCAACGCGCCGATGGCCTGGCAGCAGTCCTGGCCATTGGCACCGCAAACCCGC
CGAATTGCGTTACGCAGGAAGAAATCCCGGATTTTTATTTCCGCGTCACCAACAGCGACCATCTGACGGCCCTGAAAGACAAGTTCAAACGTATTTGTCAGGAAATGGGTGT
GCAACGTCGCTACCTGCATCACACCGAAGAAATGCTGAGCGCGCACCCGGAATTTGTCGATCGTGACGCCCCGTCTCTGGATGCACGTCTGGACATTGCCGCGGATGCCGTT
CCGGAACTGGCAGCTGAAGCGGCCAAAAAGGCCATTGCAGAATGGGGCCGTCCGGCAGCTGATATCACCCATCTGGTGGTTACCACGAATAGTGGCGCGCACGTGCCGGGT
GTTGATTTTCGCCTGGTGCCGCTGCTGGGTCTGCGCCCGTCCGTTCGTCGCACGATGCTGCATCTGAATGGTTGCTTTGCGGGTTGTGCCGCCCTGCGTCTGGCTAAAGATCTG
GCGGAAAATTCTCGTGGCGCACGCGTGCTGGTCGTGGCAGCTGAACTGACCCTGATGTATTTTACGGGCCCGGATGAAGGTTGCTTCCGCACCCTGCTGGTGCAGGGTCTGT
TTGGTGATGGTGCGGCGGCAGTTATTGTCGGTGCTGATGCGGATGACGTTGAACGTCCGCTGTTCGAAATCGTCTCAGCTGCGCAGACCATTATCCCGGAATCGGACCATGC
ACTGAACATGCGTTTTACGGAACGTCGCCTGGATGGTGTCCTGGGTCGCCAAGTGCCGGGTCTGATTGGTGACAACGTGGAACGTTGTCTGCTGGATATGTTTGGTCCGCTGC
TGGGCGGTGACGGCGGTGGCGGTTGGAATGACCTGTTTTGGGCGGTCCACCCGGGTAGCTCTACCATTATGGATCAGGTGGATGCGGCACTGGGCCTGGAACCGGGCAAGC
TGGCTGCGAGTCGTCGCGTGCTGTCCGACTACGGCAATATGAGCGGTGCTACGGTTATCTTTGCGCTGGATGAACTGCGTCGCCAACGCAAAGAAGCCGCAGCTGCGGGTGA
ATGGCCGGAACTGGGTGTTATGATGGCCTTTGGTCCGGGTATGACGGTTGATGCGATGCTGCTGCACGCCACGAGCCATGTGAACTAA 
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Table A1. Gene sequences of TAL, C3H, CYP199A2, Le4CL1, At4CL2, CCoAOMT, CUS, DCS and CURS1 with codon-optimization (continuation). 
Gene Sequence 
DCS 
(Curcuma 
longa) 
ATGGAAGCTAACGGTTACCGTATCACCCACTCTGCTGACGGTCCAGCTACCATCCTGGCTATCGGTACCGCTAACCCGACCAACGTTGTTGACCAGAACGCTTACCCGGACTTCT
ACTTCCGTGTTACCAACTCTGAATACCTGCAGGAACTGAAAGCTAAATTCCGTCGTATCTGCGAAAAAGCTGCTATCCGTAAACGTCACCTGTACCTGACCGAAGAAATCCTGCG
TGAAAACCCGTCTCTGCTGGCTCCGATGGCTCCGTCTTTCGACGCTCGTCAGGCTATCGTTGTTGAAGCTGTTCCGAAACTGGCTAAAGAAGCTGCTGAAAAAGCTATCAAAGAA
TGGGGTCGTCCGAAATCTGACATCACCCACCTGGTTTTCTGCTCTGCTTCTGGTATCGACATGCCGGGTTCTGACCTGCAGCTGCTGAAACTGCTGGGTCTGCCGCCGTCTGTTAA
CCGTGTTATGCTGTACAACGTTGGTTGCCACGCTGGTGGTACCGCTCTGCGTGTTGCTAAAGACCTGGCTGAAAACAACCGTGGTGCTCGTGTTCTGGCTGTTTGCTCTGAAGTTA
CCGTTCTGTCTTACCGTGGTCCGCACCCGGCTCACATCGAATCTCTGTTCGTTCAGGCTCTGTTCGGTGACGGTGCTGCTGCTCTGGTTGTTGGTTCTGACCCGGTTGACGGTGTTG
AACGTCCGATCTTCGAAATCGCTTCTGCTTCTCAGGTTATGCTGCCGGAATCTGCTGAAGCTGTTGGTGGTCACCTGCGTGAAATCGGTCTGACCTTCCACCTGAAATCTCAGCTG
CCGTCTATCATCGCTTCTAACATCGAACAGTCTCTGACCACCGCTTGCTCTCCGCTGGGTCTGTCTGACTGGAACCAGCTGTTCTGGGCTGTTCACCCGGGTGGTCGTGCTATCCT
GGACCAGGTTGAAGCTCGTCTGGGTCTGGAAAAAGACCGTCTGGCTGCTACCCGTCACGTTCTGTCTGAATACGGTAACATGCAGTCTGCTACCGTTCTGTTCATCCTGGACGAA
ATGCGTAACCGTTCTGCTGCTGAAGGTCACGCTACCACCGGCGAAGGTCTGGACTGGGGTGTTCTGCTGGGTTTCGGTCCAGGTCTGTCTATCGAAACCGTTGTTCTGCACTCTTG
CCGTCTGAACTAA 
CURS1 
(Curcuma 
longa) 
ATGGCTAACCTGCACGCTCTGCGTCGTGAACAGCGTGCTCAGGGTCCGGCTACCATCATGGCTATCGGTACCGCTACCCCGCCGAACCTGTACGAACAGTCTACCTTCCCGGACT
TCTACTTCCGTGTTACCAACTCTGACGACAAACAGGAACTGAAAAAAAAATTCCGTCGTATGTGCGAAAAAACCATGGTTAAAAAACGTTACCTGCACCTGACCGAAGAAATCC
TGAAAGAACGTCCGAAACTGTGCTCTTACAAAGAAGCTTCTTTCGACGACCGTCAGGACATCGTTGTTGAAGAAATCCCGCGTCTGGCTAAAGAAGCTGCTGAAAAAGCTATCA
AAGAATGGGGTCGTCCGAAATCTGAAATCACCCACCTGGTTTTCTGCTCTATCTCTGGTATCGACATGCCGGGTGCTGACTACCGTCTGGCTACCCTGCTGGGTCTGCCGCTGACC
GTTAACCGTCTGATGATCTACTCTCAGGCTTGCCACATGGGTGCTGCTATGCTGCGTATCGCTAAAGACCTGGCTGAAAACAACCGTGGTGCTCGTGTTCTGGTTGTTGCTTGCGA
AATCACCGTTCTGTCTTTCCGTGGTCCGAACGAAGGTGACTTCGAAGCTCTGGCTGGTCAGGCTGGTTTCGGTGACGGTGCTGGTGCTGTTGTTGTTGGTGCTGACCCGCTGGAAG
GTATCGAAAAACCGATCTACGAAATCGCTGCTGCTATGCAGGAAACCGTTGCTGAATCTCAGGGTGCTGTTGGTGGTCACCTGCGTGCTTTCGGTTGGACCTTCTACTTCCTGAA
CCAGCTGCCGGCTATCATCGCTGACAACCTGGGTCGTTCTCTGGAACGTGCTCTGGCTCCGCTGGGTGTTCGTGAATGGAACGACGTTTTCTGGGTTGCTCACCCGGGTAACTGG
GCTATCATCGACGCTATCGAAGCTAAACTGCAGCTGTCTCCGGACAAACTGTCTACCGCTCGTCACGTTTTCACCGAATACGGTAACATGCAGTCGGCGACCGTCTACTTCGTGA
TGGACGAACTGCGTAAACGTTCTGCTGTTGAAGGTCGTTCTACCACCGGCGACGGTCTGCAGTGGGGTGTTCTGCTGGGTTTCGGTCCAGGTCTGTCTATCGAAACCGTTGTTCTG
CGTTCTATGCCGCTGTAA 
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Appendix B: Heat Shock Promoters  
Table B1. Translation initiation rates (TIR) of ribosome binding site (RBS) of the ibpA, dnaK and fxsA in 
E. coli genome and in the construction of this study. 
 
 
  TIR 
 Promoter and RBS Sequence  ibpA dnaK fxsA 
 Genome 12651.84 5106.49 597.37 
1
st
 
construction  
Promoter described in Eco Cyc (≈ - 60 
region) to start codon of heat shock gene 
1437.04 389.64 542.96 
2
nd
 
construction 
-150 region to start codon of heat shock 
gene 
1437.04 389.64 542.96 
3
rd
 
construction 
-150 region to +23 region of heat shock 
gene 
1998.94 3726.54 597.37 
4
th
 
construction 
-150 region to transcription start + 
calculated RBS with Target TIR set to 
20000 
22373.19 19547.55 18687.32 
5
th
 
construction 
-150 region to transcription start + 
calculated RBS with Target TIR ~: 
278137.45 175751.22 18687.32 
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Table B2. Set of primers for PCR amplification for the five different stress probe constructions (forward 
and reverse primers – FW and REV). 
 
Construction Primers Sequence
a
 
1
st
  
ibpA_P_FW TGCAAAAAAAAGTCCGCTGA 
ibpA_P_REV AATCAATAGCTCCTGAAATCAGC  
dnaK_P_FW GCACAAAAAATTTTTGCATCTCC  
dnaK_P_REV CTAAACGTCTCCACTATATATTCGGT 
fxsA_P_FW CTACCAAAAATAGTTGCGCAAA 
fxsA_P_REV AGGTTTCTCCTGTAATAGCAGC 
2
nd
  
ibpA_ext_FW AAAATAACATCATCATTACGTCG 
ibpA_P_REV AATCAATAGCTCCTGAAATCAGC  
dnaK_ext_FW ATGCCTTGGCTGCGATT 
dnaK_P_REV CTAAACGTCTCCACTATATATTCGGT 
fxsA_ext_FW GAGGATTTCTACCGTAATCTG 
fxsA_P_REV AGGTTTCTCCTGTAATAGCAGC 
3
rd
  
ibpA_ext_FW AAAATAACATCATCATTACGTCG 
ibpA_ext_REV GGGGATAAATCAAAGTTACGC 
dnaK_ext_FW ATGCCTTGGCTGCGATT 
dnaK_ext_REV TCGATACCAATTATTTTACCCATCT 
fxsA_ext_FW GAGGATTTCTACCGTAATCTG 
fxsA_ext_REV GCAATAAAAGGTAACCAGCGC 
4
th
  
ibpA_ext_FW AAAATAACATCATCATTACGTCG 
ibpA_RBS_REV CCCTAATTCCGTTTATGGACCGATGTAAAAATGGGTCTG 
dnaK_ext_FW ATGCCTTGGCTGCGATT 
dnaK_RBS_REV CCTCTTAATTCGAATCTCCT TATTCGGTCATCATGTGGT 
fxsA_ext_FW GAGGATTTCTACCGTAATCTG 
fxsA_RBS_REV TCCCGATCCGTCGTGCTTTCTTTAGCTTATATTGTGGTCATTAG 
5
th
  
ibpA_ext_FW AAAATAACATCATCATTACGTCG 
ibpA_RBS2_REV TCCTTAATAGTTCGCTCGTACGATGTAAAAATGGGTCTG 
dnaK_ext_FW ATGCCTTGGCTGCGATT 
dnaK_RBS2_REV TCCTCGTCTATTCCGACTCCTATTCGGTCATCATGTGGT 
fxsA_ext_FW GAGGATTTCTACCGTAATCTG 
fxsA_RBS_REV TCCCGATCCGTCGTGCTTTCTTTAGCTTATATTGTGGTCATTAG 
a In addition to the sequences presented, all Fw primers have upstream 5’ extension to the restriction site, SphI restriction site and ClaI, 
SacI or ScaI restriction site to help selecting positive colonies. Rev primers have upstream 5’ extension to the restriction site and 
BamHI restriction site 
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Table B3. Heat shock promoter sequences studied. 
Construction Promoter 
Complete sequence inserted in pETduet_GFPmut3b  
between SphI and BamHI restriction sites 
1
st
 
ibpA 
AGTACTTGCAAAAAAAAGTCCGCTGATAAGGCTTGAAAAGTTCAT
TTCCAGACCCATTTTTACATCGTAGCCGATGAGGACGCGCCTGATG
GGTGTTCTGGCTACCTGACCTGTCCATTGTGGAAGGTCTTACATTCT
CGCTGATTTCAGGAGCTATTGATT 
dnaK 
AGTACTGCACAAAAAATTTTTGCATCTCCCCCTTGATGACGTGGTT
TACGACCCCATTTAGTAGTCAACCGCAGTGAGTGAGTCTGCAAAA
AAATGAAATTGGGCAGTTGAAACCAGACGTTTCGCCCCTATTACAG
ACTCACAACCACATGATGACCGAATATATAGTGGAGACGTTTAG 
fxsA 
AGTACTCTACCAAAAATAGTTGCGCAAACATCTTGAAATTTTGCTA
ATGACCACAATATAAGCTAAACGCGATTCGCAACCCATTCAGGTA
GCCGGGGTTAACCGGCTGCTATTACAGGAGAAACCT 
2
nd
 
ibpA 
GAGCTCAAAATAACATCATCATTACGTCGCACTGTGGCGGCTATCG
CACTTTAACGTTTCGTGCTGCCCCCTCAGTCTATGCAATAGACCAT
AAACTGCAAAAAAAAGTCCGCTGATAAGGCTTGAAAAGTTCATTT
CCAGACCCATTTTTACATCGTAGCCGATGAGGACGCGCCTGATGGG
TGTTCTGGCTACCTGACCTGTCCATTGTGGAAGGTCTTACATTCTCG
CTGATTTCAGGAGCTATTGATT 
dnaK 
GAGCTCATGCCTTGGCTGCGATTCATTCTTTATATGAATAAAATTG
CTGTCAATTTTACGTCTTGTCCTGCCATATCGCGAAATTTCTGCGCA
AAAGCACAAAAAATTTTTGCATCTCCCCCTTGATGACGTGGTTTAC
GACCCCATTTAGTAGTCAACCGCAGTGAGTGAGTCTGCAAAAAAA
TGAAATTGGGCAGTTGAAACCAGACGTTTCGCCCCTATTACAGACT
CACAACCACATGATGACCGAATATATAGTGGAGACGTTTAG 
fxsA 
GAGCTCGAGGATTTCTACCGTAATCTGGATCACTTTAAGTGTCGGT
TTTTACCCCTTAATTATTAATTTGTGAAATAGATCACCGCTTTGGGA
TTACTACCAAAAATAGTTGCGCAAACATCTTGAAATTTTGCTAATG
ACCACAATATAAGCTAAACGCGATTCGCAACCCATTCAGGTAGCC
GGGGTTAACCGGCTGCTATTACAGGAGAAACCT 
3
rd
 
ibpA 
GAGCTCAAAATAACATCATCATTACGTCGCACTGTGGCGGCTATCG
CACTTTAACGTTTCGTGCTGCCCCCTCAGTCTATGCAATAGACCAT
AAACTGCAAAAAAAAGTCCGCTGATAAGGCTTGAAAAGTTCATTT
CCAGACCCATTTTTACATCGTAGCCGATGAGGACGCGCCTGATGGG
TGTTCTGGCTACCTGACCTGTCCATTGTGGAAGGTCTTACATTCTCG
CTGATTTCAGGAGCTATTGATTATGCGTAACTTTGATTTATCCCC 
dnaK 
GAGCTCATGCCTTGGCTGCGATTCATTCTTTATATGAATAAAATTG
CTGTCAATTTTACGTCTTGTCCTGCCATATCGCGAAATTTCTGCGCA
AAAGCACAAAAAATTTTTGCATCTCCCCCTTGATGACGTGGTTTAC
GACCCCATTTAGTAGTCAACCGCAGTGAGTGAGTCTGCAAAAAAA
TGAAATTGGGCAGTTGAAACCAGACGTTTCGCCCCTATTACAGACT
CACAACCACATGATGACCGAATATATAGTGGAGACGTTTAGATGG
GTAAAATAATTGGTATCGA 
fxsA 
GAGCTCGAGGATTTCTACCGTAATCTGGATCACTTTAAGTGTCGGT
TTTTACCCCTTAATTATTAATTTGTGAAATAGATCACCGCTTTGGGA
TTACTACCAAAAATAGTTGCGCAAACATCTTGAAATTTTGCTAATG
ACCACAATATAAGCTAAACGCGATTCGCAACCCATTCAGGTAGCC
GGGGTTAACCGGCTGCTATTACAGGAGAAACCTTTGCGCTGGTTAC
CTTTTATTGC 
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Table B3. Heat shock promoter sequences studied (continuation). 
 
Construction Promoter 
Complete sequence inserted in pETduet_GFPmut3b between SphI and 
BamHI restriction sites 
4
th
 
ibpA 
GAGCTCAAAATAACATCATCATTACGTCGCACTGTGGCGGCTATC
GCACTTTAACGTTTCGTGCTGCCCCCTCAGTCTATGCAATAGACC
ATAAACTGCAAAAAAAAGTCCGCTGATAAGGCTTGAAAAGTTCA
TTTCCAGACCCATTTTTACATCGGTCCATAAACGGAATTAGGG 
dnaK 
GAGCTCATGCCTTGGCTGCGATTCATTCTTTATATGAATAAAATT
GCTGTCAATTTTACGTCTTGTCCTGCCATATCGCGAAATTTCTGC
GCAAAAGCACAAAAAATTTTTGCATCTCCCCCTTGATGACGTGGT
TTACGACCCCATTTAGTAGTCAACCGCAGTGAGTGAGTCTGCAA
AAAAATGAAATTGGGCAGTTGAAACCAGACGTTTCGCCCCTATT
ACAGACTCACAACCACATGATGACCGAATAAGGAGATTCGAATT
AAGAGG 
fxsA 
GAGCTCGAGGATTTCTACCGTAATCTGGATCACTTTAAGTGTCGG
TTTTTACCCCTTAATTATTAATTTGTGAAATAGATCACCGCTTTGG
GATTACTACCAAAAATAGTTGCGCAAACATCTTGAAATTTTGCTA
ATGACCACAATATAAGCTAAAGAAAGCACGACGGATCGGGA 
5
th
 
ibpA 
GAGCTCAAAATAACATCATCATTACGTCGCACTGTGGCGGCTATC
GCACTTTAACGTTTCGTGCTGCCCCCTCAGTCTATGCAATAGACC
ATAAACTGCAAAAAAAAGTCCGCTGATAAGGCTTGAAAAGTTCA
TTTCCAGACCCATTTTTACATCGTACGAGCGAACTATTAAGGA 
dnaK 
GAGCTCATGCCTTGGCTGCGATTCATTCTTTATATGAATAAAATT
GCTGTCAATTTTACGTCTTGTCCTGCCATATCGCGAAATTTCTGC
GCAAAAGCACAAAAAATTTTTGCATCTCCCCCTTGATGACGTGGT
TTACGACCCCATTTAGTAGTCAACCGCAGTGAGTGAGTCTGCAA
AAAAATGAAATTGGGCAGTTGAAACCAGACGTTTCGCCCCTATT
ACAGACTCACAACCACATGATGACCGAATAGGAGTCGGAATAGA
CGAGGA 
